covariateName,conceptId
drug_exposure during day -365 through 0 days relative to index: Protamines 50 MG/ML,36883270
drug_era during day -365 through 0 days relative to index: Protamines,19054245
drug_era group during day -365 through 0 days relative to index: Protamines,19054245
drug_exposure during day -365 through 0 days relative to index: 500 ML Mannitol 150 MG/ML Injection,994095
drug_era group during day -365 through 0 days relative to index: ANTIFIBRINOLYTICS,21601033
drug_era group during day -365 through 0 days relative to index: Antidotes,21605229
drug_exposure during day -365 through 0 days relative to index: Tranexamic Acid 500 MG,1303431
drug_era during day -365 through 0 days relative to index: Tranexamic Acid,1303425
drug_era group during day -365 through 0 days relative to index: Tranexamic Acid,1303425
drug_era group during day -365 through 0 days relative to index: Amino acids,21601034
drug_era during day -365 through 0 days relative to index: Piperacillin,1746114
drug_era group during day -365 through 0 days relative to index: Piperacillin,1746114
drug_exposure during day -365 through 0 days relative to index: Calcium Chloride 40 MMOL/ML / Fibrinogen 106 MG/ML / fibrinolysis inhibitor 3750 UNT/ML / Thrombin (Human) 625 UNT/ML Topical Solution [Tisseel],42543969
drug_era during day -365 through 0 days relative to index: hydroxyethyl starch 130-0.4,43012293
drug_era group during day -365 through 0 days relative to index: hydroxyethyl starch 130-0.4,43012293
drug_era group during day -365 through 0 days relative to index: Penicillins with extended spectrum,21602819
"drug_era group during day -365 through 0 days relative to index: BETA-LACTAM ANTIBACTERIALS, PENICILLINS",21602818
drug_era during day -365 through 0 days relative to index: tazobactam,1741122
drug_era group during day -365 through 0 days relative to index: tazobactam,1741122
drug_era group during day -365 through 0 days relative to index: Beta-lactamase inhibitors,21602858
drug_exposure during day -365 through 0 days relative to index: Thrombin 5000 UNT Injection,42924559
measurement during day -365 through 0 days relative to index: Brachial artery - right Diastolic blood pressure,3001810
measurement during day -365 through 0 days relative to index: Brachial artery - right Systolic blood pressure,3007295
drug_exposure during day -365 through 0 days relative to index: 500 ML hydroxyethyl starch 130-0.4 60 MG/ML Injection,1718296
measurement during day -365 through 0 days relative to index: Brachial artery - left Systolic blood pressure,3004117
measurement during day -365 through 0 days relative to index: Brachial artery - left Diastolic blood pressure,3002785
drug_era during day -365 through 0 days relative to index: Cefazolin,1771162
drug_era group during day -365 through 0 days relative to index: Cefazolin,1771162
drug_era during day -365 through 0 days relative to index: Phenylephrine,1135766
drug_era group during day -365 through 0 days relative to index: Phenylephrine,1135766
drug_era group during day -365 through 0 days relative to index: Sympathomimetics excl. antiglaucoma preparations,21605067
procedure_occurrence during day -365 through 0 days relative to index: Intubation,4202832
"drug_era group during day -365 through 0 days relative to index: Sympathomimetics, plain",21605010
drug_exposure during day -365 through 0 days relative to index: 20 ML Lidocaine 10 MG/ML Injection,43280949
drug_era during day -365 through 0 days relative to index: Mannitol,994058
drug_era group during day -365 through 0 days relative to index: Mannitol,994058
drug_exposure during day -365 through 0 days relative to index: Methylprednisolone 500 MG,35606537
drug_exposure during day -365 through 0 days relative to index: Piperacillin 4000 MG / tazobactam 500 MG Injection,46275444
drug_era group during day -365 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,21605227
drug_era group during day -365 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,21605228
measurement during day -365 through 0 days relative to index: Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE),3024250
drug_exposure during day -365 through 0 days relative to index: Papaverine 30 MG,19084350
measurement during day -365 through 0 days relative to index: Inspiration/Expiration time Ratio,21490724
drug_exposure during day -365 through 0 days relative to index: heparin 5000 UNT,44066055
measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Urine,3007733
measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Urine,3016038
measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Urine,3003181
drug_era group during day -365 through 0 days relative to index: QUINOLONE ANTIBACTERIALS,21603006
drug_era group during day -365 through 0 days relative to index: Fluoroquinolones,21603007
measurement during day -365 through 0 days relative to index: Packed erythrocytes units given [#],3039928
drug_era during day -365 through 0 days relative to index: Papaverine,1326901
drug_era group during day -365 through 0 days relative to index: Papaverine,1326901
drug_era group during day -365 through 0 days relative to index: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,21605009
condition_era group during day -365 through 0 days relative to index: Heart valve disorder,4281749
measurement during day -365 through 0 days relative to index: Fresh frozen plasma given [Volume],3022467
drug_era during day -365 through 0 days relative to index: Dopamine,1337860
drug_era group during day -365 through 0 days relative to index: Dopamine,1337860
drug_era during day -365 through 0 days relative to index: heparin,1367571
drug_era group during day -365 through 0 days relative to index: heparin,1367571
measurement during day -365 through 0 days relative to index: Segmented neutrophils/100 leukocytes in Blood,3017354
drug_exposure during day -365 through 0 days relative to index: 4 ML Acetylcysteine 200 MG/ML Inhalant Solution,43296872
drug_era group during day -365 through 0 days relative to index: NASAL PREPARATIONS,21605008
drug_era during day -365 through 0 days relative to index: Levofloxacin,1742253
drug_era group during day -365 through 0 days relative to index: Levofloxacin,1742253
observation during day -365 through 0 days relative to index: APACHE II (Acute Physiology and Chronic Health Evaluation II) score,35610218
drug_era group during day -365 through 0 days relative to index: Drugs used in erectile dysfunction,21602645
drug_era group during day -365 through 0 days relative to index: VASOPROTECTIVES,21601605
drug_exposure during day -365 through 0 days relative to index: hydroxyethyl starch 130-0.4,43012293
measurement during day -365 through 0 days relative to index: Osmolality of Urine,3026782
drug_era group during day -365 through 0 days relative to index: VASODILATORS USED IN CARDIAC DISEASES,21600315
measurement during day -365 through 0 days relative to index: Pulmonary artery Blood pressure,21490874
drug_era group during day -365 through 0 days relative to index: Organic nitrates,21600316
drug_era during day -365 through 0 days relative to index: Nitroglycerin,1361711
drug_era group during day -365 through 0 days relative to index: Nitroglycerin,1361711
drug_era group during day -365 through 0 days relative to index: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,21601606
drug_era group during day -365 through 0 days relative to index: Muscle relaxants,21601625
drug_exposure during day -365 through 0 days relative to index: 200 ML Dopamine 2 MG/ML / Glucose 50 MG/ML Injectable Solution,42918966
measurement during day -365 through 0 days relative to index: End tidal carbon dioxide concentration,4353938
drug_era group during day -365 through 0 days relative to index: Heparin group,21600972
measurement during day -365 through 0 days relative to index: Inspiratory time setting Ventilator,36304672
drug_era during day -365 through 0 days relative to index: Milrinone,1368671
drug_era group during day -365 through 0 days relative to index: Milrinone,1368671
drug_era group during day -365 through 0 days relative to index: Phosphodiesterase inhibitors,21600306
drug_era during day -365 through 0 days relative to index: Lidocaine,989878
drug_era group during day -365 through 0 days relative to index: Lidocaine,989878
"drug_era group during day -365 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",21602002
"drug_era group during day -365 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",21602003
drug_era group during day -365 through 0 days relative to index: Anesthetics for topical use,21602019
drug_era group during day -365 through 0 days relative to index: THROAT PREPARATIONS,21603215
drug_era group during day -365 through 0 days relative to index: THROAT PREPARATIONS,21603216
"drug_era group during day -365 through 0 days relative to index: Anesthetics, local",21603241
measurement during day -365 through 0 days relative to index: Fresh frozen plasma units given [#],3039106
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the respiratory tract,4180170
procedure_occurrence during day -365 through 0 days relative to index: Transfusion of fresh frozen plasma,4022171
measurement during day -365 through 0 days relative to index: Packed erythrocytes given [Volume],3011477
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of lower respiratory tract,4028876
drug_exposure during day -365 through 0 days relative to index: Thiopental 500 MG,21110393
condition_era group during day -365 through 0 days relative to index: Pneumonitis,253506
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the respiratory system,4162282
drug_exposure during day -365 through 0 days relative to index: Levofloxacin 750 MG,19085063
condition_era group during day -365 through 0 days relative to index: Inflammation of specific body systems,4178818
drug_era group during day -365 through 0 days relative to index: INTESTINAL ANTIINFLAMMATORY AGENTS,21600651
drug_era group during day -365 through 0 days relative to index: Corticosteroids acting locally,21600652
drug_era during day -365 through 0 days relative to index: Thiopental,700253
drug_era group during day -365 through 0 days relative to index: Thiopental,700253
condition_era group during day -365 through 0 days relative to index: Inflammation of specific body organs,4181063
measurement during day -365 through 0 days relative to index: Streptococcus pneumoniae Ag [Presence] in Urine,3011363
measurement during day -365 through 0 days relative to index: Haemodialysis blood flow rate,44802816
drug_exposure during day -365 through 0 days relative to index: Nitroprusside 50 MG,21149472
measurement during day -365 through 0 days relative to index: Other cells/100 leukocytes in Blood by Manual count,3041543
condition_era group during day -365 through 0 days relative to index: Pneumonia,255848
condition_era group during day -365 through 0 days relative to index: Lung consolidation,4318404
condition_occurrence during day -365 through 0 days relative to index: Dissection of aorta,320739
drug_exposure during day -365 through 0 days relative to index: 3000 ML Sodium Chloride 9 MG/ML Injection,35418840
drug_era during day -365 through 0 days relative to index: Ephedrine,1143374
drug_era group during day -365 through 0 days relative to index: Ephedrine,1143374
drug_era group during day -365 through 0 days relative to index: Alpha- and beta-adrenoreceptor agonists,21603303
drug_exposure during day -365 through 0 days relative to index: 2 ML Ipratropium 0.25 MG/ML Inhalant Solution,21126710
drug_era group during day -365 through 0 days relative to index: ADRENERGICS FOR SYSTEMIC USE,21603302
measurement during day -365 through 0 days relative to index: Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,3000593
measurement during day -365 through 0 days relative to index: Airway pressure --during inspiration,21490735
measurement during day -365 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood by Automated count,3007124
drug_era during day -365 through 0 days relative to index: Calcium Gluconate,19037038
drug_era group during day -365 through 0 days relative to index: Calcium Gluconate,19037038
measurement during day -365 through 0 days relative to index: Folate [Mass/volume] in Serum or Plasma,3036987
drug_exposure during day -365 through 0 days relative to index: Fentanyl,1154029
drug_era during day -365 through 0 days relative to index: Multivitamin preparation,36878782
drug_era group during day -365 through 0 days relative to index: Multivitamin preparation,36878782
drug_era during day -365 through 0 days relative to index: Nitroprusside,19020994
drug_era group during day -365 through 0 days relative to index: Nitroprusside,19020994
drug_era group during day -365 through 0 days relative to index: Nitroferricyanide derivatives,21600434
measurement during day -365 through 0 days relative to index: Volume of Dialysis fluid,3023665
condition_era group during day -365 through 0 days relative to index: Vascular disorder,443784
measurement during day -365 through 0 days relative to index: Tidal volume expired Respiratory system airway,21490752
"drug_era group during day -365 through 0 days relative to index: ANESTHETICS, LOCAL",21604220
drug_era group during day -365 through 0 days relative to index: Amides,21604228
measurement during day -365 through 0 days relative to index: Fluid balance 24 hour,3038018
condition_era group during day -365 through 0 days relative to index: Aneurysm of artery of trunk,4103495
drug_exposure during day -365 through 0 days relative to index: sodium phosphate,939871
condition_era group during day -365 through 0 days relative to index: Aortic aneurysm,317585
condition_era group during day -365 through 0 days relative to index: Dilatation of aorta,4132130
drug_era during day -365 through 0 days relative to index: nafamostat mesilate,43009096
drug_era group during day -365 through 0 days relative to index: nafamostat mesilate,43009096
measurement during day -365 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma,3020460
drug_era group during day -365 through 0 days relative to index: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,21603248
drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS,21605199
drug_era group during day -365 through 0 days relative to index: Corticosteroids,21605200
measurement during day -365 through 0 days relative to index: Oxygen equipment,4222965
drug_era group during day -365 through 0 days relative to index: UROLOGICALS,21602628
drug_era during day -365 through 0 days relative to index: prednisolone,1550557
drug_era group during day -365 through 0 days relative to index: prednisolone,1550557
drug_exposure during day -365 through 0 days relative to index: meropenem 500 MG,35605999
measurement during day -365 through 0 days relative to index: Metamyelocytes/100 leukocytes in Blood by Manual count,3000666
measurement during day -365 through 0 days relative to index: Band form neutrophils/100 leukocytes in Blood by Manual count,3007591
measurement during day -365 through 0 days relative to index: Promyelocytes/100 leukocytes in Blood by Manual count,3011587
measurement during day -365 through 0 days relative to index: Myelocytes/100 leukocytes in Blood by Manual count,3018229
measurement during day -365 through 0 days relative to index: Normoblasts [#/volume] in Blood,3021589
measurement during day -365 through 0 days relative to index: Blasts/100 leukocytes in Blood by Manual count,3023643
measurement during day -365 through 0 days relative to index: Variant lymphocytes/100 leukocytes in Blood by Manual count,3037234
measurement during day -365 through 0 days relative to index: Immature cells/100 leukocytes in Blood,40758562
drug_era group during day -365 through 0 days relative to index: CALCIUM,21600858
drug_era group during day -365 through 0 days relative to index: Calcium,21600859
drug_exposure during day -365 through 0 days relative to index: nafamostat mesilate 50 MG Injection,42960686
measurement during day -365 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood by Automated count,3043111
measurement during day -365 through 0 days relative to index: Plateletocrit | Bld-Ser-Plas,40791466
drug_exposure during day -365 through 0 days relative to index: Bisacodyl 5 MG,925043
drug_era during day -365 through 0 days relative to index: Trimethoprim,1705674
drug_era group during day -365 through 0 days relative to index: Trimethoprim,1705674
drug_era during day -365 through 0 days relative to index: Sulfamethoxazole,1836430
drug_era group during day -365 through 0 days relative to index: Sulfamethoxazole,1836430
drug_era group during day -365 through 0 days relative to index: SULFONAMIDES AND TRIMETHOPRIM,21602929
drug_era group during day -365 through 0 days relative to index: Trimethoprim and derivatives,21602930
drug_era group during day -365 through 0 days relative to index: Intermediate-acting sulfonamides,21602944
condition_occurrence during day -365 through 0 days relative to index: Aortic aneurysm,317585
drug_era during day -365 through 0 days relative to index: Rocuronium,19003953
drug_era group during day -365 through 0 days relative to index: Rocuronium,19003953
procedure_occurrence during day -365 through 0 days relative to index: Platelet transfusion,4130829
drug_exposure during day -365 through 0 days relative to index: Sulfamethoxazole / Trimethoprim Oral Tablet,40081388
measurement during day -365 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,3010156
measurement during day -365 through 0 days relative to index: Type of Cardiac pacemaker prosthetic lead by EKG,3017791
drug_era during day -365 through 0 days relative to index: Loperamide,991876
drug_era group during day -365 through 0 days relative to index: Loperamide,991876
drug_era group during day -365 through 0 days relative to index: ANTIPROPULSIVES,21600642
drug_era group during day -365 through 0 days relative to index: Antipropulsives,21600643
drug_era during day -365 through 0 days relative to index: Norepinephrine,1321341
drug_era group during day -365 through 0 days relative to index: Norepinephrine,1321341
measurement during day -365 through 0 days relative to index: Pacing interval Artificial cardiac pacemaker,3024513
drug_exposure during day -365 through 0 days relative to index: Filgrastim,1304850
measurement during day -365 through 0 days relative to index: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,3029187
drug_exposure during day -365 through 0 days relative to index: 4 ML Norepinephrine 1 MG/ML Injection,1321363
measurement during day -365 through 0 days relative to index: Pooled cryoprecipitate given [Volume],40757562
drug_era during day -365 through 0 days relative to index: Nicardipine,1318137
drug_era group during day -365 through 0 days relative to index: Nicardipine,1318137
drug_era during day -365 through 0 days relative to index: smectite,36878752
drug_era group during day -365 through 0 days relative to index: smectite,36878752
drug_exposure during day -365 through 0 days relative to index: Chlorhexidine,1790812
drug_era during day -365 through 0 days relative to index: Carbocysteine,19041843
drug_era group during day -365 through 0 days relative to index: Carbocysteine,19041843
drug_era group during day -365 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,21603071
drug_era group during day -365 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,21603072
drug_exposure during day -365 through 0 days relative to index: Potassium Chloride Topical Powder,40735334
"drug_era group during day -365 through 0 days relative to index: Diazepines, oxazepines, thiazepines and oxepines",21604540
drug_era group during day -365 through 0 days relative to index: ANTITHROMBOTIC AGENTS,21600960
drug_era group during day -365 through 0 days relative to index: ANTITHROMBOTIC AGENTS,21600961
condition_occurrence during day -365 through 0 days relative to index: Septic shock,196236
drug_era during day -365 through 0 days relative to index: moxifloxacin,1716903
drug_era group during day -365 through 0 days relative to index: moxifloxacin,1716903
drug_exposure during day -365 through 0 days relative to index: Omeprazole 40 MG Injection,21161812
drug_era during day -365 through 0 days relative to index: Naproxen,1115008
drug_era group during day -365 through 0 days relative to index: Naproxen,1115008
drug_era group during day -365 through 0 days relative to index: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,21605187
measurement during day -365 through 0 days relative to index: Pooled cryoprecipitate units given [#],40757537
drug_era during day -365 through 0 days relative to index: Azithromycin,1734104
drug_era group during day -365 through 0 days relative to index: Azithromycin,1734104
drug_exposure during day -365 through 0 days relative to index: Loperamide 2 MG,991935
measurement during day -365 through 0 days relative to index: Platelet distribution width,44787151
drug_exposure during day -365 through 0 days relative to index: 50 ML Propofol 10 MG/ML Injection,40220391
drug_exposure during day -365 through 0 days relative to index: Pentastarch,40161354
measurement during day -365 through 0 days relative to index: Amount of exudate,4236818
condition_era group during day -365 through 0 days relative to index: General problem AND/OR complaint,4022830
condition_era group during day -365 through 0 days relative to index: Fatigue,4223659
measurement during day -365 through 0 days relative to index: Airway suction location,3046592
measurement during day -365 through 0 days relative to index: Pooled platelet concentrate units given [#],40757535
condition_occurrence during day -365 through 0 days relative to index: Asthenia,437113
condition_era group during day -365 through 0 days relative to index: Asthenia,437113
condition_era group during day -365 through 0 days relative to index: Neoplasm of hematopoietic cell type,4189640
procedure_occurrence during day -365 through 0 days relative to index: Transfusion of cryoprecipitate,4023918
"drug_era group during day -365 through 0 days relative to index: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",21603395
measurement during day -365 through 0 days relative to index: Color of Sputum,36203862
measurement during day -365 through 0 days relative to index: Body mass index (BMI) [Ratio],3038553
drug_era group during day -365 through 0 days relative to index: Opium alkaloids and derivatives,21603396
condition_era group during day -365 through 0 days relative to index: Malignant tumor of lymphoid hemopoietic and related tissue,4147164
drug_exposure during day -365 through 0 days relative to index: Isosorbide Dinitrate 40 MG Extended Release Oral Tablet,1383988
drug_era during day -365 through 0 days relative to index: Codeine,1201620
drug_era group during day -365 through 0 days relative to index: Codeine,1201620
condition_era group during day -365 through 0 days relative to index: Pain of truncal structure,4116811
drug_era during day -365 through 0 days relative to index: levothyroxine,1501700
drug_era group during day -365 through 0 days relative to index: levothyroxine,1501700
drug_era group during day -365 through 0 days relative to index: THYROID PREPARATIONS,21602752
drug_era group during day -365 through 0 days relative to index: Thyroid hormones,21602753
drug_exposure during day -365 through 0 days relative to index: Triamcinolone,903963
drug_exposure during day -365 through 0 days relative to index: smectite 150 MG/ML Oral Suspension,42959027
drug_era during day -365 through 0 days relative to index: quetiapine,766814
drug_era group during day -365 through 0 days relative to index: quetiapine,766814
condition_occurrence during day -365 through 0 days relative to index: Kidney disorder due to diabetes mellitus,192279
measurement during day -365 through 0 days relative to index: Peak inspiratory flow Respiratory system airway,21490649
drug_exposure during day -365 through 0 days relative to index: 118 ML Hydrocortisone 10 MG/ML Topical Lotion,42919239
drug_era during day -365 through 0 days relative to index: streptococcus faecalis,36879181
drug_era group during day -365 through 0 days relative to index: streptococcus faecalis,36879181
drug_era during day -365 through 0 days relative to index: Bacillus subtilis,42898675
drug_era group during day -365 through 0 days relative to index: Bacillus subtilis,42898675
drug_exposure during day -365 through 0 days relative to index: Morphine Sulfate 10 MG,40169889
drug_era during day -365 through 0 days relative to index: Pentastarch,40161354
drug_era group during day -365 through 0 days relative to index: Pentastarch,40161354
measurement during day -365 through 0 days relative to index: Erythrocytes [#/area] in Urine sediment by Microscopy high power field,3035124
measurement during day -365 through 0 days relative to index: Leukocytes [#/area] in Urine sediment by Microscopy high power field,3035583
drug_era during day -365 through 0 days relative to index: Tobramycin,902722
drug_era group during day -365 through 0 days relative to index: Tobramycin,902722
drug_era group during day -365 through 0 days relative to index: THYROID THERAPY,21602751
condition_era group during day -365 through 0 days relative to index: Diabetic complication,442793
drug_exposure during day -365 through 0 days relative to index: tramadol hydrochloride 150 MG,19134121
drug_exposure during day -365 through 0 days relative to index: Azithromycin 500 MG Injection,35603389
condition_era group during day -365 through 0 days relative to index: Soft tissue lesion,4344497
drug_exposure during day -365 through 0 days relative to index: Albuterol 0.1 MG/ACTUAT,1154496
drug_exposure during day -365 through 0 days relative to index: quetiapine 25 MG Oral Tablet,766820
drug_era group during day -365 through 0 days relative to index: ANTI-DEMENTIA DRUGS,21604792
drug_era group during day -365 through 0 days relative to index: ANTIGLAUCOMA PREPARATIONS AND MIOTICS,21603671
drug_exposure during day -365 through 0 days relative to index: Levetiracetam 100 MG/ML Oral Solution,19102504
condition_occurrence during day -365 through 0 days relative to index: Dyspnea,312437
drug_exposure during day -365 through 0 days relative to index: Sucralfate 66.6999999999999886 MG/ML,42955234
drug_exposure during day -365 through 0 days relative to index: Zolpidem tartrate 6.25 MG,40163503
drug_exposure during day -365 through 0 days relative to index: 100 ML Mannitol 200 MG/ML Injection,21059334
drug_exposure during day -365 through 0 days relative to index: Epinephrine,1343916
condition_era group during day -365 through 0 days relative to index: Vomiting,441408
drug_era group during day -365 through 0 days relative to index: Anticholinesterases,21604793
measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Blood,3000483
drug_era during day -365 through 0 days relative to index: Epinephrine,1343916
drug_era group during day -365 through 0 days relative to index: Epinephrine,1343916
drug_era group during day -365 through 0 days relative to index: Sympathomimetics in glaucoma therapy,21603672
drug_exposure during day -365 through 0 days relative to index: Tobramycin 80 MG,44104083
condition_occurrence during day -365 through 0 days relative to index: Altered mental status,436222
condition_era group during day -365 through 0 days relative to index: Altered mental status,436222
drug_era during day -365 through 0 days relative to index: Pseudoephedrine,1154332
drug_era group during day -365 through 0 days relative to index: Pseudoephedrine,1154332
drug_era group during day -365 through 0 days relative to index: NASAL DECONGESTANTS FOR SYSTEMIC USE,21603207
drug_era group during day -365 through 0 days relative to index: Sympathomimetics,21603208
measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Urine by Automated test strip,40761899
condition_era group during day -365 through 0 days relative to index: Abdominal aortic aneurysm,198177
condition_era group during day -365 through 0 days relative to index: Aneurysm of descending aorta,4140448
condition_era group during day -365 through 0 days relative to index: Abdominal aortic ectasia,37016191
condition_era group during day -365 through 0 days relative to index: Dilatation of descending aorta,40486130
condition_era group during day -365 through 0 days relative to index: Abnormality of abdominal aorta,40491455
drug_exposure during day -365 through 0 days relative to index: Granisetron 1 MG,1000792
drug_era during day -365 through 0 days relative to index: fosaprepitant,35605594
drug_era group during day -365 through 0 days relative to index: fosaprepitant,35605594
measurement during day -365 through 0 days relative to index: Pooled platelets given [Volume],40757561
drug_exposure during day -365 through 0 days relative to index: Ciprofloxacin 500 MG Oral Tablet,19075380
condition_occurrence during day -365 through 0 days relative to index: Vomiting,441408
measurement during day -365 through 0 days relative to index: Cancer Ag 19-9 [Units/volume] in Serum or Plasma,3022914
measurement during day -365 through 0 days relative to index: Nitric oxide [VFr/PPres] Airway adaptor,21490806
drug_exposure during day -365 through 0 days relative to index: Codeine 20 MG,1100337
procedure_occurrence during day -365 through 0 days relative to index: Aspiration of lung lesion,4337040
drug_era during day -365 through 0 days relative to index: Nifedipine,1318853
drug_era group during day -365 through 0 days relative to index: Nifedipine,1318853
drug_era during day -365 through 0 days relative to index: tolterodine,913782
drug_era group during day -365 through 0 days relative to index: tolterodine,913782
drug_exposure during day -365 through 0 days relative to index: fosaprepitant 150 MG Injection,35605599
condition_era group during day -365 through 0 days relative to index: Difficulty breathing,4041664
drug_era during day -365 through 0 days relative to index: Cefixime,1796435
drug_era group during day -365 through 0 days relative to index: Cefixime,1796435
drug_era during day -365 through 0 days relative to index: Metformin,1503297
drug_era group during day -365 through 0 days relative to index: Metformin,1503297
drug_era group during day -365 through 0 days relative to index: Biguanides,21600745
"drug_era group during day -365 through 0 days relative to index: Iron trivalent, oral preparations",21601091
drug_exposure during day -365 through 0 days relative to index: Levothyroxine Sodium 0.1 MG Oral Tablet,40169766
drug_exposure during day -365 through 0 days relative to index: Succinylcholine 50 MG/ML,21032905
condition_era group during day -365 through 0 days relative to index: Fracture of bone of head,4302223
condition_era group during day -365 through 0 days relative to index: Urogenital injury,4155499
drug_exposure during day -365 through 0 days relative to index: Piroxicam Transdermal System,42973740
drug_exposure during day -365 through 0 days relative to index: Donepezil hydrochloride 10 MG Oral Tablet,40223768
condition_era group during day -365 through 0 days relative to index: Gastrointestinal infection,37396146
drug_era during day -365 through 0 days relative to index: Colchicine,1101554
drug_era group during day -365 through 0 days relative to index: Colchicine,1101554
drug_era group during day -365 through 0 days relative to index: TETRACYCLINES,21602797
drug_era group during day -365 through 0 days relative to index: Tetracyclines,21602798
drug_era group during day -365 through 0 days relative to index: Preparations with no effect on uric acid metabolism,21604140
condition_era group during day -365 through 0 days relative to index: Neoplasm of small intestine,4131614
drug_exposure during day -365 through 0 days relative to index: Rifampin 300 MG,1763296
drug_era during day -365 through 0 days relative to index: Saccharomyces boulardii,991855
drug_era group during day -365 through 0 days relative to index: Saccharomyces boulardii,991855
drug_era group during day -365 through 0 days relative to index: ANTIDIARRHEAL MICROORGANISMS,21600667
drug_era group during day -365 through 0 days relative to index: Antidiarrheal microorganisms,21600668
drug_era group during day -365 through 0 days relative to index: Bisphosphonates,21604148
drug_exposure during day -365 through 0 days relative to index: glimepiride 1 MG Oral Tablet,1597761
drug_era group during day -365 through 0 days relative to index: Protein kinase inhibitors,21603771
condition_era group during day -365 through 0 days relative to index: Dyspnea,312437
condition_era group during day -365 through 0 days relative to index: Inflammatory disease of liver,194990
condition_occurrence during day -365 through 0 days relative to index: Stable angina,4119942
condition_era group during day -365 through 0 days relative to index: Stable angina,4119942
drug_era during day -365 through 0 days relative to index: olmesartan,40226742
drug_era group during day -365 through 0 days relative to index: olmesartan,40226742
drug_era during day -365 through 0 days relative to index: Epoetin Alfa,1301125
drug_era group during day -365 through 0 days relative to index: Epoetin Alfa,1301125
drug_era group during day -365 through 0 days relative to index: DRUGS FOR TREATMENT OF BONE DISEASES,21604146
drug_era group during day -365 through 0 days relative to index: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,21604147
measurement during day -365 through 0 days relative to index: Pulmonary artery wedge pressure,21490776
drug_exposure during day -365 through 0 days relative to index: Sugammadex 100 MG/ML Injection,35604514
measurement during day -365 through 0 days relative to index: Activated clotting time (ACT) of Blood by Coagulation assay,3016948
condition_era group during day -365 through 0 days relative to index: Hematologic neoplasm,4044013
condition_era group during day -365 through 0 days relative to index: Neoplasm affecting hematopoietic structure,4212328
condition_era group during day -365 through 0 days relative to index: Neoplasm of duodenum,4131615
condition_era group during day -365 through 0 days relative to index: Mass of duodenum,4142124
condition_era group during day -365 through 0 days relative to index: Small intestinal mass,42596182
drug_exposure during day -365 through 0 days relative to index: Fentanyl 0.05 MG/HR Transdermal System,42903228
drug_exposure during day -365 through 0 days relative to index: Spironolactone 50 MG Oral Tablet,970283
drug_era during day -365 through 0 days relative to index: olanzapine,785788
drug_era group during day -365 through 0 days relative to index: olanzapine,785788
condition_era group during day -365 through 0 days relative to index: Vascular insufficiency,4311420
drug_exposure during day -365 through 0 days relative to index: 300 ACTUAT Ipratropium 0.02 MG/ACTUAT Inhalant Solution,44218199
drug_exposure during day -365 through 0 days relative to index: 30000 MG dexpanthenol 0.05 MG/MG Topical Ointment,43142397
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of digestive system,4190185
drug_exposure during day -365 through 0 days relative to index: moxifloxacin 400 MG Oral Tablet,1716905
drug_era during day -365 through 0 days relative to index: Sugammadex,35604506
drug_era group during day -365 through 0 days relative to index: Sugammadex,35604506
drug_exposure during day -365 through 0 days relative to index: Hyaluronidase 1500 UNT Injection,42481754
condition_era group during day -365 through 0 days relative to index: Lesion of nerve root and/or plexus,43531045
condition_era group during day -365 through 0 days relative to index: Mass of lymphoreticular structure,4116962
condition_era group during day -365 through 0 days relative to index: Neoplasm of liver,4130518
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of liver,4246127
index year: 2004,0
drug_era during day -365 through 0 days relative to index: iron sucrose,1395773
drug_era group during day -365 through 0 days relative to index: iron sucrose,1395773
"drug_era group during day -365 through 0 days relative to index: Iron, parenteral preparations",21601101
drug_exposure during day -365 through 0 days relative to index: Lorazepam 0.5 MG,19082488
drug_exposure during day -365 through 0 days relative to index: gemcitabine 1000 MG,35603173
drug_exposure during day -365 through 0 days relative to index: Ketoprofen Transdermal System,42971876
measurement during day -365 through 0 days relative to index: Devices and restraints Set,3043211
drug_exposure during day -365 through 0 days relative to index: Levofloxacin Injection,46287433
condition_era group during day -365 through 0 days relative to index: Cough,254761
drug_exposure during day -365 through 0 days relative to index: Saccharomyces boulardii 250 MG Oral Capsule,19121591
condition_era group during day -365 through 0 days relative to index: Platelet disorder,4332151
drug_exposure during day -365 through 0 days relative to index: gemcitabine 200 MG,35603170
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of retroperitoneum,198091
drug_era during day -365 through 0 days relative to index: Bisoprolol,1338005
drug_era group during day -365 through 0 days relative to index: Bisoprolol,1338005
measurement during day -365 through 0 days relative to index: PT panel - Platelet poor plasma by Coagulation assay,3045501
condition_era group during day -365 through 0 days relative to index: Gout,440674
condition_era group during day -365 through 0 days relative to index: Blood urate abnormal,4041541
procedure_occurrence during day -365 through 0 days relative to index: Anastomosis of extracranial-intracranial arteries,4139137
condition_era group during day -365 through 0 days relative to index: Blood urate raised,4148593
condition_era group during day -365 through 0 days relative to index: Increased uric acid level,4169747
condition_era group during day -365 through 0 days relative to index: Degenerative disease of the central nervous system,4213310
condition_era group during day -365 through 0 days relative to index: Vascular disease of abdomen,4027369
measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae IgM Ab [Presence] in Serum,3021082
drug_era during day -365 through 0 days relative to index: Cephalothin,19086759
drug_era group during day -365 through 0 days relative to index: Cephalothin,19086759
drug_exposure during day -365 through 0 days relative to index: Pyridostigmine Bromide 5 MG/ML,40173881
condition_era group during day -365 through 0 days relative to index: Hydrocephalus,4043738
condition_occurrence during day -365 through 0 days relative to index: Intracranial tumor,4116092
condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary bladder,197508
condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary tract proper,4180915
condition_occurrence during day -365 through 0 days relative to index: Internal carotid artery stenosis,4121624
condition_era group during day -365 through 0 days relative to index: Internal carotid artery stenosis,4121624
drug_exposure during day -365 through 0 days relative to index: Bacillus subtilis / streptococcus faecalis Extended Release Oral Capsule,42958966
drug_exposure during day -365 through 0 days relative to index: Zolpidem tartrate 5 MG Oral Tablet,40163500
condition_era group during day -365 through 0 days relative to index: Thrombocytopenic disorder,432870
condition_era group during day -365 through 0 days relative to index: Musculoskeletal and connective tissue disorder,4208786
condition_occurrence during day -365 through 0 days relative to index: Skin lesion,4316083
"drug_era group during day -365 through 0 days relative to index: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",21600744
measurement during day -365 through 0 days relative to index: Glucose [Presence] in Urine by Test strip,3009261
measurement during day -365 through 0 days relative to index: Ketones [Presence] in Urine,3028893
measurement during day -365 through 0 days relative to index: Albumin [Presence] in Urine by Test strip,3029937
drug_exposure during day -365 through 0 days relative to index: mosapride 5 MG Oral Powder,42945136
"drug_exposure during day -365 through 0 days relative to index: 250 ML Albumin Human, USP 50 MG/ML Injection",35605895
measurement during day -365 through 0 days relative to index: Passive range of motion panel Quantitative,3032292
drug_era during day -365 through 0 days relative to index: rosuvastatin,1510813
drug_era group during day -365 through 0 days relative to index: rosuvastatin,1510813
condition_occurrence during day -365 through 0 days relative to index: Gout,440674
drug_exposure during day -365 through 0 days relative to index: Digoxin 0.25 MG,1326411
drug_era group during day -365 through 0 days relative to index: Sulfonylureas,21600749
condition_occurrence during day -365 through 0 days relative to index: Intertrochanteric fracture,4133012
condition_era group during day -365 through 0 days relative to index: Intertrochanteric fracture,4133012
condition_era group during day -365 through 0 days relative to index: Chronic liver disease,4212540
drug_exposure during day -365 through 0 days relative to index: Amlodipine 5 MG,1332450
condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary system,4169598
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of urinary organ,40488919
drug_exposure during day -365 through 0 days relative to index: Warfarin 5 MG/ML,21105414
drug_era during day -365 through 0 days relative to index: abciximab,19047423
drug_era group during day -365 through 0 days relative to index: abciximab,19047423
condition_era group during day -365 through 0 days relative to index: Respiratory tract infection,4170143
drug_exposure during day -365 through 0 days relative to index: Bisoprolol Fumarate 2.5 MG Oral Tablet,40166188
drug_exposure during day -365 through 0 days relative to index: Ondansetron 8 MG,1000612
condition_era group during day -365 through 0 days relative to index: Pancreatitis,4192640
condition_era group during day -365 through 0 days relative to index: Hepatitis due to infection,194087
condition_era group during day -365 through 0 days relative to index: Chronic hepatitis,200763
condition_era group during day -365 through 0 days relative to index: Viral hepatitis,4291005
condition_era group during day -365 through 0 days relative to index: Liver disorder due to infection,4341650
drug_exposure during day -365 through 0 days relative to index: flomoxef sodium 500 MG,42961515
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of urinary system,76349
condition_occurrence during day -365 through 0 days relative to index: Bronchopneumonia,256722
condition_era group during day -365 through 0 days relative to index: Bronchopneumonia,256722
measurement during day -365 through 0 days relative to index: Systolic blood pressure,3004249
measurement during day -365 through 0 days relative to index: Diastolic blood pressure,3012888
measurement during day -365 through 0 days relative to index: Body temperature,3020891
measurement during day -365 through 0 days relative to index: Respiratory rate,3024171
measurement during day -365 through 0 days relative to index: Heart rate,3027018
condition_era group during day -365 through 0 days relative to index: Neoplasm of urinary system,79768
drug_exposure during day -365 through 0 days relative to index: 5 ML abciximab 2 MG/ML Injectable Solution,43591572
drug_era during day -365 through 0 days relative to index: glimepiride,1597756
drug_era group during day -365 through 0 days relative to index: glimepiride,1597756
condition_era group during day -365 through 0 days relative to index: Contusion,441737
condition_era group during day -365 through 0 days relative to index: Viral disease,440029
condition_era group during day -365 through 0 days relative to index: Backache,134736
drug_exposure during day -365 through 0 days relative to index: Glucose 333 MG/ML,19088904
measurement during day -365 through 0 days relative to index: Pupillary response Right pupil,21490963
condition_era group during day -365 through 0 days relative to index: Internal injury of abdominal organs,4169252
condition_occurrence during day -365 through 0 days relative to index: Disorder of respiratory system,320136
measurement during day -365 through 0 days relative to index: Mid upper arm circumference,4111666
condition_era group during day -365 through 0 days relative to index: Infective pneumonia,443410
condition_era group during day -365 through 0 days relative to index: Atrioventricular block,316135
drug_era during day -365 through 0 days relative to index: duloxetine,715259
drug_era group during day -365 through 0 days relative to index: duloxetine,715259
condition_era group during day -365 through 0 days relative to index: Atrioventricular conduction disorder,4305210
condition_era group during day -365 through 0 days relative to index: Metastatic malignant neoplasm of viscera,37310458
condition_era group during day -365 through 0 days relative to index: Heart block,320425
drug_exposure during day -365 through 0 days relative to index: cilostazol 50 MG,1350336
drug_era during day -365 through 0 days relative to index: Methoxy polyethylene glycol-epoetin beta,19015768
drug_era group during day -365 through 0 days relative to index: Methoxy polyethylene glycol-epoetin beta,19015768
drug_exposure during day -365 through 0 days relative to index: Dopamine,1337860
drug_era during day -365 through 0 days relative to index: voglibose,43009032
drug_era group during day -365 through 0 days relative to index: voglibose,43009032
condition_era group during day -365 through 0 days relative to index: Conduction disorder of the heart,316999
condition_era group during day -365 through 0 days relative to index: Aphasia,440424
measurement during day -365 through 0 days relative to index: Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay,3019209
condition_era group during day -365 through 0 days relative to index: Chronic viral hepatitis,4012113
condition_occurrence during day -365 through 0 days relative to index: Diabetic foot,4087682
condition_era group during day -365 through 0 days relative to index: Diabetic foot,4087682
condition_era group during day -365 through 0 days relative to index: Vascular disorder of intestine,4134603
condition_era group during day -365 through 0 days relative to index: Soft tissue disorder due to diabetes mellitus,4082346
drug_exposure during day -365 through 0 days relative to index: 250 ML Sodium Chloride 9 MG/ML Injection,40221386
condition_occurrence during day -365 through 0 days relative to index: Secondary malignant neoplasm of liver,198700
condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of liver,198700
measurement during day -365 through 0 days relative to index: aPTT in Blood by Coagulation assay,3013466
measurement during day -365 through 0 days relative to index: Pupil shape [Shape] of Right pupil,21494990
drug_exposure during day -365 through 0 days relative to index: Ginkgo biloba extract 80 MG Oral Tablet,1391915
procedure_occurrence during day -365 through 0 days relative to index: Craniotomy,4101626
condition_era group during day -365 through 0 days relative to index: Traumatic injury,440921
condition_era group during day -365 through 0 days relative to index: Rupture of artery,321886
condition_era group during day -365 through 0 days relative to index: Organic mental disorder,374009
condition_occurrence during day -365 through 0 days relative to index: Cerebral artery occlusion,372924
condition_occurrence during day -365 through 0 days relative to index: Low tension glaucoma,441561
condition_era group during day -365 through 0 days relative to index: Low tension glaucoma,441561
condition_occurrence during day -365 through 0 days relative to index: Acute pulmonary edema,261600
condition_era group during day -365 through 0 days relative to index: Stenosis of precerebral artery,374371
procedure_occurrence during day -365 through 0 days relative to index: Fiberoptic bronchoscopy,4311817
measurement during day -365 through 0 days relative to index: Pupil diameter Right eye Manual,3010321
condition_era group during day -365 through 0 days relative to index: Coma,380834
measurement during day -365 through 0 days relative to index: Assessment for risk of delirium,35610515
measurement during day -365 through 0 days relative to index: Tracheostomy tube diameter,36305611
drug_era during day -365 through 0 days relative to index: Sodium Chloride,967823
drug_era group during day -365 through 0 days relative to index: Sodium Chloride,967823
drug_era group during day -365 through 0 days relative to index: MINERAL SUPPLEMENTS,21600857
drug_era group during day -365 through 0 days relative to index: OTHER MINERAL SUPPLEMENTS,21600884
drug_era group during day -365 through 0 days relative to index: Sodium,21600885
drug_era group during day -365 through 0 days relative to index: Solutions affecting the electrolyte balance,21601160
drug_era group during day -365 through 0 days relative to index: IRRIGATING SOLUTIONS,21601167
drug_era group during day -365 through 0 days relative to index: Salt solutions,21601179
drug_era group during day -365 through 0 days relative to index: I.V. SOLUTION ADDITIVES,21601194
drug_era group during day -365 through 0 days relative to index: Electrolyte solutions,21601195
drug_era group during day -365 through 0 days relative to index: SENSORY ORGANS,21603550
drug_era group during day -365 through 0 days relative to index: OPHTHALMOLOGICALS,21603551
drug_era group during day -365 through 0 days relative to index: OTHER OPHTHALMOLOGICALS,21605125
drug_era group during day -365 through 0 days relative to index: Other ophthalmologicals,21605126
drug_era during day -365 through 0 days relative to index: Metoprolol,1307046
drug_era group during day -365 through 0 days relative to index: Metoprolol,1307046
drug_era during day -365 through 0 days relative to index: Acetylcysteine,1139042
drug_era group during day -365 through 0 days relative to index: Acetylcysteine,1139042
drug_era during day -365 through 0 days relative to index: Morphine,1110410
drug_era group during day -365 through 0 days relative to index: Morphine,1110410
"drug_era group during day -365 through 0 days relative to index: Synthetic anticholinergics, esters with tertiary amino group",21600129
measurement during day -365 through 0 days relative to index: Left ventricular Stroke volume index,21490880
drug_exposure during day -365 through 0 days relative to index: magnesium citrate,967861
procedure_occurrence during day -365 through 0 days relative to index: Laparoscopic procedure,4196958
condition_occurrence during day -365 through 0 days relative to index: Complete atrioventricular block,320744
condition_era group during day -365 through 0 days relative to index: Complete atrioventricular block,320744
condition_era group during day -365 through 0 days relative to index: Apnea,321689
drug_exposure during day -365 through 0 days relative to index: 50 ML Leucovorin 10 MG/ML Injection,21098271
drug_exposure during day -365 through 0 days relative to index: Linagliptin 5 MG Oral Tablet,40239218
condition_occurrence during day -365 through 0 days relative to index: Loss of consciousness,372448
condition_occurrence during day -365 through 0 days relative to index: Abnormal gait,437643
drug_era during day -365 through 0 days relative to index: lafutidine,43009003
drug_era group during day -365 through 0 days relative to index: lafutidine,43009003
condition_occurrence during day -365 through 0 days relative to index: Hospital acquired pneumonia,4143092
condition_era group during day -365 through 0 days relative to index: Hospital acquired pneumonia,4143092
condition_era group during day -365 through 0 days relative to index: Healthcare associated infectious disease,4256893
condition_era group during day -365 through 0 days relative to index: Complication of health care,45772881
drug_era during day -365 through 0 days relative to index: Felodipine,1353776
drug_era group during day -365 through 0 days relative to index: Felodipine,1353776
procedure_occurrence during day -365 through 0 days relative to index: Pure tone audiometry,4091134
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of digestive tract,4043371
condition_era group during day -365 through 0 days relative to index: Appendicitis,440448
condition_era group during day -365 through 0 days relative to index: Acute appendicitis,4310400
drug_exposure during day -365 through 0 days relative to index: glimepiride 4 MG Oral Tablet,1597773
measurement during day -365 through 0 days relative to index: Mini-mental state examination,4169175
condition_era group during day -365 through 0 days relative to index: Musculoskeletal pain,4150129
drug_era during day -365 through 0 days relative to index: Linagliptin,40239216
drug_era group during day -365 through 0 days relative to index: Linagliptin,40239216
condition_era group during day -365 through 0 days relative to index: Spontaneous intracranial hemorrhage,42538062
measurement during day -365 through 0 days relative to index: Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,3003985
measurement during day -365 through 0 days relative to index: Methyl ethyl ketone [Moles/volume] in Serum or Plasma,3029348
measurement during day -365 through 0 days relative to index: Acetoacetate [Moles/volume] in Serum or Plasma,3035526
condition_era group during day -365 through 0 days relative to index: Carotid artery stenosis,442615
drug_exposure during day -365 through 0 days relative to index: Amikacin 500 MG,43135328
drug_era during day -365 through 0 days relative to index: ezetimibe,1526475
drug_era group during day -365 through 0 days relative to index: ezetimibe,1526475
drug_era group during day -365 through 0 days relative to index: Other lipid modifying agents,21601888
condition_era group during day -365 through 0 days relative to index: Blood drug level high,4042074
condition_era group during day -365 through 0 days relative to index: Dementia,4182210
condition_era group during day -365 through 0 days relative to index: Ruptured aneurysm of artery,4049072
"measurement during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Serum or Plasma",3015632
measurement during day -365 through 0 days relative to index: Frailty Index score,37018726
condition_era group during day -365 through 0 days relative to index: Embolism,4185607
drug_era during day -365 through 0 days relative to index: Trimebutine,19005512
drug_era group during day -365 through 0 days relative to index: Trimebutine,19005512
condition_era group during day -365 through 0 days relative to index: Lower respiratory tract infection,4175297
condition_occurrence during day -365 through 0 days relative to index: Dementia,4182210
drug_era group during day -365 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,21600932
drug_era group during day -365 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,21600933
condition_occurrence during day -365 through 0 days relative to index: Asthma,317009
condition_era group during day -365 through 0 days relative to index: Asthma,317009
measurement during day -365 through 0 days relative to index: Theophylline [Mass/volume] in Serum or Plasma,3016072
condition_era group during day -365 through 0 days relative to index: Finding related to ability to move,4270829
drug_era during day -365 through 0 days relative to index: beraprost sodium,43009013
drug_era group during day -365 through 0 days relative to index: beraprost sodium,43009013
condition_era group during day -365 through 0 days relative to index: Infectious disease of lung,4028389
condition_era group during day -365 through 0 days relative to index: Lesion of face,35624868
drug_exposure during day -365 through 0 days relative to index: voglibose 0.299999999999999989 MG Oral Tablet,42961189
drug_exposure during day -365 through 0 days relative to index: Bromhexine 8 MG,19087032
measurement during day -365 through 0 days relative to index: Incontinent voids [#] Urinary tract,21493950
measurement during day -365 through 0 days relative to index: Breath rate setting Ventilator,3007469
condition_era group during day -365 through 0 days relative to index: Dermatophytosis,135473
condition_occurrence during day -365 through 0 days relative to index: Retinopathy due to diabetes mellitus,4174977
condition_era group during day -365 through 0 days relative to index: Paralysis,440377
condition_era group during day -365 through 0 days relative to index: Measurement finding above reference range,40484935
measurement during day -365 through 0 days relative to index: Left ventricular Stroke volume,3036518
drug_era during day -365 through 0 days relative to index: Alprostadil,1381504
drug_era group during day -365 through 0 days relative to index: Alprostadil,1381504
drug_era group during day -365 through 0 days relative to index: Prostaglandins,21600361
condition_occurrence during day -365 through 0 days relative to index: Dyspnea on exertion,4263848
condition_era group during day -365 through 0 days relative to index: Dyspnea on exertion,4263848
drug_era during day -365 through 0 days relative to index: tianeptine,19041910
drug_era group during day -365 through 0 days relative to index: tianeptine,19041910
condition_occurrence during day -365 through 0 days relative to index: Heart failure,316139
"drug_era during day -365 through 0 days relative to index: Insulin, Glulisine, Human",1544838
"drug_era group during day -365 through 0 days relative to index: Insulin, Glulisine, Human",1544838
drug_era group during day -365 through 0 days relative to index: Various alimentary tract and metabolism products,21600951
drug_exposure during day -365 through 0 days relative to index: Warfarin Sodium 2 MG,40163523
"drug_era group during day -365 through 0 days relative to index: LOW-CEILING DIURETICS, EXCL. THIAZIDES",21601489
"drug_era group during day -365 through 0 days relative to index: Sulfonamides, plain",21601490
drug_exposure during day -365 through 0 days relative to index: ebastine 10 MG / Pseudoephedrine 120 MG Extended Release Oral Capsule,42965082
condition_era group during day -365 through 0 days relative to index: Head and neck injury,4154162
condition_era group during day -365 through 0 days relative to index: Finding related to ability to perform gross motor function,4270828
drug_exposure during day -365 through 0 days relative to index: Carboplatin 450 MG Injectable Solution,40930844
drug_era during day -365 through 0 days relative to index: Warfarin,1310149
drug_era group during day -365 through 0 days relative to index: Warfarin,1310149
drug_era group during day -365 through 0 days relative to index: Vitamin K antagonists,21600962
index year: 2016,0
condition_era group during day -365 through 0 days relative to index: Soft tissue infection,4320030
drug_era during day -365 through 0 days relative to index: candesartan,1351557
drug_era group during day -365 through 0 days relative to index: candesartan,1351557
drug_exposure during day -365 through 0 days relative to index: beraprost sodium 0.0200000000000000004 MG,42960522
condition_era group during day -365 through 0 days relative to index: Vertigo,439383
condition_era group during day -365 through 0 days relative to index: Cholecystitis,192956
condition_occurrence during day -365 through 0 days relative to index: Postoperative hemorrhage,4002836
index year: 2008,0
condition_era group during day -365 through 0 days relative to index: Complication associated with device,43021974
measurement during day -365 through 0 days relative to index: Mitral valve Peak A wave by US.doppler,3037723
drug_exposure during day -365 through 0 days relative to index: Urokinase 100000 UNT,21154690
"drug_exposure during day -365 through 0 days relative to index: 10 ML Insulin, Glulisine, Human 100 UNT/ML Injectable Solution",35781940
drug_exposure during day -365 through 0 days relative to index: glimepiride 2 MG / Metformin 500 MG Oral Tablet,42953740
condition_era group during day -365 through 0 days relative to index: Ruptured cerebral aneurysm,4120104
drug_exposure during day -365 through 0 days relative to index: olopatadine 5 MG Oral Tablet,42954552
condition_occurrence during day -365 through 0 days relative to index: Vocal cord paralysis,261599
condition_era group during day -365 through 0 days relative to index: Vocal cord paralysis,261599
condition_era group during day -365 through 0 days relative to index: Paralysis of glottis,4024361
condition_era group during day -365 through 0 days relative to index: Paralysis of larynx,4233244
drug_exposure during day -365 through 0 days relative to index: myrtol,19018433
condition_era group during day -365 through 0 days relative to index: Depressive disorder,440383
measurement during day -365 through 0 days relative to index: Thyrotropin receptor Ab [Units/volume] in Serum,3017044
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of bilateral lower extremities,37109138
drug_era during day -365 through 0 days relative to index: Thioctate,1386670
drug_era group during day -365 through 0 days relative to index: Thioctate,1386670
drug_era during day -365 through 0 days relative to index: Cefadroxil,1769535
drug_era group during day -365 through 0 days relative to index: Cefadroxil,1769535
condition_era group during day -365 through 0 days relative to index: Retinopathy due to diabetes mellitus,4174977
condition_era group during day -365 through 0 days relative to index: Acute ischemic heart disease,319844
condition_era group during day -365 through 0 days relative to index: Infection of skin and/or subcutaneous tissue,201093
condition_era group during day -365 through 0 days relative to index: Infection of skin,4029043
condition_occurrence during day -365 through 0 days relative to index: Malignant tumor of lung,443388
drug_exposure during day -365 through 0 days relative to index: Simvastatin 20 MG,1539465
condition_era group during day -365 through 0 days relative to index: Laceration - injury,443419
condition_era group during day -365 through 0 days relative to index: Gastrointestinal and digestive injury,4106203
condition_era group during day -365 through 0 days relative to index: Acute pulmonary edema,261600
measurement during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood by Pulse oximetry,40762499
drug_era during day -365 through 0 days relative to index: Glucose,1560524
drug_era group during day -365 through 0 days relative to index: Glucose,1560524
drug_era group during day -365 through 0 days relative to index: Solutions for parenteral nutrition,21601154
drug_era group during day -365 through 0 days relative to index: GENERAL NUTRIENTS,21605342
drug_era group during day -365 through 0 days relative to index: OTHER NUTRIENTS,21605348
drug_era group during day -365 through 0 days relative to index: Carbohydrates,21605351
drug_exposure during day -365 through 0 days relative to index: Atenolol 25 MG Oral Tablet,19018811
measurement during day -365 through 0 days relative to index: Pupillary response Left pupil,21491763
condition_era group during day -365 through 0 days relative to index: Acute myocardial infarction,312327
drug_era during day -365 through 0 days relative to index: Bromhexine,19030493
drug_era group during day -365 through 0 days relative to index: Bromhexine,19030493
drug_era during day -365 through 0 days relative to index: atorvastatin,1545958
drug_era group during day -365 through 0 days relative to index: atorvastatin,1545958
measurement during day -365 through 0 days relative to index: Uterus Fundal height Tape measure,3023791
condition_era group during day -365 through 0 days relative to index: Multi-infarct dementia,379778
condition_era group during day -365 through 0 days relative to index: Intracranial artery occlusion with infarction,763168
condition_era group during day -365 through 0 days relative to index: Multi-infarct state,4045742
condition_era group during day -365 through 0 days relative to index: Diffuse cerebrovascular disease,4121341
condition_era group during day -365 through 0 days relative to index: Occlusion of cerebral artery with stroke,43531605
condition_era group during day -365 through 0 days relative to index: Heart failure,316139
drug_exposure during day -365 through 0 days relative to index: Rifampin 600 MG,1763297
condition_occurrence during day -365 through 0 days relative to index: Diabetes mellitus,201820
drug_exposure during day -365 through 0 days relative to index: Metformin hydrochloride 250 MG,40164902
drug_era during day -365 through 0 days relative to index: Levobupivacaine,19098741
drug_era group during day -365 through 0 days relative to index: Levobupivacaine,19098741
condition_era group during day -365 through 0 days relative to index: Urinary tract infectious disease,81902
drug_era group during day -365 through 0 days relative to index: OTHER CARDIAC PREPARATIONS,21600360
drug_era during day -365 through 0 days relative to index: Digoxin,1326303
drug_era group during day -365 through 0 days relative to index: Digoxin,1326303
drug_era group during day -365 through 0 days relative to index: CARDIAC GLYCOSIDES,21601239
drug_era group during day -365 through 0 days relative to index: Digitalis glycosides,21601240
measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in 24 hour Urine,3001349
condition_era group during day -365 through 0 days relative to index: Postoperative hemorrhage,4002836
condition_era group during day -365 through 0 days relative to index: Superficial mycosis,4077081
drug_exposure during day -365 through 0 days relative to index: gabexate mesilate 100 MG,42962864
measurement during day -365 through 0 days relative to index: Follitropin [Units/volume] in Serum or Plasma,3023323
drug_exposure during day -365 through 0 days relative to index: Diltiazem Hydrochloride 30 MG,1328688
drug_era during day -365 through 0 days relative to index: desmopressin,1517070
drug_era group during day -365 through 0 days relative to index: desmopressin,1517070
measurement during day -365 through 0 days relative to index: Cancer Ag 125 [Units/volume] in Serum or Plasma,3037551
condition_era group during day -365 through 0 days relative to index: Cellulitis,435613
condition_era group during day -365 through 0 days relative to index: Abscess of trunk,4176868
measurement during day -365 through 0 days relative to index: Lutropin [Units/volume] in Serum or Plasma,3009214
drug_exposure during day -365 through 0 days relative to index: 1000 ML Glucose 50 MG/ML / Potassium Chloride 0.03 MEQ/ML / Sodium Chloride 4.5 MG/ML Injection,19123352
drug_era during day -365 through 0 days relative to index: Buspirone,733301
drug_era group during day -365 through 0 days relative to index: Buspirone,733301
drug_era during day -365 through 0 days relative to index: Isosorbide,1383815
drug_era group during day -365 through 0 days relative to index: Isosorbide,1383815
drug_era group during day -365 through 0 days relative to index: Azaspirodecanedione derivatives,21604600
drug_era during day -365 through 0 days relative to index: Pheniramine,933952
drug_era group during day -365 through 0 days relative to index: Pheniramine,933952
condition_occurrence during day -365 through 0 days relative to index: Multi-infarct dementia,379778
condition_occurrence during day -365 through 0 days relative to index: Myocardial infarction,4329847
condition_era group during day -365 through 0 days relative to index: Diabetes mellitus,201820
drug_era group during day -365 through 0 days relative to index: VARIOUS,21605212
condition_era group during day -365 through 0 days relative to index: Gastritis,201340
condition_occurrence during day -365 through 0 days relative to index: Urinary tract infectious disease,81902
condition_era group during day -365 through 0 days relative to index: Inflammatory disease of the central nervous system,4190307
measurement during day -365 through 0 days relative to index: Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay,3005307
condition_era group during day -365 through 0 days relative to index: Empyema,4209859
condition_era group during day -365 through 0 days relative to index: Arthropathy of knee joint,4324765
drug_era during day -365 through 0 days relative to index: valsartan,1308842
drug_era group during day -365 through 0 days relative to index: valsartan,1308842
measurement during day -365 through 0 days relative to index: Pupil shape [Shape] of Left pupil,21494473
drug_era during day -365 through 0 days relative to index: Risedronate,1516800
drug_era group during day -365 through 0 days relative to index: Risedronate,1516800
drug_exposure during day -365 through 0 days relative to index: fluticasone 0.5 MG / salmeterol 0.05 MG Dry Powder Inhaler,43181576
condition_era group during day -365 through 0 days relative to index: Cerebral infarction,443454
drug_exposure during day -365 through 0 days relative to index: desmopressin,1517070
procedure_occurrence during day -365 through 0 days relative to index: Speech audiometry,4091138
condition_era group during day -365 through 0 days relative to index: Gastroesophageal reflux disease,318800
condition_occurrence during day -365 through 0 days relative to index: Osteoarthritis of knee,4079750
condition_era group during day -365 through 0 days relative to index: Osteoarthritis of knee,4079750
condition_era group during day -365 through 0 days relative to index: Lesion of genitalia,37110208
drug_era during day -365 through 0 days relative to index: Captopril,1340128
drug_era group during day -365 through 0 days relative to index: Captopril,1340128
condition_occurrence during day -365 through 0 days relative to index: Pulmonary embolism,440417
drug_era group during day -365 through 0 days relative to index: HYPOTHALAMIC HORMONES,21602709
drug_era group during day -365 through 0 days relative to index: Somatostatin and analogues,21602714
drug_exposure during day -365 through 0 days relative to index: pneumococcal capsular polysaccharide type 23F vaccine,40163692
condition_occurrence during day -365 through 0 days relative to index: Gastroesophageal reflux disease,318800
condition_occurrence during day -365 through 0 days relative to index: Hoarse,4177176
condition_era group during day -365 through 0 days relative to index: Hoarse,4177176
condition_era group during day -365 through 0 days relative to index: Infectious disease of genitourinary system,4099350
drug_exposure during day -365 through 0 days relative to index: Mirtazapine 7.5 MG Oral Tablet,19112586
drug_era group during day -365 through 0 days relative to index: POTASSIUM-SPARING AGENTS,21601532
condition_occurrence during day -365 through 0 days relative to index: Intracranial hemorrhage,439847
condition_era group during day -365 through 0 days relative to index: Perforation of large intestine,4119306
measurement during day -365 through 0 days relative to index: Ventilation mode Ventilator,3004921
measurement during day -365 through 0 days relative to index: Inhaled oxygen concentration,3020716
condition_occurrence during day -365 through 0 days relative to index: Suicide attempt,4219484
measurement during day -365 through 0 days relative to index: C peptide [Mass/volume] in Serum or Plasma --baseline,40760490
drug_era during day -365 through 0 days relative to index: Ketamine,785649
drug_era group during day -365 through 0 days relative to index: Ketamine,785649
drug_exposure during day -365 through 0 days relative to index: mequitazine 5 MG,19090530
condition_era group during day -365 through 0 days relative to index: Chronic digestive system disorder,4134593
condition_era group during day -365 through 0 days relative to index: Empyema of pleura,4238808
drug_exposure during day -365 through 0 days relative to index: Dobutamine 250 MG Injection,43290740
measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in 24 hour Urine,3011705
measurement during day -365 through 0 days relative to index: Myoglobin [Mass/volume] in Serum or Plasma,3005895
index year: 2009,0
drug_era during day -365 through 0 days relative to index: Amisulpride,19057607
drug_era group during day -365 through 0 days relative to index: Amisulpride,19057607
drug_era group during day -365 through 0 days relative to index: Benzamides,21604547
condition_era group during day -365 through 0 days relative to index: Postprocedural infection,36712821
condition_occurrence during day -365 through 0 days relative to index: Gastritis,201340
condition_era group during day -365 through 0 days relative to index: Bacterial respiratory infection,4207184
measurement during day -365 through 0 days relative to index: dRVVT actual/normal (normalized LA screen),3010528
drug_era during day -365 through 0 days relative to index: Spironolactone,970250
drug_era group during day -365 through 0 days relative to index: Spironolactone,970250
drug_era group during day -365 through 0 days relative to index: Aldosterone antagonists,21601533
condition_era group during day -365 through 0 days relative to index: Degenerative disorder of muscle,4180012
drug_exposure during day -365 through 0 days relative to index: Ketamine Injection,36890540
condition_occurrence during day -365 through 0 days relative to index: Difficulty passing urine,4010658
condition_era group during day -365 through 0 days relative to index: Difficulty passing urine,4010658
condition_era group during day -365 through 0 days relative to index: Finding related to ability to pass urine,4182138
condition_era group during day -365 through 0 days relative to index: Open wound of head,4243161
condition_era group during day -365 through 0 days relative to index: Open wound of head AND/OR neck,4246695
condition_era group during day -365 through 0 days relative to index: Myocardial lesion,4103192
condition_era group during day -365 through 0 days relative to index: Myocardial infarction,4329847
condition_era group during day -365 through 0 days relative to index: Myocardial necrosis,4354249
condition_era group during day -365 through 0 days relative to index: Dementia associated with another disease,374888
condition_era group during day -365 through 0 days relative to index: Myocardial disease,4239975
drug_era during day -365 through 0 days relative to index: Octreotide,1522957
drug_era group during day -365 through 0 days relative to index: Octreotide,1522957
condition_era group during day -365 through 0 days relative to index: Degenerative disorder of musculoskeletal system,4178680
condition_era group during day -365 through 0 days relative to index: Infective disorder of head,4176944
condition_era group during day -365 through 0 days relative to index: Mass of back,4203098
condition_era group during day -365 through 0 days relative to index: Vascular dementia,443605
measurement during day -365 through 0 days relative to index: Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma,3038136
drug_era during day -365 through 0 days relative to index: flomoxef sodium,43009087
drug_era group during day -365 through 0 days relative to index: flomoxef sodium,43009087
condition_occurrence during day -365 through 0 days relative to index: Ruptured abdominal aortic aneurysm,195559
condition_era group during day -365 through 0 days relative to index: Paralytic syndrome on one side of the body,43531639
drug_exposure during day -365 through 0 days relative to index: Paroxetine Hydrochloride 12.5 MG,35604571
drug_exposure during day -365 through 0 days relative to index: Psyllium,957797
drug_exposure during day -365 through 0 days relative to index: 250 ML Dobutamine 1 MG/ML Injection,19076658
measurement during day -365 through 0 days relative to index: Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma,3041449
drug_exposure during day -365 through 0 days relative to index: 50 ML Sodium Chloride 9 MG/ML Injection,40221384
condition_era group during day -365 through 0 days relative to index: Laceration of head and neck,4155030
condition_era group during day -365 through 0 days relative to index: Laceration of head,4179823
"drug_exposure during day -365 through 0 days relative to index: 3 ML Regular Insulin, Human 100 UNT/ML Pen Injector",42921644
drug_era during day -365 through 0 days relative to index: eperisone hydrochloride,43009085
drug_era group during day -365 through 0 days relative to index: eperisone hydrochloride,43009085
drug_exposure during day -365 through 0 days relative to index: Cefazolin 1000 MG,46287336
measurement during day -365 through 0 days relative to index: Magnesium [Moles/volume] in Serum or Plasma,3012095
drug_exposure during day -365 through 0 days relative to index: 1000 ML Calcium Chloride 0.200000000000000011 MG/ML / Lactate 3.10000000000000009 MG/ML / Potassium Chloride 0.299999999999999989 MG/ML / Sodium Chloride 6 MG/ML Injectable Solution,42918203
measurement during day -365 through 0 days relative to index: Fibrin D-dimer [Units/volume] in Platelet poor plasma,3023361
drug_era group during day -365 through 0 days relative to index: ANTIHEMORRHAGICS,21601032
drug_era group during day -365 through 0 days relative to index: First-generation cephalosporins,21602869
drug_era during day -365 through 0 days relative to index: Lactate,19011035
drug_era group during day -365 through 0 days relative to index: Lactate,19011035
drug_era during day -365 through 0 days relative to index: Calcium Chloride,19036781
drug_era group during day -365 through 0 days relative to index: Calcium Chloride,19036781
drug_era group during day -365 through 0 days relative to index: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,21602360
"drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",21602361
drug_era group during day -365 through 0 days relative to index: Organic acids,21602384
condition_era group during day -365 through 0 days relative to index: Structural disorder of heart,4027255
drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES,21603552
drug_era group during day -365 through 0 days relative to index: Other antiinfectives,21603594
measurement during day -365 through 0 days relative to index: Pentaspan given [Volume],3021829
"measurement during day -365 through 0 days relative to index: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",46236952
measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Urine,3017250
drug_exposure during day -365 through 0 days relative to index: 50 ML Nitroglycerin 1 MG/ML Injection,43701681
measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain,3027744
measurement during day -365 through 0 days relative to index: Breath termination sensitivity setting Ventilator,3046338
measurement during day -365 through 0 days relative to index: Mycobacterium sp identified in Unspecified specimen by Organism specific culture,3005702
drug_exposure during day -365 through 0 days relative to index: Albuterol 2.5 MG/ACTUAT,19100356
drug_era group during day -365 through 0 days relative to index: Osmotically acting laxatives,21600565
"drug_era group during day -365 through 0 days relative to index: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",21600424
condition_era group during day -365 through 0 days relative to index: Pain of cardiovascular structure,4115408
condition_era group during day -365 through 0 days relative to index: Angina pectoris,321318
drug_era group during day -365 through 0 days relative to index: Antiinfectives and antiseptics for local oral treatment,21600011
condition_era group during day -365 through 0 days relative to index: Chest pain,77670
drug_era group during day -365 through 0 days relative to index: Other antiepileptics,21604428
drug_era during day -365 through 0 days relative to index: Calcium polystyrene sulfonate product,19112563
drug_era group during day -365 through 0 days relative to index: Calcium polystyrene sulfonate product,19112563
measurement during day -365 through 0 days relative to index: Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,3044936
condition_occurrence during day -365 through 0 days relative to index: Pneumonia,255848
"drug_era group during day -365 through 0 days relative to index: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",21604847
drug_era group during day -365 through 0 days relative to index: ANTIPROTOZOALS,21604848
drug_era during day -365 through 0 days relative to index: Metronidazole,1707164
drug_era group during day -365 through 0 days relative to index: Metronidazole,1707164
drug_era group during day -365 through 0 days relative to index: Other chemotherapeutics,21602095
drug_era group during day -365 through 0 days relative to index: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,21604849
drug_era group during day -365 through 0 days relative to index: Nitroimidazole derivatives,21604856
drug_era group during day -365 through 0 days relative to index: ANTIHYPERTENSIVES,21600381
drug_exposure during day -365 through 0 days relative to index: Vancomycin 100000 MG,40752945
measurement during day -365 through 0 days relative to index: Blood product.other given [Volume],3025360
condition_era group during day -365 through 0 days relative to index: Heart disease,321588
drug_exposure during day -365 through 0 days relative to index: 2 ML Alfentanil 0.5 MG/ML Injection,35606190
drug_era during day -365 through 0 days relative to index: zolpidem,744740
drug_era group during day -365 through 0 days relative to index: zolpidem,744740
drug_era group during day -365 through 0 days relative to index: Benzodiazepine related drugs,21604653
condition_era group during day -365 through 0 days relative to index: Septic shock,196236
measurement during day -365 through 0 days relative to index: Positive end expiratory pressure setting Ventilator,3022875
drug_era during day -365 through 0 days relative to index: itopride hydrochloride,43009053
drug_era group during day -365 through 0 days relative to index: itopride hydrochloride,43009053
condition_era group during day -365 through 0 days relative to index: Ischemic heart disease,4185932
drug_exposure during day -365 through 0 days relative to index: Acetaminophen 32 MG/ML,1127523
condition_era group during day -365 through 0 days relative to index: Acute infectious disease,4271450
drug_era group during day -365 through 0 days relative to index: BETA BLOCKING AGENTS,21601664
drug_era group during day -365 through 0 days relative to index: BETA BLOCKING AGENTS,21601665
measurement during day -365 through 0 days relative to index: Invasive Diastolic blood pressure,21490851
measurement during day -365 through 0 days relative to index: Invasive Systolic blood pressure,21490853
measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection,3014162
procedure_occurrence during day -365 through 0 days relative to index: CT of brain without contrast,4244986
drug_era during day -365 through 0 days relative to index: darbepoetin alfa,1304643
drug_era group during day -365 through 0 days relative to index: darbepoetin alfa,1304643
drug_era during day -365 through 0 days relative to index: tiropramide,19100759
drug_era group during day -365 through 0 days relative to index: tiropramide,19100759
"drug_era group during day -365 through 0 days relative to index: Synthetic antispasmodics, amides with tertiary amines",21600161
procedure_occurrence during day -365 through 0 days relative to index: CT of chest,4058335
measurement during day -365 through 0 days relative to index: Viscosity of Body fluid,3010190
drug_era during day -365 through 0 days relative to index: Vitamin K 1,19044727
drug_era group during day -365 through 0 days relative to index: Vitamin K 1,19044727
drug_era group during day -365 through 0 days relative to index: VITAMIN K AND OTHER HEMOSTATICS,21601043
drug_era group during day -365 through 0 days relative to index: Vitamin K,21601044
measurement during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,3008152
measurement during day -365 through 0 days relative to index: pH of Arterial blood,3019977
measurement during day -365 through 0 days relative to index: Physical findings of Skin,3013135
measurement during day -365 through 0 days relative to index: Mental status,3018668
measurement during day -365 through 0 days relative to index: Respiration rhythm,3020481
measurement during day -365 through 0 days relative to index: Aldrete scoring system,35610399
measurement during day -365 through 0 days relative to index: Level of responsiveness NEMSIS,40770382
measurement during day -365 through 0 days relative to index: Cytomegalovirus Ag [Presence] in Blood,3036961
drug_era group during day -365 through 0 days relative to index: ANTIGOUT PREPARATIONS,21604128
drug_era group during day -365 through 0 days relative to index: ANTIGOUT PREPARATIONS,21604129
drug_exposure during day -365 through 0 days relative to index: ramosetron hydrochloride Injectable Solution,42960507
drug_era during day -365 through 0 days relative to index: Levetiracetam,711584
drug_era group during day -365 through 0 days relative to index: Levetiracetam,711584
procedure_occurrence during day -365 through 0 days relative to index: MRI of brain with contrast,36717294
drug_era during day -365 through 0 days relative to index: donepezil,715997
drug_era group during day -365 through 0 days relative to index: donepezil,715997
condition_era group during day -365 through 0 days relative to index: Kidney disorder due to diabetes mellitus,192279
measurement during day -365 through 0 days relative to index: Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA),3027206
measurement during day -365 through 0 days relative to index: Apolipoprotein B [Mass/volume] in Serum or Plasma,3014791
drug_exposure during day -365 through 0 days relative to index: Cisplatin 10 MG,40983098
drug_era during day -365 through 0 days relative to index: Alfentanil,19059528
drug_era group during day -365 through 0 days relative to index: Alfentanil,19059528
measurement during day -365 through 0 days relative to index: Signs and symptoms of delirium (from CAM) [CAM.MDSv3],40757758
measurement during day -365 through 0 days relative to index: Disorganized thinking in last 7 days [CAM.CMS],40757760
measurement during day -365 through 0 days relative to index: Altered level of consciousness in last 7 day [CAM.CMS],40757761
measurement during day -365 through 0 days relative to index: Apolipoprotein A-I [Mass/volume] in Serum or Plasma,3008364
condition_occurrence during day -365 through 0 days relative to index: Chronic idiopathic pulmonary fibrosis,45763751
drug_exposure during day -365 through 0 days relative to index: Povidone-Iodine,1750087
drug_era group during day -365 through 0 days relative to index: PERIPHERAL VASODILATORS,21601560
drug_era group during day -365 through 0 days relative to index: PERIPHERAL VASODILATORS,21601561
drug_era during day -365 through 0 days relative to index: Trazodone,703547
drug_era group during day -365 through 0 days relative to index: Trazodone,703547
measurement during day -365 through 0 days relative to index: Lactate [Moles/volume] in Arterial plasma,3020410
drug_era during day -365 through 0 days relative to index: Propofol,753626
drug_era group during day -365 through 0 days relative to index: Propofol,753626
measurement during day -365 through 0 days relative to index: Left ventricular Ejection fraction by US 2D modified biplane,3007326
measurement during day -365 through 0 days relative to index: Left ventricular End-diastolic volume by US.2D+Calculated by biplane ellipse method,3012854
drug_exposure during day -365 through 0 days relative to index: Labetalol hydrochloride 100 MG,40169682
CHADS2VASc,0
drug_exposure during day -365 through 0 days relative to index: Glucose / Potassium Chloride / Sodium Chloride Injection,1593062
condition_occurrence during day -365 through 0 days relative to index: Injury of kidney,4220631
drug_era during day -365 through 0 days relative to index: pyridoxine,19005046
drug_era group during day -365 through 0 days relative to index: pyridoxine,19005046
drug_era group during day -365 through 0 days relative to index: OTHER PLAIN VITAMIN PREPARATIONS,21600840
drug_era group during day -365 through 0 days relative to index: Other plain vitamin preparations,21600841
drug_era group during day -365 through 0 days relative to index: ANTIFUNGALS FOR DERMATOLOGICAL USE,21601908
drug_era group during day -365 through 0 days relative to index: ANTIFUNGALS FOR TOPICAL USE,21601909
drug_era group during day -365 through 0 days relative to index: Other vasodilators used in cardiac diseases,21600337
drug_era during day -365 through 0 days relative to index: Fentanyl,1154029
drug_era group during day -365 through 0 days relative to index: Fentanyl,1154029
drug_era during day -365 through 0 days relative to index: pregabalin,734354
drug_era group during day -365 through 0 days relative to index: pregabalin,734354
drug_era during day -365 through 0 days relative to index: Scopolamine,965748
drug_era group during day -365 through 0 days relative to index: Scopolamine,965748
drug_era during day -365 through 0 days relative to index: Nicorandil,19014977
drug_era group during day -365 through 0 days relative to index: Nicorandil,19014977
measurement during day -365 through 0 days relative to index: Body surface area,3005424
measurement during day -365 through 0 days relative to index: Body weight,3025315
drug_era during day -365 through 0 days relative to index: gemcitabine,1314924
drug_era group during day -365 through 0 days relative to index: gemcitabine,1314924
drug_era group during day -365 through 0 days relative to index: Salicylic acid and derivatives,21604304
condition_era group during day -365 through 0 days relative to index: Liver mass,4101227
measurement during day -365 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,3000067
measurement during day -365 through 0 days relative to index: Fluid output gastrointestinal ostomy [Volume] Measured,21491184
drug_era during day -365 through 0 days relative to index: Succinylcholine,836208
drug_era group during day -365 through 0 days relative to index: Succinylcholine,836208
drug_era group during day -365 through 0 days relative to index: Choline derivatives,21604075
drug_exposure during day -365 through 0 days relative to index: Levofloxacin 500 MG Oral Tablet,1742255
drug_exposure during day -365 through 0 days relative to index: Centella asiatica extract,42898716
condition_era group during day -365 through 0 days relative to index: Kidney lesion,45769862
drug_era during day -365 through 0 days relative to index: cilostazol,1350310
drug_era group during day -365 through 0 days relative to index: cilostazol,1350310
drug_exposure during day -365 through 0 days relative to index: Oxytetracycline / Polymyxin B Ophthalmic Ointment,40067028
measurement during day -365 through 0 days relative to index: Creatine kinase.MB [Mass/volume] in Serum or Plasma,3005785
drug_exposure during day -365 through 0 days relative to index: 10 ML Nitroglycerin 1 MG/ML Injectable Solution,36895616
drug_era during day -365 through 0 days relative to index: Nicergoline,19018352
drug_era group during day -365 through 0 days relative to index: Nicergoline,19018352
drug_era group during day -365 through 0 days relative to index: Ergot alkaloids,21601579
measurement during day -365 through 0 days relative to index: Cholesterol in LDL [Mass/volume] in Serum or Plasma,3028437
measurement during day -365 through 0 days relative to index: Cholesterol in HDL [Mass/volume] in Serum or Plasma,3007070
drug_exposure during day -365 through 0 days relative to index: Oxycodone Hydrochloride 20 MG Oral Tablet,40232730
drug_exposure during day -365 through 0 days relative to index: Ambroxol 15 MG,19108252
condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of trunk,4314071
drug_era during day -365 through 0 days relative to index: pinaverium,19025198
drug_era group during day -365 through 0 days relative to index: pinaverium,19025198
measurement during day -365 through 0 days relative to index: Nausea and vomiting status,4234653
drug_era during day -365 through 0 days relative to index: clopidogrel,1322184
drug_era group during day -365 through 0 days relative to index: clopidogrel,1322184
drug_era during day -365 through 0 days relative to index: Labetalol,1386957
drug_era group during day -365 through 0 days relative to index: Labetalol,1386957
measurement during day -365 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,3005673
drug_exposure during day -365 through 0 days relative to index: Amlodipine 10 MG Oral Tablet,19073093
condition_era group during day -365 through 0 days relative to index: Neoplasm of bladder,200680
condition_era group during day -365 through 0 days relative to index: Lesion of bladder,4104155
condition_era group during day -365 through 0 days relative to index: Neoplasm of urinary tract proper,4112878
condition_era group during day -365 through 0 days relative to index: Mass of urinary bladder,4177067
drug_exposure during day -365 through 0 days relative to index: candesartan cilexetil 16 MG Oral Tablet,1351583
measurement during day -365 through 0 days relative to index: Triglyceride [Mass/volume] in Serum or Plasma,3022192
drug_era during day -365 through 0 days relative to index: Carboplatin,1344905
drug_era group during day -365 through 0 days relative to index: Carboplatin,1344905
condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of nervous system,373425
measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by India ink prep,3021198
condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of central nervous system,4312288
condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of head,4313083
condition_occurrence during day -365 through 0 days relative to index: Cough,254761
measurement during day -365 through 0 days relative to index: Rheumatoid factor [Units/volume] in Serum or Plasma,3021614
drug_era during day -365 through 0 days relative to index: venlafaxine,743670
drug_era group during day -365 through 0 days relative to index: venlafaxine,743670
condition_occurrence during day -365 through 0 days relative to index: Surgical procedure,4301351
drug_exposure during day -365 through 0 days relative to index: Ciprofloxacin 250 MG,1797556
measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae IgA Ab [Presence] in Serum,3016357
drug_era during day -365 through 0 days relative to index: Aztreonam,1715117
drug_era group during day -365 through 0 days relative to index: Aztreonam,1715117
drug_era group during day -365 through 0 days relative to index: Monobactams,21602918
drug_era during day -365 through 0 days relative to index: Aspirin,1112807
drug_era group during day -365 through 0 days relative to index: Aspirin,1112807
drug_exposure during day -365 through 0 days relative to index: Pseudoephedrine / Triprolidine Oral Tablet,40078134
drug_exposure during day -365 through 0 days relative to index: Unknown concept,9999999999
condition_occurrence during day -365 through 0 days relative to index: Chronic type B viral hepatitis,194574
condition_era group during day -365 through 0 days relative to index: Chronic type B viral hepatitis,194574
condition_era group during day -365 through 0 days relative to index: Type B viral hepatitis,4281232
measurement during day -365 through 0 days relative to index: Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA),3049473
condition_occurrence during day -365 through 0 days relative to index: Secondary malignant neoplasm of brain,4246451
condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of brain,4246451
drug_exposure during day -365 through 0 days relative to index: Fibrinogen Prefilled Syringe,36884632
drug_era group during day -365 through 0 days relative to index: Alpha and beta blocking agents,21601698
condition_occurrence during day -365 through 0 days relative to index: Dyslipidemia,4159131
condition_era group during day -365 through 0 days relative to index: Dyslipidemia,4159131
condition_era group during day -365 through 0 days relative to index: Mass of urinary system structure,4116963
drug_exposure during day -365 through 0 days relative to index: venlafaxine 37.5 MG Extended Release Oral Capsule,19134632
condition_occurrence during day -365 through 0 days relative to index: Shock,201965
drug_exposure during day -365 through 0 days relative to index: Valproate Injection,1593786
drug_era during day -365 through 0 days relative to index: Mirtazapine,725131
drug_era group during day -365 through 0 days relative to index: Mirtazapine,725131
drug_exposure during day -365 through 0 days relative to index: Ceftazidime 10000 MG,44105004
condition_era group during day -365 through 0 days relative to index: Metastasis to digestive organs,4166589
drug_exposure during day -365 through 0 days relative to index: docetaxel 20 MG,43293511
drug_exposure during day -365 through 0 days relative to index: 2.5 ML Rocuronium 10 MG/ML Injectable Solution,43775978
measurement during day -365 through 0 days relative to index: Streptolysin O Ab [Units/volume] in Serum or Plasma,3021236
measurement during day -365 through 0 days relative to index: Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma,3038911
condition_era group during day -365 through 0 days relative to index: Bacterial infectious disease,432545
condition_occurrence during day -365 through 0 days relative to index: Cerebrovascular disease,381591
condition_era group during day -365 through 0 days relative to index: Peritonitis,196152
condition_era group during day -365 through 0 days relative to index: Joint pain,77074
condition_occurrence during day -365 through 0 days relative to index: Rhabdomyolysis,4345578
condition_era group during day -365 through 0 days relative to index: Rhabdomyolysis,4345578
drug_era during day -365 through 0 days relative to index: Adenosine,1309204
drug_era group during day -365 through 0 days relative to index: Adenosine,1309204
condition_occurrence during day -365 through 0 days relative to index: Acute exacerbation of chronic obstructive airways disease,257004
condition_era group during day -365 through 0 days relative to index: Acute exacerbation of chronic obstructive airways disease,257004
drug_exposure during day -365 through 0 days relative to index: Ramipril 5 MG Oral Tablet,1334492
drug_exposure during day -365 through 0 days relative to index: Cefadroxil 500 MG Oral Capsule,19074847
measurement during day -365 through 0 days relative to index: Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,3023378
condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of intra-abdominal organs,4312023
drug_era during day -365 through 0 days relative to index: carvedilol,1346823
drug_era group during day -365 through 0 days relative to index: carvedilol,1346823
measurement during day -365 through 0 days relative to index: Fluid output emesis [Mass],3024355
drug_exposure during day -365 through 0 days relative to index: carvedilol 6.25 MG Oral Tablet,19022749
condition_era group during day -365 through 0 days relative to index: Cerebral degeneration presenting primarily with dementia,4092747
condition_occurrence during day -365 through 0 days relative to index: Low blood pressure,317002
drug_era during day -365 through 0 days relative to index: Bupropion,750982
drug_era group during day -365 through 0 days relative to index: Bupropion,750982
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of thorax,4145380
measurement during day -365 through 0 days relative to index: Level of consciousness [NIH Stroke Scale],42868658
measurement during day -365 through 0 days relative to index: LOC questions [NIH Stroke Scale],42868659
measurement during day -365 through 0 days relative to index: LOC commands [NIH Stroke Scale],42868660
measurement during day -365 through 0 days relative to index: Best gaze [NIH Stroke Scale],42868661
measurement during day -365 through 0 days relative to index: Visual [NIH Stroke Scale],42868662
measurement during day -365 through 0 days relative to index: Facial palsy [NIH Stroke Scale],42868663
measurement during day -365 through 0 days relative to index: Limb ataxia [NIH Stroke Scale],42868666
measurement during day -365 through 0 days relative to index: Sensory [NIH Stroke Scale],42868667
measurement during day -365 through 0 days relative to index: Best language [NIH Stroke Scale],42868668
measurement during day -365 through 0 days relative to index: Dysarthria [NIH Stroke Scale],42868669
measurement during day -365 through 0 days relative to index: Extinction and inattention [NIH Stroke Scale],42868670
measurement during day -365 through 0 days relative to index: Total score [NIH Stroke Scale],42869844
condition_era group during day -365 through 0 days relative to index: Respiratory tuberculosis,45771090
drug_exposure during day -365 through 0 days relative to index: Carbidopa 25 MG / Levodopa 250 MG Oral Tablet,789612
condition_occurrence during day -365 through 0 days relative to index: Type 2 diabetes mellitus,201826
condition_era group during day -365 through 0 days relative to index: Type 2 diabetes mellitus,201826
measurement during day -365 through 0 days relative to index: Mitral valve medial annulus Tissue velocity.A-wave.max by US.tissue doppler,21493301
measurement during day -365 through 0 days relative to index: Hepatitis B virus surface Ag [Presence] in Serum by Radioimmunoassay (RIA),3004563
drug_era group during day -365 through 0 days relative to index: Alpha glucosidase inhibitors,21600775
drug_era during day -365 through 0 days relative to index: telmisartan,1317640
drug_era group during day -365 through 0 days relative to index: telmisartan,1317640
drug_era group during day -365 through 0 days relative to index: LIPID MODIFYING AGENTS,21601853
"drug_era group during day -365 through 0 days relative to index: LIPID MODIFYING AGENTS, PLAIN",21601854
condition_era group during day -365 through 0 days relative to index: Complication of procedure,442019
drug_era group during day -365 through 0 days relative to index: HMG CoA reductase inhibitors,21601855
condition_era group during day -365 through 0 days relative to index: Granulomatous disorder,4029363
condition_era group during day -365 through 0 days relative to index: Arterial thrombosis,4278217
condition_occurrence during day -365 through 0 days relative to index: Glioblastoma,4272187
drug_era during day -365 through 0 days relative to index: Acarbose,1529331
drug_era group during day -365 through 0 days relative to index: Acarbose,1529331
drug_exposure during day -365 through 0 days relative to index: Omeprazole 20 MG,19081767
condition_era group during day -365 through 0 days relative to index: Subdural hematoma,4318408
drug_exposure during day -365 through 0 days relative to index: Acetaminophen 325 MG Oral Tablet,1127433
drug_exposure during day -365 through 0 days relative to index: Captopril 12.5 MG,19081025
drug_era group during day -365 through 0 days relative to index: PSYCHOLEPTICS,21604489
"drug_era group during day -365 through 0 days relative to index: ACE INHIBITORS, PLAIN",21601783
"drug_era group during day -365 through 0 days relative to index: ACE inhibitors, plain",21601784
drug_exposure during day -365 through 0 days relative to index: glimepiride 2 MG,1597776
drug_exposure during day -365 through 0 days relative to index: Ketoprofen 100 MG Injectable Solution,41272174
drug_era group during day -365 through 0 days relative to index: HYPNOTICS AND SEDATIVES,21604606
condition_era group during day -365 through 0 days relative to index: Tuberculosis,434557
condition_era group during day -365 through 0 days relative to index: Cerebral hemorrhage,376713
condition_occurrence during day -365 through 0 days relative to index: Backache,134736
condition_era group during day -365 through 0 days relative to index: Bacterial lower respiratory infection,4208662
condition_occurrence during day -365 through 0 days relative to index: Poisoning by drug AND/OR medicinal substance,438028
drug_exposure during day -365 through 0 days relative to index: levosulpiride 25 MG Oral Tablet,42962531
drug_exposure during day -365 through 0 days relative to index: Acarbose 50 MG Oral Tablet,1529352
drug_exposure during day -365 through 0 days relative to index: Phenylephrine 10 MG,1136806
measurement during day -365 through 0 days relative to index: Posterior tibial artery - left Systolic blood pressure,3012778
measurement during day -365 through 0 days relative to index: Posterior tibial artery - left Diastolic blood pressure,3034535
measurement during day -365 through 0 days relative to index: Posterior tibial artery - right Systolic blood pressure,3027070
measurement during day -365 through 0 days relative to index: Posterior tibial artery - right Diastolic blood pressure,3034766
measurement during day -365 through 0 days relative to index: Fluid intake nasogastric tube Measured,3017465
measurement during day -365 through 0 days relative to index: Gas delivery system Fresh gas.air flow setting [Flow],42528496
drug_era group during day -365 through 0 days relative to index: MYDRIATICS AND CYCLOPLEGICS,21605058
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of esophagus,26638
condition_occurrence during day -365 through 0 days relative to index: Primary malignant neoplasm of esophagus,26638
procedure_occurrence during day -365 through 0 days relative to index: Aortocoronary bypass of four or more coronary arteries,4008625
drug_exposure during day -365 through 0 days relative to index: Nitroglycerin 25 MG,36893170
drug_era group during day -365 through 0 days relative to index: PROPULSIVES,21600482
drug_era group during day -365 through 0 days relative to index: Propulsives,21600483
drug_era group during day -365 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,21603444
drug_era group during day -365 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,21603445
measurement during day -365 through 0 days relative to index: Fungus.microscopic observation [Identifier] in Unspecified specimen by Periodic acid-Schiff stain,3041483
drug_era group during day -365 through 0 days relative to index: Pyrimidine analogues,21601434
drug_exposure during day -365 through 0 days relative to index: 2 ML Metoclopramide 5 MG/ML Injection,19078921
"measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum, Plasma or Blood",44816672
drug_era group during day -365 through 0 days relative to index: ANTIMETABOLITES,21601421
measurement during day -365 through 0 days relative to index: Pneumocystis jiroveci DNA [Presence] in Unspecified specimen by NAA with probe detection,3009595
drug_era group during day -365 through 0 days relative to index: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,21601445
drug_exposure during day -365 through 0 days relative to index: Vitamin K 1 10 MG/ML Injectable Solution,19044756
drug_exposure during day -365 through 0 days relative to index: celecoxib 200 MG,19081053
drug_era group during day -365 through 0 days relative to index: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,21603728
drug_era group during day -365 through 0 days relative to index: Anthracyclines and related substances,21603731
measurement during day -365 through 0 days relative to index: Leukocyte esterase [Presence] in Body fluid by Automated test strip,46236251
drug_era group during day -365 through 0 days relative to index: Triazole derivatives,21603079
measurement during day -365 through 0 days relative to index: Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay,3046760
measurement during day -365 through 0 days relative to index: Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge,3007363
drug_era group during day -365 through 0 days relative to index: Monoclonal antibodies,21603754
measurement during day -365 through 0 days relative to index: Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge,3005713
drug_era during day -365 through 0 days relative to index: Fluconazole,1754994
drug_era group during day -365 through 0 days relative to index: Fluconazole,1754994
measurement during day -365 through 0 days relative to index: Platelets given [Volume],3011394
condition_era group during day -365 through 0 days relative to index: Interstitial lung disease,4119786
condition_era group during day -365 through 0 days relative to index: White blood cell count abnormal,4013991
drug_exposure during day -365 through 0 days relative to index: fluticasone 0.25 MG / salmeterol 0.05 MG Dry Powder Inhaler,43170556
measurement during day -365 through 0 days relative to index: Fluid intake intravascular Measured,3037253
drug_era during day -365 through 0 days relative to index: Oseltamivir,1799139
drug_era group during day -365 through 0 days relative to index: Oseltamivir,1799139
drug_era group during day -365 through 0 days relative to index: Neuraminidase inhibitors,21603177
drug_era during day -365 through 0 days relative to index: Ceftazidime,1776684
drug_era group during day -365 through 0 days relative to index: Ceftazidime,1776684
procedure_occurrence during day -365 through 0 days relative to index: Previous chest wall incision - reopening,4121000
drug_exposure during day -365 through 0 days relative to index: darbepoetin alfa Prefilled Syringe,40142274
condition_era group during day -365 through 0 days relative to index: White blood cell disorder,434008
condition_era group during day -365 through 0 days relative to index: Bleeding from mouth,4330466
measurement during day -365 through 0 days relative to index: Protein Fractions [Interpretation] in Urine by Electrophoresis,3007822
drug_era during day -365 through 0 days relative to index: Carbamazepine,740275
drug_era group during day -365 through 0 days relative to index: Carbamazepine,740275
condition_era group during day -365 through 0 days relative to index: Leukopenia,435224
condition_era group during day -365 through 0 days relative to index: Intestinal infectious disease,198678
drug_era group during day -365 through 0 days relative to index: Dipeptidyl peptidase 4 (DPP-4) inhibitors,21600783
condition_era group during day -365 through 0 days relative to index: Hemoglobin low,4013074
condition_era group during day -365 through 0 days relative to index: RBC count abnormal,4013518
condition_era group during day -365 through 0 days relative to index: RBC count low,4013842
condition_era group during day -365 through 0 days relative to index: Hemoglobin level outside reference range,40480513
measurement during day -365 through 0 days relative to index: Cerebral perfusion pressure,21490695
drug_exposure during day -365 through 0 days relative to index: 2 ML Methotrexate 25 MG/ML Injectable Solution,36895253
condition_era group during day -365 through 0 days relative to index: Polyp of large intestine,4164337
condition_occurrence during day -365 through 0 days relative to index: Polyp of colon,4285898
condition_era group during day -365 through 0 days relative to index: Polyp of colon,4285898
condition_era group during day -365 through 0 days relative to index: Anemia,439777
condition_era group during day -365 through 0 days relative to index: Cytopenia,4179922
condition_era group during day -365 through 0 days relative to index: Erythropenia,4267432
drug_exposure during day -365 through 0 days relative to index: pregabalin 75 MG,734397
condition_occurrence during day -365 through 0 days relative to index: Respiratory failure,4256228
condition_era group during day -365 through 0 days relative to index: Pancytopenia,432881
drug_exposure during day -365 through 0 days relative to index: Fusidate 20 MG/ML Topical Ointment,41022931
drug_exposure during day -365 through 0 days relative to index: 5 ML hyaluronate 1 MG/ML Ophthalmic Solution,42921254
drug_exposure during day -365 through 0 days relative to index: amphotericin B liposomal 50 MG,35604135
drug_exposure during day -365 through 0 days relative to index: 5 ML Fluorometholone 1 MG/ML Ophthalmic Solution,21048527
condition_era group during day -365 through 0 days relative to index: Rupture of aorta,4173464
condition_era group during day -365 through 0 days relative to index: Herpesvirus infection,435463
drug_exposure during day -365 through 0 days relative to index: Domperidone,19037833
condition_era group during day -365 through 0 days relative to index: Myocarditis,314383
drug_exposure during day -365 through 0 days relative to index: ivy leaf extract,36878639
drug_era during day -365 through 0 days relative to index: amphotericin B liposomal,19056402
drug_era group during day -365 through 0 days relative to index: amphotericin B liposomal,19056402
drug_exposure during day -365 through 0 days relative to index: Esomeprazole 20 MG Oral Tablet,19101746
condition_era group during day -365 through 0 days relative to index: Polyp of intestine,4112731
measurement during day -365 through 0 days relative to index: Protein S [Units/volume] in Platelet poor plasma by Chromogenic method,3001182
condition_era group during day -365 through 0 days relative to index: Epigastric pain,197381
condition_era group during day -365 through 0 days relative to index: Central abdominal pain,4012222
condition_era group during day -365 through 0 days relative to index: Chronic inflammatory disorder,444208
condition_occurrence during day -365 through 0 days relative to index: Anemia,439777
condition_occurrence during day -365 through 0 days relative to index: Abdominal aortic aneurysm without rupture,321314
condition_era group during day -365 through 0 days relative to index: Abdominal aortic aneurysm without rupture,321314
drug_era during day -365 through 0 days relative to index: Roxithromycin,19063874
drug_era group during day -365 through 0 days relative to index: Roxithromycin,19063874
condition_occurrence during day -365 through 0 days relative to index: Acute non-Q wave infarction,4145721
condition_era group during day -365 through 0 days relative to index: Acute non-Q wave infarction,4145721
procedure_occurrence during day -365 through 0 days relative to index: MRI of cervical spine,4082840
condition_era group during day -365 through 0 days relative to index: Goiter,135772
condition_era group during day -365 through 0 days relative to index: Fracture of rib,4142905
drug_exposure during day -365 through 0 days relative to index: buspirone hydrochloride 10 MG Oral Tablet,40167431
procedure_occurrence during day -365 through 0 days relative to index: MRI of lumbar and sacral spine with contrast,4335804
condition_era group during day -365 through 0 days relative to index: Pneumothorax,253796
measurement during day -365 through 0 days relative to index: Cancer Ag 15-3 [Units/volume] in Serum or Plasma,3006588
drug_era during day -365 through 0 days relative to index: Calcium Citrate,19058572
drug_era group during day -365 through 0 days relative to index: Calcium Citrate,19058572
drug_exposure during day -365 through 0 days relative to index: Trimebutine 100 MG Oral Tablet,19005513
condition_era group during day -365 through 0 days relative to index: Non-toxic nodular goiter,136661
condition_era group during day -365 through 0 days relative to index: Simple goiter,141825
condition_era group during day -365 through 0 days relative to index: Tooth disorder,4122115
procedure_occurrence during day -365 through 0 days relative to index: Exploratory laparotomy,4253523
drug_exposure during day -365 through 0 days relative to index: 24 HR rivastigmine 0.192 MG/HR Transdermal System,19127019
measurement during day -365 through 0 days relative to index: Osteocalcin [Mass/volume] in Serum or Plasma,3028772
drug_era during day -365 through 0 days relative to index: Simvastatin,1539403
drug_era group during day -365 through 0 days relative to index: Simvastatin,1539403
drug_era during day -365 through 0 days relative to index: Losartan,1367500
drug_era group during day -365 through 0 days relative to index: Losartan,1367500
drug_exposure during day -365 through 0 days relative to index: Methoxy polyethylene glycol-epoetin beta 0.2 MG/ML Injectable Solution,19015852
measurement during day -365 through 0 days relative to index: Frequency of bowel action,4091043
measurement during day -365 through 0 days relative to index: Pulmonary artery Mean blood pressure,3028074
drug_era group during day -365 through 0 days relative to index: Third-generation cephalosporins,21602894
measurement during day -365 through 0 days relative to index: Bispectral index,4134573
measurement during day -365 through 0 days relative to index: Minute volume setting Ventilator,3045410
measurement during day -365 through 0 days relative to index: Osmolality of Serum or Plasma,3008295
measurement during day -365 through 0 days relative to index: Blood loss.total intraoperative [Volume] Estimated,3021505
drug_era during day -365 through 0 days relative to index: Ceftriaxone,1777806
drug_era group during day -365 through 0 days relative to index: Ceftriaxone,1777806
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of coronary arteries,4306317
"drug_era group during day -365 through 0 days relative to index: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",21600600
drug_era group during day -365 through 0 days relative to index: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,21601386
measurement during day -365 through 0 days relative to index: Right atrial pressure,21490680
condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive organ,4111798
condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive system,4028253
drug_era group during day -365 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,21600002
drug_era group during day -365 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,21600003
condition_era group during day -365 through 0 days relative to index: Mass of digestive structure,4115106
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of gastrointestinal tract,4179720
condition_era group during day -365 through 0 days relative to index: Neoplasm of gastrointestinal tract,4130373
condition_occurrence during day -365 through 0 days relative to index: Preinfarction syndrome,315296
condition_era group during day -365 through 0 days relative to index: Preinfarction syndrome,315296
condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive tract,196931
measurement during day -365 through 0 days relative to index: Haemodialysis anticoagulant bolus dose,44802883
measurement during day -365 through 0 days relative to index: Morphology [Interpretation] in Blood Narrative,3000093
measurement during day -365 through 0 days relative to index: Event description adverse event MERSTH,3033689
drug_exposure during day -365 through 0 days relative to index: Ephedrine,1143374
measurement during day -365 through 0 days relative to index: Position AndOr immobilizer used during EMS transport,36305922
drug_era during day -365 through 0 days relative to index: Calcium Carbonate,19035704
drug_era group during day -365 through 0 days relative to index: Calcium Carbonate,19035704
drug_era during day -365 through 0 days relative to index: Bisacodyl,924939
drug_era group during day -365 through 0 days relative to index: Bisacodyl,924939
drug_era group during day -365 through 0 days relative to index: Contact laxatives,21600537
drug_era during day -365 through 0 days relative to index: Filgrastim,1304850
drug_era group during day -365 through 0 days relative to index: Filgrastim,1304850
drug_exposure during day -365 through 0 days relative to index: 100 ML Glucose 500 MG/ML Injection,793469
drug_era group during day -365 through 0 days relative to index: Colony stimulating factors,21603850
drug_era group during day -365 through 0 days relative to index: IMMUNOSTIMULANTS,21603848
drug_era group during day -365 through 0 days relative to index: IMMUNOSTIMULANTS,21603849
measurement during day -365 through 0 days relative to index: Oxygen saturation in Mixed venous blood,3018465
drug_era group during day -365 through 0 days relative to index: CHEMOTHERAPEUTICS FOR TOPICAL USE,21602073
drug_exposure during day -365 through 0 days relative to index: Multivitamin preparation 5 MG,40889208
drug_era during day -365 through 0 days relative to index: Metoclopramide,906780
drug_era group during day -365 through 0 days relative to index: Metoclopramide,906780
procedure_occurrence during day -365 through 0 days relative to index: Transfusion of red blood cells,4022173
condition_era group during day -365 through 0 days relative to index: Aneurysm,4332246
drug_era during day -365 through 0 days relative to index: Methylprednisolone,1506270
drug_era group during day -365 through 0 days relative to index: Methylprednisolone,1506270
drug_exposure during day -365 through 0 days relative to index: Calcium polystyrene sulfonate product 5000 MG Oral Granules,42941185
condition_era group during day -365 through 0 days relative to index: Arterial aneurysm,312336
condition_era group during day -365 through 0 days relative to index: Distention of artery,4087641
condition_era group during day -365 through 0 days relative to index: Coronary arteriosclerosis,317576
condition_era group during day -365 through 0 days relative to index: Aneurysm of peripheral artery,43021868
drug_era during day -365 through 0 days relative to index: Ciprofloxacin,1797513
drug_era group during day -365 through 0 days relative to index: Ciprofloxacin,1797513
measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Gram stain,3037167
condition_era group during day -365 through 0 days relative to index: Mass of trunk,4206591
drug_era group during day -365 through 0 days relative to index: ANTIVIRALS FOR SYSTEMIC USE,21603126
drug_era group during day -365 through 0 days relative to index: DIRECT ACTING ANTIVIRALS,21603127
condition_era group during day -365 through 0 days relative to index: Abdominal mass,192438
drug_era during day -365 through 0 days relative to index: aprepitant,936748
drug_era group during day -365 through 0 days relative to index: aprepitant,936748
measurement during day -365 through 0 days relative to index: Enolase.neuron specific [Mass/volume] in Serum or Plasma,3028531
drug_era during day -365 through 0 days relative to index: L-Ornithine-L-Aspartate,36878696
drug_era group during day -365 through 0 days relative to index: L-Ornithine-L-Aspartate,36878696
measurement during day -365 through 0 days relative to index: Colloid oncotic pressure [Partial pressure] in Plasma,3008247
measurement during day -365 through 0 days relative to index: Aortic pressure,4081029
measurement during day -365 through 0 days relative to index: Venous pressure,4090818
measurement during day -365 through 0 days relative to index: Haemodialysis ultrafiltration rate,44802820
measurement during day -365 through 0 days relative to index: Temperature,45771331
drug_exposure during day -365 through 0 days relative to index: L-Ornithine-L-Aspartate,36878696
measurement during day -365 through 0 days relative to index: Major crossmatch [Interpretation],3004592
drug_exposure during day -365 through 0 days relative to index: Hydrocortisone 100 MG Injection,975505
drug_exposure during day -365 through 0 days relative to index: aprepitant 80 MG Oral Capsule,19102465
drug_era group during day -365 through 0 days relative to index: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,21602683
drug_era group during day -365 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,21604801
drug_exposure during day -365 through 0 days relative to index: aprepitant 125 MG Oral Capsule,19102466
drug_era during day -365 through 0 days relative to index: Cosyntropin,19008009
drug_era group during day -365 through 0 days relative to index: Cosyntropin,19008009
drug_era group during day -365 through 0 days relative to index: ACTH,21602684
drug_exposure during day -365 through 0 days relative to index: 250 ML moxifloxacin 1.6 MG/ML Injection,1716908
condition_era group during day -365 through 0 days relative to index: Cardiac arrest,321042
drug_era group during day -365 through 0 days relative to index: PARASYMPATHOMIMETICS,21604802
drug_exposure during day -365 through 0 days relative to index: Hydrocortisone 250 MG,19110892
drug_exposure during day -365 through 0 days relative to index: Silymarin 140 MG Oral Capsule,19103635
drug_exposure during day -365 through 0 days relative to index: fibrinogen concentrate (human),19044986
drug_exposure during day -365 through 0 days relative to index: Cosyntropin 0.25 MG,44039373
drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,21603932
drug_exposure during day -365 through 0 days relative to index: Potassium Chloride 600 MG Extended Release Oral Tablet,21066825
"drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",21603933
drug_exposure during day -365 through 0 days relative to index: Epinephrine 1 MG,44078900
condition_occurrence during day -365 through 0 days relative to index: Cardiac arrest,321042
drug_era group during day -365 through 0 days relative to index: Drugs for treatment of hyperkalemia and hyperphosphatemia,21605263
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intra-abdominal organs,197804
measurement during day -365 through 0 days relative to index: Pressure.bilevel positive airway Ventilator,40762053
drug_era group during day -365 through 0 days relative to index: Other drugs for functional gastrointestinal disorders,21600174
condition_era group during day -365 through 0 days relative to index: Skin or mucosa lesion,4083787
measurement during day -365 through 0 days relative to index: Aortic valve Peak systolic flow by US.doppler,3028570
drug_exposure during day -365 through 0 days relative to index: Levetiracetam 500 MG,19085062
index year: 2011,0
measurement during day -365 through 0 days relative to index: Aortic valve Mean systole pressure gradient by US.doppler+Calculated by simplified Bernoulli,21493999
measurement during day -365 through 0 days relative to index: Inattention in last 7 days [CAM.CMS],40757759
drug_exposure during day -365 through 0 days relative to index: 500 ML Calcium Chloride 0.200000000000000011 MG/ML / Glucose 50 MG/ML / Lactate 6.24000000000000021 MG/ML / Potassium Chloride 0.299999999999999989 MG/ML / Sodium Chloride 6 MG/ML Injectable Solution,42918553
drug_era during day -365 through 0 days relative to index: aceclofenac,19029393
drug_era group during day -365 through 0 days relative to index: aceclofenac,19029393
procedure_occurrence during day -365 through 0 days relative to index: CT of brain perfusion,4198764
condition_era group during day -365 through 0 days relative to index: Dyssomnia,435657
measurement during day -365 through 0 days relative to index: Toileting,4043519
condition_occurrence during day -365 through 0 days relative to index: Epidural hemorrhage,4306943
measurement during day -365 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,3007220
condition_era group during day -365 through 0 days relative to index: Infectious disease of abdomen,4028062
measurement during day -365 through 0 days relative to index: Valproate [Mass/volume] in Serum or Plasma,3016201
drug_era during day -365 through 0 days relative to index: Zinc Sulfate,19044522
drug_era group during day -365 through 0 days relative to index: Zinc Sulfate,19044522
drug_exposure during day -365 through 0 days relative to index: lansoprazole 15 MG,19095231
drug_era group during day -365 through 0 days relative to index: Zinc,21600888
condition_era group during day -365 through 0 days relative to index: Abnormal blood cell count,42538830
measurement during day -365 through 0 days relative to index: Cortisol [Mass/volume] in Serum or Plasma --pre XXX challenge,3017955
condition_occurrence during day -365 through 0 days relative to index: Diagnostic procedure,4304358
drug_exposure during day -365 through 0 days relative to index: polystyrene sulfonate Oral Powder,41017262
drug_era during day -365 through 0 days relative to index: polystyrene sulfonate,45775570
drug_era group during day -365 through 0 days relative to index: polystyrene sulfonate,45775570
measurement during day -365 through 0 days relative to index: Acute collapse,4052905
drug_era group during day -365 through 0 days relative to index: Nucleosides and nucleotides excl. reverse transcriptase inhibitors,21603130
condition_era group during day -365 through 0 days relative to index: Lesion of liver,4104000
drug_era during day -365 through 0 days relative to index: Choline,1195334
drug_era group during day -365 through 0 days relative to index: Choline,1195334
condition_era group during day -365 through 0 days relative to index: Respiratory insufficiency,318459
condition_era group during day -365 through 0 days relative to index: Respiratory failure,4256228
condition_era group during day -365 through 0 days relative to index: Congenital cardiovascular disorder,42538522
drug_exposure during day -365 through 0 days relative to index: Adenosine,1309204
condition_era group during day -365 through 0 days relative to index: Lesion of skin and/or skin-associated mucous membrane,37018424
"drug_era group during day -365 through 0 days relative to index: Beta blocking agents, non-selective",21601666
drug_era during day -365 through 0 days relative to index: Dextran,1352890
drug_era group during day -365 through 0 days relative to index: Dextran,1352890
drug_exposure during day -365 through 0 days relative to index: Ciprofloxacin 400 MG,19088843
drug_era group during day -365 through 0 days relative to index: Second-generation cephalosporins,21602882
procedure_occurrence during day -365 through 0 days relative to index: Colonoscopy,4249893
"condition_era group during day -365 through 0 days relative to index: Ear, nose and throat disorder",4339468
condition_era group during day -365 through 0 days relative to index: Neoplasm of intrathoracic organs,4054836
drug_era during day -365 through 0 days relative to index: Propranolol,1353766
drug_era group during day -365 through 0 days relative to index: Propranolol,1353766
condition_era group during day -365 through 0 days relative to index: Vascular insufficiency of intestine,192673
condition_era group during day -365 through 0 days relative to index: Gastrointestinal tract vascular insufficiency,4195665
drug_era during day -365 through 0 days relative to index: Domperidone,19037833
drug_era group during day -365 through 0 days relative to index: Domperidone,19037833
"drug_exposure during day -365 through 0 days relative to index: 10 ML Regular Insulin, Human 100 UNT/ML Injection",43297029
condition_era group during day -365 through 0 days relative to index: Acute renal failure syndrome,197320
condition_era group during day -365 through 0 days relative to index: Acute renal impairment,4126305
condition_era group during day -365 through 0 days relative to index: Skin lesion,4316083
condition_era group during day -365 through 0 days relative to index: Congenital anomaly of cardiovascular system,141124
condition_era group during day -365 through 0 days relative to index: Neoplasm of intestinal tract,4131598
drug_era during day -365 through 0 days relative to index: Acyclovir,1703687
drug_era group during day -365 through 0 days relative to index: Acyclovir,1703687
drug_era group during day -365 through 0 days relative to index: Antivirals,21602082
drug_era group during day -365 through 0 days relative to index: Antivirals,21603585
measurement during day -365 through 0 days relative to index: Corticotropin [Mass/volume] in Plasma --pre XXX challenge,40761729
condition_occurrence during day -365 through 0 days relative to index: Acute Q wave myocardial infarction,4126801
condition_era group during day -365 through 0 days relative to index: Acute Q wave myocardial infarction,4126801
condition_occurrence during day -365 through 0 days relative to index: Hydrocephalus,4043738
procedure_occurrence during day -365 through 0 days relative to index: MRI of lumbar and sacral spine,4202579
drug_exposure during day -365 through 0 days relative to index: 50 ML Propofol 20 MG/ML Injection,43737706
condition_era group during day -365 through 0 days relative to index: Parkinsonism,4140090
drug_exposure during day -365 through 0 days relative to index: Morphine Sulfate 5 MG/ML Injection,35605859
drug_exposure during day -365 through 0 days relative to index: isopropyl palmitate,42900479
drug_exposure during day -365 through 0 days relative to index: aceclofenac 100 MG,19086516
measurement during day -365 through 0 days relative to index: Gas delivery system Fresh gas.nitrous oxide flow setting [Flow],42528498
measurement during day -365 through 0 days relative to index: Bacteria identified in Bronchoalveolar lavage by Aerobe culture,3045360
measurement during day -365 through 0 days relative to index: Body height,3036277
drug_exposure during day -365 through 0 days relative to index: tiropramide 100 MG,42926946
condition_era group during day -365 through 0 days relative to index: Congenital malformation,4079975
drug_exposure during day -365 through 0 days relative to index: Midazolam 5 MG/ML Injection,46287622
condition_era group during day -365 through 0 days relative to index: Intestinal obstruction,193518
condition_era group during day -365 through 0 days relative to index: Gastrointestinal obstruction,4129389
condition_occurrence during day -365 through 0 days relative to index: Diabetic complication,442793
procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,2000000201
drug_era during day -365 through 0 days relative to index: sitagliptin,1580747
drug_era group during day -365 through 0 days relative to index: sitagliptin,1580747
measurement during day -365 through 0 days relative to index: Beta-2-Microglobulin [Mass/volume] in Serum or Plasma,3013201
condition_era group during day -365 through 0 days relative to index: Occlusion of artery,4162038
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intestinal tract,195482
condition_era group during day -365 through 0 days relative to index: Cerebral artery occlusion,372924
measurement during day -365 through 0 days relative to index: Troponin I.cardiac [Mass/volume] in Serum or Plasma,3021337
drug_era during day -365 through 0 days relative to index: tamsulosin,924566
drug_era group during day -365 through 0 days relative to index: tamsulosin,924566
drug_era group during day -365 through 0 days relative to index: ANXIOLYTICS,21604564
condition_era group during day -365 through 0 days relative to index: Abscess of digestive system,42536507
condition_era group during day -365 through 0 days relative to index: Degenerative brain disorder,375239
drug_era during day -365 through 0 days relative to index: Amitriptyline,710062
drug_era group during day -365 through 0 days relative to index: Amitriptyline,710062
drug_era during day -365 through 0 days relative to index: Nalbuphine,1114122
drug_era group during day -365 through 0 days relative to index: Nalbuphine,1114122
drug_era group during day -365 through 0 days relative to index: Morphinan derivatives,21604288
gender = FEMALE,8532
gender = MALE,8507
drug_era during day -365 through 0 days relative to index: Amlodipine,1332418
drug_era group during day -365 through 0 days relative to index: Amlodipine,1332418
condition_era group during day -365 through 0 days relative to index: Peripheral arterial occlusive disease,317309
procedure_occurrence during day -365 through 0 days relative to index: Sigmoidoscopy,4087381
condition_era group during day -365 through 0 days relative to index: Mass of intestine,42596177
drug_era group during day -365 through 0 days relative to index: CARDIOVASCULAR SYSTEM,21601237
drug_era group during day -365 through 0 days relative to index: Hydantoin derivatives,21604397
index year: 2014,0
drug_era group during day -365 through 0 days relative to index: CARDIAC THERAPY,21601238
drug_era during day -365 through 0 days relative to index: Phenytoin,740910
drug_era group during day -365 through 0 days relative to index: Phenytoin,740910
condition_occurrence during day -365 through 0 days relative to index: Peritonitis,196152
condition_occurrence during day -365 through 0 days relative to index: Primary malignant neoplasm of colon,197500
condition_occurrence during day -365 through 0 days relative to index: Abscess of liver,201901
condition_era group during day -365 through 0 days relative to index: Abscess of liver,201901
condition_era group during day -365 through 0 days relative to index: Abdominal visceral abscess,4171019
procedure_occurrence during day -365 through 0 days relative to index: MR angiography of brain and neck without contrast,36713053
condition_era group during day -365 through 0 days relative to index: Neoplasm of large intestine,4130514
drug_exposure during day -365 through 0 days relative to index: Nefopam 10 MG/ML Injectable Solution,19104216
condition_occurrence during day -365 through 0 days relative to index: Cataract,375545
drug_era during day -365 through 0 days relative to index: mequitazine,19009145
drug_era group during day -365 through 0 days relative to index: mequitazine,19009145
drug_era group during day -365 through 0 days relative to index: Phenothiazine derivatives,21603479
condition_era group during day -365 through 0 days relative to index: Traumatic pneumothorax,4234083
procedure_occurrence during day -365 through 0 days relative to index: Laryngoscopy,4103523
condition_era group during day -365 through 0 days relative to index: Cerebral degeneration,4168666
index year: 2015,0
drug_exposure during day -365 through 0 days relative to index: Lidocaine 25 MG/ML / Prilocaine 25 MG/ML Topical Cream,989898
drug_era during day -365 through 0 days relative to index: Nortriptyline,721724
drug_era group during day -365 through 0 days relative to index: Nortriptyline,721724
condition_era group during day -365 through 0 days relative to index: Congenital anomaly of head,4337941
drug_exposure during day -365 through 0 days relative to index: Alprazolam 0.25 MG,781095
condition_era group during day -365 through 0 days relative to index: Cardiac arrhythmia,44784217
condition_era group during day -365 through 0 days relative to index: Pain in limb,138525
drug_era group during day -365 through 0 days relative to index: Alpha-adrenoreceptor antagonists,21602667
drug_exposure during day -365 through 0 days relative to index: Choline 400 MG Oral Capsule,19063928
drug_era group during day -365 through 0 days relative to index: Centrally acting sympathomimetics,21604753
drug_era group during day -365 through 0 days relative to index: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,21602666
condition_era group during day -365 through 0 days relative to index: Pericarditis,4138837
condition_occurrence during day -365 through 0 days relative to index: Pulmonary thromboembolism,4121618
condition_era group during day -365 through 0 days relative to index: Pulmonary thromboembolism,4121618
condition_era group during day -365 through 0 days relative to index: Pulmonary thrombosis,4239826
condition_era group during day -365 through 0 days relative to index: Pulmonary artery thrombosis,4240612
condition_occurrence during day -365 through 0 days relative to index: Malignant tumor of colon,4180790
drug_era during day -365 through 0 days relative to index: Cefuroxime,1778162
drug_era group during day -365 through 0 days relative to index: Cefuroxime,1778162
drug_exposure during day -365 through 0 days relative to index: Ondansetron 4 MG,19083034
"drug_exposure during day -365 through 0 days relative to index: 3 ML Insulin, Glulisine, Human 100 UNT/ML Prefilled Syringe",21058194
index year: 2012,0
condition_era group during day -365 through 0 days relative to index: Impaired cognition,443432
drug_era during day -365 through 0 days relative to index: Nefopam,19015602
drug_era group during day -365 through 0 days relative to index: Nefopam,19015602
drug_era group during day -365 through 0 days relative to index: Other analgesics and antipyretics,21604354
drug_era during day -365 through 0 days relative to index: Hydromorphone,1126658
drug_era group during day -365 through 0 days relative to index: Hydromorphone,1126658
condition_era group during day -365 through 0 days relative to index: Large intestinal mass,42596178
index year: 2017,0
condition_era group during day -365 through 0 days relative to index: Abdominal abscess,4326255
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of large intestine,4246125
drug_exposure during day -365 through 0 days relative to index: Phenytoin,740910
condition_occurrence during day -365 through 0 days relative to index: Ureteric stone,201916
condition_era group during day -365 through 0 days relative to index: Ureteric stone,201916
condition_era group during day -365 through 0 days relative to index: Calculus of upper urinary tract,36713581
measurement during day -365 through 0 days relative to index: Thoracentesis,4240305
condition_era group during day -365 through 0 days relative to index: Meningitis,435785
condition_occurrence during day -365 through 0 days relative to index: Cerebrovascular accident,381316
drug_era group during day -365 through 0 days relative to index: COUGH AND COLD PREPARATIONS,21603365
"drug_era group during day -365 through 0 days relative to index: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",21603366
drug_era group during day -365 through 0 days relative to index: Mucolytics,21603379
drug_exposure during day -365 through 0 days relative to index: Metoprolol 100 MG,19083036
drug_exposure during day -365 through 0 days relative to index: Nortriptyline 10 MG,721761
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of pelvis,198988
condition_era group during day -365 through 0 days relative to index: Congenital vascular disorder,439415
condition_era group during day -365 through 0 days relative to index: Congenital vascular malformation,4267553
condition_era group during day -365 through 0 days relative to index: Bladder dysfunction,4224118
condition_occurrence during day -365 through 0 days relative to index: Neurogenic dysfunction of the urinary bladder,4262178
condition_era group during day -365 through 0 days relative to index: Neurogenic dysfunction of the urinary bladder,4262178
condition_era group during day -365 through 0 days relative to index: Pelvic injury,4154168
drug_exposure during day -365 through 0 days relative to index: 2.5 ML latanoprost 0.05 MG/ML Ophthalmic Solution,43209210
measurement during day -365 through 0 days relative to index: Human serum albumin,4306032
drug_era group during day -365 through 0 days relative to index: HORMONE ANTAGONISTS AND RELATED AGENTS,21603829
drug_era during day -365 through 0 days relative to index: Doxazosin,1363053
drug_era group during day -365 through 0 days relative to index: Doxazosin,1363053
condition_era group during day -365 through 0 days relative to index: Lesion of neck,4185207
drug_era group during day -365 through 0 days relative to index: Benzodiazepine derivatives,21604565
condition_era group during day -365 through 0 days relative to index: Cerebrovascular accident,381316
measurement during day -365 through 0 days relative to index: Creatinine renal clearance in 24 hour Urine and Serum or Plasma,3005770
measurement during day -365 through 0 days relative to index: Annotation comment [Interpretation] Narrative,3049878
drug_era group during day -365 through 0 days relative to index: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,21600279
drug_era group during day -365 through 0 days relative to index: Adrenergic and dopaminergic agents,21600280
condition_era group during day -365 through 0 days relative to index: Glaucoma,437541
condition_era group during day -365 through 0 days relative to index: Neoplasm of colon,4130995
condition_era group during day -365 through 0 days relative to index: Degenerative disorder of eye,375807
drug_era during day -365 through 0 days relative to index: magnesium citrate,967861
drug_era group during day -365 through 0 days relative to index: magnesium citrate,967861
drug_era group during day -365 through 0 days relative to index: Magnesium,21600892
condition_era group during day -365 through 0 days relative to index: Fracture of pelvis,4300192
drug_exposure during day -365 through 0 days relative to index: tianeptine 12.5 MG,19041932
condition_era group during day -365 through 0 days relative to index: Cataract,375545
measurement during day -365 through 0 days relative to index: Cardiac rhythm type,4091457
measurement during day -365 through 0 days relative to index: Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA),3015352
measurement during day -365 through 0 days relative to index: Indicator of Surgery Cancer,2000000019
condition_era group during day -365 through 0 days relative to index: Fracture of neck of femur,433856
drug_era during day -365 through 0 days relative to index: Alprazolam,781039
drug_era group during day -365 through 0 days relative to index: Alprazolam,781039
condition_era group during day -365 through 0 days relative to index: Paralytic syndrome,374377
condition_era group during day -365 through 0 days relative to index: Lesion of eye structure,4201554
procedure_occurrence during day -365 through 0 days relative to index: Radiography of kidney-ureter-bladder,4135471
"drug_era group during day -365 through 0 days relative to index: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",21600409
drug_era group during day -365 through 0 days relative to index: Alpha-adrenoreceptor antagonists,21600410
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of colon,197500
condition_occurrence during day -365 through 0 days relative to index: Fracture of rib,4142905
condition_era group during day -365 through 0 days relative to index: Colonic lesion,45763613
condition_era group during day -365 through 0 days relative to index: Soft tissue injury,4083964
drug_exposure during day -365 through 0 days relative to index: Fentanyl 0.025 MG/HR Transdermal System,42902803
condition_era group during day -365 through 0 days relative to index: Postoperative complication,4300243
condition_era group during day -365 through 0 days relative to index: Perioperative complication,42538046
drug_era group during day -365 through 0 days relative to index: Other antithrombotic agents,21601027
drug_era during day -365 through 0 days relative to index: rivaroxaban,40241331
drug_era group during day -365 through 0 days relative to index: rivaroxaban,40241331
condition_era group during day -365 through 0 days relative to index: Osteoarthritis,80180
drug_exposure during day -365 through 0 days relative to index: Nalbuphine Hydrochloride 10 MG/ML Injection,1593600
condition_era group during day -365 through 0 days relative to index: Encephalitis,378143
condition_era group during day -365 through 0 days relative to index: Malignant tumor of colon,4180790
condition_occurrence during day -365 through 0 days relative to index: Fracture of neck of femur,433856
condition_era group during day -365 through 0 days relative to index: Mass of colon,4143250
measurement during day -365 through 0 days relative to index: P wave axis,3006698
drug_era group during day -365 through 0 days relative to index: Corticosteroids for local oral treatment,21600033
measurement during day -365 through 0 days relative to index: P-R Interval,3007794
measurement during day -365 through 0 days relative to index: Plasma given [Volume],3000751
drug_era during day -365 through 0 days relative to index: Magnesium Sulfate,19093848
drug_era group during day -365 through 0 days relative to index: Magnesium Sulfate,19093848
drug_era during day -365 through 0 days relative to index: Bupivacaine,732893
drug_era group during day -365 through 0 days relative to index: Bupivacaine,732893
drug_exposure during day -365 through 0 days relative to index: 5 ML Rocuronium 10 MG/ML Injection,43291560
drug_era group during day -365 through 0 days relative to index: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,21602054
drug_exposure during day -365 through 0 days relative to index: Nicardipine hydrochloride 10 MG,40165073
drug_exposure during day -365 through 0 days relative to index: Piperacillin 2000 MG / tazobactam 250 MG Injection,46275427
measurement during day -365 through 0 days relative to index: Medication route [Identifier] of Dose,3043591
drug_era during day -365 through 0 days relative to index: Potassium Chloride,19049105
drug_era group during day -365 through 0 days relative to index: Potassium Chloride,19049105
drug_exposure during day -365 through 0 days relative to index: Metronidazole 500 MG,1707403
measurement during day -365 through 0 days relative to index: Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,3013801
"measurement during day -365 through 0 days relative to index: Current medication, Insulin type",3033755
drug_exposure during day -365 through 0 days relative to index: Calcium Carbonate 500 MG,19036113
drug_era during day -365 through 0 days relative to index: esmolol,19063575
drug_era group during day -365 through 0 days relative to index: esmolol,19063575
drug_exposure during day -365 through 0 days relative to index: 100 ML Glucose 50 MG/ML Injection,36249736
drug_exposure during day -365 through 0 days relative to index: Ambroxol 30 MG,19086956
index year: 2019,0
drug_exposure during day -365 through 0 days relative to index: 2 ML Budesonide 0.5 MG/ML Inhalant Solution,21176012
drug_exposure during day -365 through 0 days relative to index: Methylprednisolone 40 MG Injection,1506430
condition_era group during day -365 through 0 days relative to index: Bleeding,437312
measurement during day -365 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,3026910
measurement during day -365 through 0 days relative to index: Aortic valve Orifice area by US.continuity.VTI+Diameter,3003445
drug_exposure during day -365 through 0 days relative to index: Chlorpheniramine Maleate 4 MG,40223461
condition_era group during day -365 through 0 days relative to index: Shock,201965
drug_era during day -365 through 0 days relative to index: Triprolidine,1105889
drug_era group during day -365 through 0 days relative to index: Triprolidine,1105889
"drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",21604091
drug_era group during day -365 through 0 days relative to index: Other centrally acting agents,21604114
drug_era group during day -365 through 0 days relative to index: Opioid anesthetics,21604200
condition_era group during day -365 through 0 days relative to index: Neoplasm of head,4054835
drug_era group during day -365 through 0 days relative to index: IMMUNOSUPPRESSANTS,21603890
drug_era group during day -365 through 0 days relative to index: IMMUNOSUPPRESSANTS,21603891
drug_exposure during day -365 through 0 days relative to index: itopride hydrochloride 50 MG,42962325
measurement during day -365 through 0 days relative to index: Insulin dose,44805570
measurement during day -365 through 0 days relative to index: Pain severity [Score] [PhenX],40766725
procedure_occurrence during day -365 through 0 days relative to index: MRI of head and neck with contrast,45765716
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of pulmonary artery with contrast,36717296
condition_era group during day -365 through 0 days relative to index: Malignant tumor of lung,443388
condition_era group during day -365 through 0 days relative to index: Neoplasm of lung,4128888
drug_exposure during day -365 through 0 days relative to index: Fluorouracil,955632
condition_era group during day -365 through 0 days relative to index: Neoplasm of lower respiratory tract,4112735
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of lower respiratory tract,4334322
condition_era group during day -365 through 0 days relative to index: Lesion of lung,4116778
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of lung,258369
condition_era group during day -365 through 0 days relative to index: Lung mass,4203096
condition_era group during day -365 through 0 days relative to index: Intracranial tumor,4116092
condition_era group during day -365 through 0 days relative to index: Infection of digestive system,4193990
drug_era during day -365 through 0 days relative to index: azelastine,934075
drug_era group during day -365 through 0 days relative to index: azelastine,934075
drug_era group during day -365 through 0 days relative to index: DECONGESTANTS AND ANTIALLERGICS,21605071
drug_era group during day -365 through 0 days relative to index: Other antiallergics,21605084
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intrathoracic organs,4247331
drug_era group during day -365 through 0 days relative to index: Bulk-forming laxatives,21600554
drug_exposure during day -365 through 0 days relative to index: 2 ML Dexmedetomidine 0.1 MG/ML Injection,19076175
drug_exposure during day -365 through 0 days relative to index: Valproate 60 MG/ML Oral Solution,36884836
condition_occurrence during day -365 through 0 days relative to index: Primary malignant neoplasm of lung,258369
drug_exposure during day -365 through 0 days relative to index: Folic Acid 1 MG,1387574
drug_era during day -365 through 0 days relative to index: remifentanil,19016749
drug_era group during day -365 through 0 days relative to index: remifentanil,19016749
measurement during day -365 through 0 days relative to index: Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma,3005411
"drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",21604070
condition_era group during day -365 through 0 days relative to index: Lesion of lumbar spine,4185976
condition_era group during day -365 through 0 days relative to index: Radiology result abnormal,441969
condition_era group during day -365 through 0 days relative to index: Imaging result abnormal,4256761
drug_era during day -365 through 0 days relative to index: hyaluronate,787787
drug_era group during day -365 through 0 days relative to index: hyaluronate,787787
drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,21604170
drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,21604171
drug_era group during day -365 through 0 days relative to index: Other drugs for disorders of the musculo-skeletal system,21604178
drug_era during day -365 through 0 days relative to index: Paroxetine,722031
drug_era group during day -365 through 0 days relative to index: Paroxetine,722031
drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS,21604069
drug_exposure during day -365 through 0 days relative to index: remifentanil 1 MG,35605373
condition_occurrence during day -365 through 0 days relative to index: Standard chest X-ray abnormal,4056837
condition_era group during day -365 through 0 days relative to index: Standard chest X-ray abnormal,4056837
condition_era group during day -365 through 0 days relative to index: Plain X-ray result abnormal,4058779
condition_era group during day -365 through 0 days relative to index: Imaging of thorax abnormal,40482228
drug_era group during day -365 through 0 days relative to index: MUSCULO-SKELETAL SYSTEM,21603931
condition_era group during day -365 through 0 days relative to index: Lesion of rectum,4103995
drug_era during day -365 through 0 days relative to index: ferric carboxymaltose,43560392
drug_era group during day -365 through 0 days relative to index: ferric carboxymaltose,43560392
drug_exposure during day -365 through 0 days relative to index: 10 ML ferric carboxymaltose 180 MG/ML Injectable Solution,43700290
drug_exposure during day -365 through 0 days relative to index: Finasteride 5 MG Oral Tablet,19077375
drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES FOR SYSTEMIC USE,21602795
drug_exposure during day -365 through 0 days relative to index: isoniazid 100 MG,19081585
drug_era group during day -365 through 0 days relative to index: ANTIBACTERIALS FOR SYSTEMIC USE,21602796
drug_era during day -365 through 0 days relative to index: isoniazid,1782521
drug_era group during day -365 through 0 days relative to index: isoniazid,1782521
condition_era group during day -365 through 0 days relative to index: Anorectal disorder,4145825
drug_era group during day -365 through 0 days relative to index: Hydrazides,21603102
procedure_occurrence during day -365 through 0 days relative to index: MRI of liver with contrast,4329640
condition_era group during day -365 through 0 days relative to index: Acute disease of cardiovascular system,4028367
condition_era group during day -365 through 0 days relative to index: Malignant tumor of large intestine,443396
condition_era group during day -365 through 0 days relative to index: Malignant tumor of rectum,443390
condition_era group during day -365 through 0 days relative to index: Rectal mass,4087647
condition_era group during day -365 through 0 days relative to index: Neoplasm of rectum,4131616
drug_exposure during day -365 through 0 days relative to index: Amikacin 250 MG,43201362
drug_exposure during day -365 through 0 days relative to index: Lidocaine 700 MG Transdermal System,43138833
drug_era group during day -365 through 0 days relative to index: Phenylpiperidine derivatives,21604269
condition_era group during day -365 through 0 days relative to index: Spinal injury,4095850
condition_era group during day -365 through 0 days relative to index: Traumatic and/or non-traumatic injury of back,37016775
condition_era group during day -365 through 0 days relative to index: Traumatic injury of vertebral region of back,42537893
drug_exposure during day -365 through 0 days relative to index: Calcium Citrate / Cholecalciferol Oral Tablet,40017418
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of anorectum,40481902
drug_exposure during day -365 through 0 days relative to index: 0.8 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe,40160991
drug_era during day -365 through 0 days relative to index: Benserazide,19016463
drug_era group during day -365 through 0 days relative to index: Benserazide,19016463
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of colon and/or rectum,36683531
condition_occurrence during day -365 through 0 days relative to index: Subarachnoid hemorrhage due to traumatic injury,4134162
condition_era group during day -365 through 0 days relative to index: Subarachnoid hemorrhage due to traumatic injury,4134162
condition_era group during day -365 through 0 days relative to index: Pulmonary embolism,440417
condition_era group during day -365 through 0 days relative to index: Trunk arterial embolus,4194610
drug_era during day -365 through 0 days relative to index: Ketoprofen,1185922
drug_era group during day -365 through 0 days relative to index: Ketoprofen,1185922
condition_occurrence during day -365 through 0 days relative to index: Primary malignant neoplasm of rectum,74582
condition_occurrence during day -365 through 0 days relative to index: Vertigo of central origin,381035
condition_era group during day -365 through 0 days relative to index: Vertigo of central origin,381035
condition_era group during day -365 through 0 days relative to index: Arterial embolus and thrombosis,312337
drug_exposure during day -365 through 0 days relative to index: atorvastatin 20 MG Oral Tablet,19123592
drug_era group during day -365 through 0 days relative to index: Other cardiac preparations,21600363
drug_exposure during day -365 through 0 days relative to index: Sertraline 50 MG Oral Tablet,739209
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of rectum,74582
condition_era group during day -365 through 0 days relative to index: Dyslexia AND/OR speech dysfunction,4024717
condition_occurrence during day -365 through 0 days relative to index: Dysarthria,4196636
condition_era group during day -365 through 0 days relative to index: Dysarthria,4196636
condition_era group during day -365 through 0 days relative to index: Aneurysm of head and neck artery,4117771
drug_era during day -365 through 0 days relative to index: Insulin Glargine,1502905
drug_era group during day -365 through 0 days relative to index: Insulin Glargine,1502905
drug_exposure during day -365 through 0 days relative to index: Diltiazem Hydrochloride 90 MG Extended Release Oral Capsule,19133613
drug_era group during day -365 through 0 days relative to index: Direct factor Xa inhibitors,43534760
condition_occurrence during day -365 through 0 days relative to index: Malignant tumor of rectum,443390
condition_era group during day -365 through 0 days relative to index: Anomaly of eye,37018677
drug_era during day -365 through 0 days relative to index: Alendronate,1557272
drug_era group during day -365 through 0 days relative to index: Alendronate,1557272
measurement during day -365 through 0 days relative to index: Protein C [Units/volume] in Platelet poor plasma by Chromogenic method,3001149
drug_exposure during day -365 through 0 days relative to index: 3 ML Insulin Glargine 100 UNT/ML Injection,43258829
drug_era during day -365 through 0 days relative to index: Sertraline,739138
drug_era group during day -365 through 0 days relative to index: Sertraline,739138
condition_era group during day -365 through 0 days relative to index: Acute cholangitis,4267297
measurement during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Blood,3021119
condition_era group during day -365 through 0 days relative to index: Atherosclerosis of artery,40479625
drug_era during day -365 through 0 days relative to index: Ampicillin,1717327
drug_era group during day -365 through 0 days relative to index: Ampicillin,1717327
drug_exposure during day -365 through 0 days relative to index: Ampicillin 500 MG,19082973
drug_exposure during day -365 through 0 days relative to index: Azithromycin 250 MG Oral Tablet,19073777
drug_exposure during day -365 through 0 days relative to index: 1000 ML Glucose 100 MG/ML Injection,36249712
condition_era group during day -365 through 0 days relative to index: Malignant neoplastic disease,443392
condition_era group during day -365 through 0 days relative to index: Malignant tumor of digestive organ,4116238
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of digestive system,40491001
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm,439392
drug_era during day -365 through 0 days relative to index: Tramadol,1103314
drug_era group during day -365 through 0 days relative to index: Tramadol,1103314
drug_era group during day -365 through 0 days relative to index: Other opioids,21604296
drug_era group during day -365 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,21600490
drug_era group during day -365 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,21600491
drug_era group during day -365 through 0 days relative to index: Serotonin (5HT3) antagonists,21600492
drug_era group during day -365 through 0 days relative to index: ANTINEOPLASTIC AGENTS,21601387
measurement during day -365 through 0 days relative to index: Iron binding capacity [Mass/volume] in Serum or Plasma,3021044
measurement during day -365 through 0 days relative to index: Iron [Mass/volume] in Serum or Plasma,3002400
measurement during day -365 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma,3001122
"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",21602098
"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS, PLAIN",21602099
drug_era during day -365 through 0 days relative to index: Hydrocortisone,975125
drug_era group during day -365 through 0 days relative to index: Hydrocortisone,975125
"drug_era group during day -365 through 0 days relative to index: Corticosteroids, weak (group I)",21602100
"drug_era group during day -365 through 0 days relative to index: Corticosteroids, moderately potent (group II)",21602104
drug_era group during day -365 through 0 days relative to index: OTHER ANTINEOPLASTIC AGENTS,21603746
drug_exposure during day -365 through 0 days relative to index: 2 ML Tramadol 50 MG/ML Injection,43286055
measurement during day -365 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,3003785
drug_exposure during day -365 through 0 days relative to index: Piperacillin 4000 MG,46275443
measurement during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Body fluid,3012133
measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Body fluid,3019210
measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Cerebral spinal fluid,3036172
measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction,40763084
condition_era group during day -365 through 0 days relative to index: Neoplasm of intra-abdominal organs,4054503
drug_era group during day -365 through 0 days relative to index: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),21600109
condition_occurrence during day -365 through 0 days relative to index: Aortic valve stenosis,4189343
drug_exposure during day -365 through 0 days relative to index: Lactulose Oral Solution,40051138
drug_era group during day -365 through 0 days relative to index: ALKYLATING AGENTS,21601388
measurement during day -365 through 0 days relative to index: Fungus identified in Unspecified specimen by Culture,3000494
drug_era group during day -365 through 0 days relative to index: Nucleoside and nucleotide reverse transcriptase inhibitors,21603159
drug_era during day -365 through 0 days relative to index: Water,19010309
drug_era group during day -365 through 0 days relative to index: Water,19010309
drug_exposure during day -365 through 0 days relative to index: Water Injection,43516273
drug_exposure during day -365 through 0 days relative to index: Acetaminophen 325 MG / tramadol hydrochloride 37.5 MG Oral Tablet,1103359
drug_exposure during day -365 through 0 days relative to index: Acetaminophen 650 MG Oral Tablet,1125393
drug_era group during day -365 through 0 days relative to index: Nitrogen mustard analogues,21601389
condition_occurrence during day -365 through 0 days relative to index: Inadequate food diet,4010022
drug_exposure during day -365 through 0 days relative to index: Glucose 200 MG/ML Injection,36249593
"drug_era group during day -365 through 0 days relative to index: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",21602968
drug_era during day -365 through 0 days relative to index: Cyclophosphamide,1310317
drug_era group during day -365 through 0 days relative to index: Cyclophosphamide,1310317
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of trunk,4312698
drug_exposure during day -365 through 0 days relative to index: Cyclophosphamide 500 MG,35606510
measurement during day -365 through 0 days relative to index: Cells [#/volume] in Body fluid by Manual count,3008151
drug_exposure during day -365 through 0 days relative to index: Dexamethasone 0.5 MG,1518605
drug_era group during day -365 through 0 days relative to index: Anticholinesterases,21604803
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of abdomen,36684472
drug_exposure during day -365 through 0 days relative to index: Zinc Sulfate,19044522
drug_era group during day -365 through 0 days relative to index: ANTI-ACNE PREPARATIONS,21602281
drug_era group during day -365 through 0 days relative to index: ANTI-ACNE PREPARATIONS FOR TOPICAL USE,21602282
"drug_era group during day -365 through 0 days relative to index: Belladonna alkaloids, semisynthetic, quaternary ammonium compounds",21600195
drug_exposure during day -365 through 0 days relative to index: Fentanyl 0.012 MG/HR Transdermal System,42902404
drug_exposure during day -365 through 0 days relative to index: Naproxen 500 MG,1115092
"drug_exposure during day -365 through 0 days relative to index: heparin sodium, porcine 100 UNT/ML",43011476
drug_exposure during day -365 through 0 days relative to index: Levodropropizine 6 MG/ML Oral Suspension,42929751
drug_era during day -365 through 0 days relative to index: Fluorouracil,955632
drug_era group during day -365 through 0 days relative to index: Fluorouracil,955632
drug_era during day -365 through 0 days relative to index: ropinirole,713823
drug_era group during day -365 through 0 days relative to index: ropinirole,713823
drug_era during day -365 through 0 days relative to index: Ceftizoxime,1777254
drug_era group during day -365 through 0 days relative to index: Ceftizoxime,1777254
drug_exposure during day -365 through 0 days relative to index: 30 ML Adenosine 3 MG/ML Injection,46234165
drug_exposure during day -365 through 0 days relative to index: Escitalopram 10 MG,19098080
condition_occurrence during day -365 through 0 days relative to index: Liver cell carcinoma,4001171
condition_era group during day -365 through 0 days relative to index: Liver cell carcinoma,4001171
condition_era group during day -365 through 0 days relative to index: Adenocarcinoma of liver,4252535
drug_exposure during day -365 through 0 days relative to index: 50 ML Dexmedetomidine 0.004 MG/ML Injection,35603042
drug_exposure during day -365 through 0 days relative to index: hemocoagulase 1 UNT/ML,42960571
drug_exposure during day -365 through 0 days relative to index: erdosteine 300 MG,19109748
drug_era during day -365 through 0 days relative to index: afloqualone,43009034
drug_era group during day -365 through 0 days relative to index: afloqualone,43009034
drug_exposure during day -365 through 0 days relative to index: Choline 400 MG Oral Tablet,1195354
condition_era group during day -365 through 0 days relative to index: Acidosis,435517
drug_exposure during day -365 through 0 days relative to index: Fluconazole 100 MG,1755073
condition_era group during day -365 through 0 days relative to index: Metabolic acidosis,4245042
condition_era group during day -365 through 0 days relative to index: Low blood pressure,317002
condition_era group during day -365 through 0 days relative to index: Nerve root disorder,4216397
drug_era during day -365 through 0 days relative to index: Cefotetan,1774932
drug_era group during day -365 through 0 days relative to index: Cefotetan,1774932
measurement during day -365 through 0 days relative to index: Hepatitis A virus IgG Ab [Presence] in Serum,3006631
drug_exposure during day -365 through 0 days relative to index: Leucovorin 15 MG,1388829
measurement during day -365 through 0 days relative to index: Acute leukemia panel - Unspecified specimen by Flow cytometry (FC),3045592
procedure_occurrence during day -365 through 0 days relative to index: Transfusion of platelet concentrate,4035234
drug_era during day -365 through 0 days relative to index: Nimodipine,1319133
drug_era group during day -365 through 0 days relative to index: Nimodipine,1319133
drug_era during day -365 through 0 days relative to index: Naloxone,1114220
drug_era group during day -365 through 0 days relative to index: Naloxone,1114220
drug_exposure during day -365 through 0 days relative to index: gabapentin 300 MG,797432
drug_era during day -365 through 0 days relative to index: ivy leaf extract,36878639
drug_era group during day -365 through 0 days relative to index: ivy leaf extract,36878639
condition_occurrence during day -365 through 0 days relative to index: Acute respiratory distress,4191650
condition_era group during day -365 through 0 days relative to index: Acute respiratory distress,4191650
condition_era group during day -365 through 0 days relative to index: Neoplasm of upper aerodigestive tract,4232106
drug_era during day -365 through 0 days relative to index: Dalteparin,1301065
drug_era group during day -365 through 0 days relative to index: Dalteparin,1301065
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of head,442131
"condition_era group during day -365 through 0 days relative to index: Malignant tumor of ear, nose and throat",4116236
condition_era group during day -365 through 0 days relative to index: Compression fracture of vertebral column,4179527
condition_era group during day -365 through 0 days relative to index: Compression fracture,40481450
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of upper respiratory tract,40493020
measurement during day -365 through 0 days relative to index: Patient location,40759935
condition_era group during day -365 through 0 days relative to index: Loss of consciousness,372448
condition_era group during day -365 through 0 days relative to index: Decreased level of consciousness,40481424
drug_exposure during day -365 through 0 days relative to index: Granisetron 34.3 MG Transdermal System Box of 1,36420015
drug_exposure during day -365 through 0 days relative to index: Midazolam 5 MG/ML,19086213
drug_era during day -365 through 0 days relative to index: Omega-3 Fatty Acids,19106973
drug_era group during day -365 through 0 days relative to index: Omega-3 Fatty Acids,19106973
condition_era group during day -365 through 0 days relative to index: Neoplasm of upper respiratory tract,4054511
"condition_era group during day -365 through 0 days relative to index: Tumor of ear, nose and throat",4112586
drug_era during day -365 through 0 days relative to index: Coptis chinensis root extract,43525922
drug_era group during day -365 through 0 days relative to index: Coptis chinensis root extract,43525922
drug_exposure during day -365 through 0 days relative to index: Coptis chinensis root extract / ivy leaf extract Oral Suspension,42959259
drug_exposure during day -365 through 0 days relative to index: Kanamycin 1000 MG,42939508
condition_occurrence during day -365 through 0 days relative to index: Compression fracture of vertebral column,4179527
drug_exposure during day -365 through 0 days relative to index: Valproate 600 MG,36879524
condition_occurrence during day -365 through 0 days relative to index: Pleural effusion,254061
"drug_era group during day -365 through 0 days relative to index: Antiarrhythmics, class Ic",21600264
condition_era group during day -365 through 0 days relative to index: Headache disorder,375527
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of neck,30346
drug_exposure during day -365 through 0 days relative to index: Cefotetan 1000 MG,35605994
measurement during day -365 through 0 days relative to index: Zinc [Mass/volume] in Serum or Plasma,3017394
condition_era group during day -365 through 0 days relative to index: Disturbance of consciousness,376961
drug_era during day -365 through 0 days relative to index: irinotecan,1367268
drug_era group during day -365 through 0 days relative to index: irinotecan,1367268
drug_exposure during day -365 through 0 days relative to index: Bisoprolol Fumarate 5 MG Oral Tablet,40162878
condition_occurrence during day -365 through 0 days relative to index: Cardiorespiratory arrest,4256374
condition_era group during day -365 through 0 days relative to index: Cardiorespiratory arrest,4256374
condition_era group during day -365 through 0 days relative to index: Pleural effusion,254061
drug_era during day -365 through 0 days relative to index: sodium phosphate,939871
drug_era group during day -365 through 0 days relative to index: sodium phosphate,939871
drug_era during day -365 through 0 days relative to index: Kanamycin,1784749
drug_era group during day -365 through 0 days relative to index: Kanamycin,1784749
measurement during day -365 through 0 days relative to index: Prolactin [Mass/volume] in Serum or Plasma,3004722
procedure_occurrence during day -365 through 0 days relative to index: Cardiovascular stress test using treadmill,2007055
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of brain and neck artery,37109061
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of brain,380055
condition_era group during day -365 through 0 days relative to index: Oral lesion,43530620
drug_exposure during day -365 through 0 days relative to index: Gentamicin,45892419
procedure_occurrence during day -365 through 0 days relative to index: CT of temporal bone without contrast,36713274
drug_exposure during day -365 through 0 days relative to index: Diazepam 2 MG,723141
measurement during day -365 through 0 days relative to index: Estradiol (E2) [Mass/volume] in Serum or Plasma,3025285
drug_era during day -365 through 0 days relative to index: Misoprostol,1150871
drug_era group during day -365 through 0 days relative to index: Misoprostol,1150871
drug_era group during day -365 through 0 days relative to index: Prostaglandins,21600092
condition_era group during day -365 through 0 days relative to index: Cerebellar disorder,4329160
condition_era group during day -365 through 0 days relative to index: Neoplasm of neck,4129244
measurement during day -365 through 0 days relative to index: Microalbumin [Mass/volume] in Urine,3000034
drug_exposure during day -365 through 0 days relative to index: Clindamycin 300 MG,19085270
drug_exposure during day -365 through 0 days relative to index: Furosemide 40 MG,957138
condition_era group during day -365 through 0 days relative to index: Musculoskeletal infective disorder,4193176
observation during day -365 through 0 days relative to index: Discharge summary,40318997
drug_exposure during day -365 through 0 days relative to index: 5.20000000000000018 ML Megestrol 125 MG/ML Oral Suspension,42921068
drug_exposure during day -365 through 0 days relative to index: 0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe,40160973
condition_era group during day -365 through 0 days relative to index: Autoimmune disease,434621
condition_occurrence during day -365 through 0 days relative to index: Unruptured aneurysm of middle cerebral artery,4077957
condition_era group during day -365 through 0 days relative to index: Malignant tumor of neck,4178979
condition_era group during day -365 through 0 days relative to index: Neck pain,24134
drug_exposure during day -365 through 0 days relative to index: polaprezinc 75 MG Oral Tablet,42961057
drug_era during day -365 through 0 days relative to index: Propafenone,1353256
drug_era group during day -365 through 0 days relative to index: Propafenone,1353256
condition_era group during day -365 through 0 days relative to index: Neoplasm of endocrine system,4300595
measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose,3010300
"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, long-acting",21600735
drug_era group during day -365 through 0 days relative to index: HIGH-CEILING DIURETICS,21601516
"drug_era group during day -365 through 0 days relative to index: Sulfonamides, plain",21601517
condition_era group during day -365 through 0 days relative to index: Intraparenchymal hemorrhage of brain,40492969
drug_era during day -365 through 0 days relative to index: Furosemide,956874
drug_era group during day -365 through 0 days relative to index: Furosemide,956874
drug_exposure during day -365 through 0 days relative to index: Doxazosin 4 MG Extended Release Oral Tablet,1363086
drug_exposure during day -365 through 0 days relative to index: Irinotecan hydrochloride 20 MG/ML,40174869
drug_exposure during day -365 through 0 days relative to index: Metformin hydrochloride 1000 MG Oral Tablet,40164897
drug_exposure during day -365 through 0 days relative to index: 12 ML Propofol 10 MG/ML Injectable Solution,42920550
drug_era group during day -365 through 0 days relative to index: DIURETICS,21601461
condition_occurrence during day -365 through 0 days relative to index: Malignant tumor of pancreas,4180793
measurement during day -365 through 0 days relative to index: Magnesium Ionized [Moles/volume] in Serum or Plasma,3021197
measurement during day -365 through 0 days relative to index: Lactate [Moles/volume] in Blood,3047181
measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Blood,3000285
measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Blood,3005456
measurement during day -365 through 0 days relative to index: Tricuspid valve Maximum regurgitant blood flow velocity during systole by US.doppler,3002076
measurement during day -365 through 0 days relative to index: Systemic vascular Resistance,3035146
measurement during day -365 through 0 days relative to index: Left ventricular Cardiac output,3005555
measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Blood,3018572
drug_exposure during day -365 through 0 days relative to index: 1000 ML Glucose 50 MG/ML / Potassium Chloride 0.02 MEQ/ML / Sodium Chloride 4.5 MG/ML Injection,1593063
measurement during day -365 through 0 days relative to index: Left ventricular End-systolic volume by US.2D+Calculated by biplane ellipse method,3024038
measurement during day -365 through 0 days relative to index: Mitral valve medial annulus Tissue velocity.E-wave.max by US.tissue doppler,21490991
measurement during day -365 through 0 days relative to index: Mitral valve medial annulus Tissue velocity.S-wave.max by US.tissue doppler,21491102
drug_era group during day -365 through 0 days relative to index: OTHER ANALGESICS AND ANTIPYRETICS,21604303
measurement during day -365 through 0 days relative to index: Mitral valve Peak E wave by US.doppler,3015509
measurement during day -365 through 0 days relative to index: Mitral valve medial annulus E-wave/Tissue velocity.E-wave.max by US.doppler+tissue doppler,21492071
measurement during day -365 through 0 days relative to index: Thyrotropin [Units/volume] in Blood,3023399
measurement during day -365 through 0 days relative to index: Thyroxine (T4) free [Mass/volume] in Serum or Plasma,3008598
measurement during day -365 through 0 days relative to index: Left atrial End-systolic volume by US.2D+Calculated by biplane area-length method,21494018
measurement during day -365 through 0 days relative to index: Left atrial End-systolic volume (by US.2D+Calculated by biplane area-length method)/Body surface area,21494019
measurement during day -365 through 0 days relative to index: Mitral valve E-wave deceleration time by US.doppler,21492073
Charlson index - Romano adaptation,0
drug_era during day -365 through 0 days relative to index: Acetaminophen,1125315
drug_era group during day -365 through 0 days relative to index: Acetaminophen,1125315
drug_era group during day -365 through 0 days relative to index: Anilides,21604343
measurement during day -365 through 0 days relative to index: Formula used to compute body surface area,3000838
measurement during day -365 through 0 days relative to index: Left ventricular Myocardial mass by US.M-mode+Calculated by cube method,46236792
measurement during day -365 through 0 days relative to index: Left ventricle [Length] Minor axis.diastole US.M-mode+Measured,3014726
measurement during day -365 through 0 days relative to index: Left ventricle [Length] Short axis during systole US.M-mode+Measured,3015876
measurement during day -365 through 0 days relative to index: Left ventricular Myocardial mass/Body surface area [Mass/Area] by US.M-mode+Calculated by cube method,46236336
measurement during day -365 through 0 days relative to index: Left atrial Diameter anterior-posterior systole by US.M-mode,3035095
measurement during day -365 through 0 days relative to index: Right ventricular Intrachamber systolic pressure estimated by US,42529426
drug_exposure during day -365 through 0 days relative to index: 100 ML Mannitol 150 MG/ML Injectable Solution,43757325
measurement during day -365 through 0 days relative to index: Inflation trigger pressure setting Ventilator,36305890
drug_era during day -365 through 0 days relative to index: Esomeprazole,904453
drug_era group during day -365 through 0 days relative to index: Esomeprazole,904453
drug_era during day -365 through 0 days relative to index: Oxycodone,1124957
drug_era group during day -365 through 0 days relative to index: Oxycodone,1124957
drug_era group during day -365 through 0 days relative to index: ANALGESICS,21604253
drug_exposure during day -365 through 0 days relative to index: Ceftriaxone 2000 MG Prefilled Syringe,36894724
"measurement during day -365 through 0 days relative to index: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz)",3030104
"measurement during day -365 through 0 days relative to index: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)",40764999
drug_exposure during day -365 through 0 days relative to index: 200 ML Glucose 50 MG/ML Injectable Solution,42918925
drug_era group during day -365 through 0 days relative to index: INTESTINAL ANTIINFECTIVES,21600601
drug_era group during day -365 through 0 days relative to index: Antibiotics,21600602
drug_exposure during day -365 through 0 days relative to index: 1000 ML Glucose 50 MG/ML / Sodium Chloride 9 MG/ML Injection,36249703
condition_era group during day -365 through 0 days relative to index: Atrial fibrillation,313217
condition_era group during day -365 through 0 days relative to index: Renal impairment,4030518
condition_era group during day -365 through 0 days relative to index: Atrial arrhythmia,4068155
condition_era group during day -365 through 0 days relative to index: Supraventricular arrhythmia,4248028
drug_era during day -365 through 0 days relative to index: Lactulose,987245
drug_era group during day -365 through 0 days relative to index: Lactulose,987245
condition_occurrence during day -365 through 0 days relative to index: Atrial fibrillation,313217
condition_era group during day -365 through 0 days relative to index: Kidney disease,198124
measurement during day -365 through 0 days relative to index: QRS duration,3022022
measurement during day -365 through 0 days relative to index: Q-T interval,3025809
measurement during day -365 through 0 days relative to index: Q-T interval corrected,3026258
measurement during day -365 through 0 days relative to index: Paced heart rate by EKG,21490782
measurement during day -365 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Serum or Plasma,3004905
drug_era during day -365 through 0 days relative to index: Hydroxyzine,777221
drug_era group during day -365 through 0 days relative to index: Hydroxyzine,777221
drug_era group during day -365 through 0 days relative to index: Diphenylmethane derivatives,21604589
measurement during day -365 through 0 days relative to index: Physical findings skin ulcer,3007254
measurement during day -365 through 0 days relative to index: Intubation tube depth Respiratory system,3046004
measurement during day -365 through 0 days relative to index: Endotracheal tube Diameter,21491186
measurement during day -365 through 0 days relative to index: Pupil diameter Left eye Manual,3026611
drug_era during day -365 through 0 days relative to index: celecoxib,1118084
drug_era group during day -365 through 0 days relative to index: celecoxib,1118084
"drug_era during day -365 through 0 days relative to index: Regular Insulin, Human",1596977
"drug_era group during day -365 through 0 days relative to index: Regular Insulin, Human",1596977
"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, intermediate-acting",21600722
index year: 2010,0
measurement during day -365 through 0 days relative to index: Chromosome analysis panel - Blood by G-banded,40765089
measurement during day -365 through 0 days relative to index: Patient safety,45875976
measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Blood by Test strip manual,3014053
measurement during day -365 through 0 days relative to index: Cardiac catheterization access site,21494835
drug_era group during day -365 through 0 days relative to index: Macrolides,21602969
measurement during day -365 through 0 days relative to index: Albumin given [Volume],3010008
drug_era group during day -365 through 0 days relative to index: Coxibs,21603991
measurement during day -365 through 0 days relative to index: Richmond agitation-sedation scale,36684829
condition_era group during day -365 through 0 days relative to index: Fibrillation,4226399
condition_occurrence during day -365 through 0 days relative to index: Acute myocardial infarction,312327
measurement during day -365 through 0 days relative to index: Inflation trigger flow setting Ventilator,36303561
drug_era group during day -365 through 0 days relative to index: ANTIANEMIC PREPARATIONS,21601077
measurement during day -365 through 0 days relative to index: Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain,3018543
measurement during day -365 through 0 days relative to index: Invasive Mean blood pressure,21490852
drug_era group during day -365 through 0 days relative to index: ANTIMYCOBACTERIALS,21603089
drug_era group during day -365 through 0 days relative to index: DRUGS FOR TREATMENT OF TUBERCULOSIS,21603090
measurement during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,3016771
drug_exposure during day -365 through 0 days relative to index: Dexamethasone,1518254
"drug_era during day -365 through 0 days relative to index: Albumin Human, USP",1344143
"drug_era group during day -365 through 0 days relative to index: Albumin Human, USP",1344143
"drug_exposure during day -365 through 0 days relative to index: 100 ML Albumin Human, USP 2 MG/ML Injection",586658
measurement during day -365 through 0 days relative to index: Erythrocyte Distribution Width | Red Blood Cells,40773752
drug_exposure during day -365 through 0 days relative to index: Sodium Bicarbonate 500 MG Oral Tablet,939539
drug_exposure during day -365 through 0 days relative to index: Fentanyl 0.05 MG/ML Injection,35603429
measurement during day -365 through 0 days relative to index: Circulation status,4225712
drug_era during day -365 through 0 days relative to index: Enoxaparin,1301025
drug_era group during day -365 through 0 days relative to index: Enoxaparin,1301025
measurement during day -365 through 0 days relative to index: Nuclear Ab [Presence] in Serum by Hep2 substrate,40762162
drug_era during day -365 through 0 days relative to index: Midazolam,708298
drug_era group during day -365 through 0 days relative to index: Midazolam,708298
drug_era group during day -365 through 0 days relative to index: Benzodiazepine derivatives,21604635
measurement during day -365 through 0 days relative to index: QRS axis,3006277
drug_era during day -365 through 0 days relative to index: Neostigmine,717136
drug_era group during day -365 through 0 days relative to index: Neostigmine,717136
condition_era group during day -365 through 0 days relative to index: Spinal stenosis,77079
measurement during day -365 through 0 days relative to index: Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma,3023173
drug_exposure during day -365 through 0 days relative to index: Oxycodone Hydrochloride 10 MG Oral Tablet,40232707
measurement during day -365 through 0 days relative to index: Tidal volume inspired spontaneous+mechanical --on ventilator,3033780
condition_occurrence during day -365 through 0 days relative to index: Acute non-ST segment elevation myocardial infarction,4270024
condition_era group during day -365 through 0 days relative to index: Acute non-ST segment elevation myocardial infarction,4270024
drug_era during day -365 through 0 days relative to index: Sodium Bicarbonate,939506
drug_era group during day -365 through 0 days relative to index: Sodium Bicarbonate,939506
measurement during day -365 through 0 days relative to index: Pulse intensity Dorsal pedal artery - right by palpation,44816680
drug_exposure during day -365 through 0 days relative to index: Cisplatin 50 MG,35604085
drug_era group during day -365 through 0 days relative to index: Other antihistamines for systemic use,21603503
measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma --pre-meal,3040820
procedure_occurrence during day -365 through 0 days relative to index: Transthoracic echocardiography,4335825
condition_era group during day -365 through 0 days relative to index: Measurement finding outside reference range,40481841
measurement during day -365 through 0 days relative to index: Cortisol [Mass/volume] in Serum or Plasma,3009682
measurement during day -365 through 0 days relative to index: Procalcitonin [Mass/volume] in Serum or Plasma,3046279
measurement during day -365 through 0 days relative to index: Blood group antibody screen [Presence] in Serum or Plasma,3001079
measurement during day -365 through 0 days relative to index: Hepatitis B virus core IgG Ab [Presence] in Serum by Immunoassay,3043974
measurement during day -365 through 0 days relative to index: Mean blood pressure,3027598
measurement during day -365 through 0 days relative to index: Pulse intensity Dorsal pedal artery - left by palpation,3019743
drug_era group during day -365 through 0 days relative to index: IRON PREPARATIONS,21601078
measurement during day -365 through 0 days relative to index: Respiratory rate by Airway flow measurement,21490846
measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Urine,3037121
drug_era during day -365 through 0 days relative to index: Sucralfate,1036228
drug_era group during day -365 through 0 days relative to index: Sucralfate,1036228
drug_exposure during day -365 through 0 days relative to index: Carbocysteine,19041843
procedure_occurrence during day -365 through 0 days relative to index: Transesophageal echocardiography,4019824
drug_era group during day -365 through 0 days relative to index: Acetic acid derivatives and related substances,21603940
measurement during day -365 through 0 days relative to index: Protein/Creatinine ratio in urine,2000000331
condition_occurrence during day -365 through 0 days relative to index: Chronic kidney disease,46271022
measurement during day -365 through 0 days relative to index: Protein/Creatinine [Mass Ratio] in Urine,3001582
measurement during day -365 through 0 days relative to index: Hemoglobin.gastrointestinal [Mass/mass] in Stool,3024966
drug_era during day -365 through 0 days relative to index: Carbidopa,740560
drug_era group during day -365 through 0 days relative to index: Carbidopa,740560
"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, fast-acting",21600714
measurement during day -365 through 0 days relative to index: Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,3032567
drug_exposure during day -365 through 0 days relative to index: Lidocaine Oral Solution,44055826
condition_era group during day -365 through 0 days relative to index: Measurement finding below reference range,40484533
condition_occurrence during day -365 through 0 days relative to index: End-stage renal disease,193782
measurement during day -365 through 0 days relative to index: Vancomycin [Mass/volume] in Serum or Plasma,3005715
drug_era group during day -365 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,21600128
condition_era group during day -365 through 0 days relative to index: Compression fracture of lumbosacral spine,764678
condition_era group during day -365 through 0 days relative to index: Compression fracture of lumbar spine,4140300
drug_era group during day -365 through 0 days relative to index: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,21602682
condition_era group during day -365 through 0 days relative to index: Chronic kidney disease,46271022
drug_era group during day -365 through 0 days relative to index: Enzymes,21601006
"measurement during day -365 through 0 days relative to index: Current medication, Bolus delivered",3031816
measurement during day -365 through 0 days relative to index: PCA lockout time Infusion pump,21490888
condition_occurrence during day -365 through 0 days relative to index: Chest pain,77670
condition_occurrence during day -365 through 0 days relative to index: Injury of head,375415
measurement during day -365 through 0 days relative to index: Beta hydroxybutyrate [Moles/volume] in Blood by Test strip,40769111
condition_era group during day -365 through 0 days relative to index: End-stage renal disease,193782
drug_era group during day -365 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,21601765
drug_exposure during day -365 through 0 days relative to index: rebamipide 100 MG,42960166
drug_era during day -365 through 0 days relative to index: ramosetron hydrochloride,43009099
drug_era group during day -365 through 0 days relative to index: ramosetron hydrochloride,43009099
condition_era group during day -365 through 0 days relative to index: Chronic disease of genitourinary system,4134595
drug_era group during day -365 through 0 days relative to index: ANTIPSYCHOTICS,21604490
drug_exposure during day -365 through 0 days relative to index: Carbidopa 25 MG / Levodopa 100 MG Oral Tablet,789581
measurement during day -365 through 0 days relative to index: Orientia tsutsugamushi Ab [Titer] in Serum,3006338
condition_occurrence during day -365 through 0 days relative to index: Compression fracture of lumbar spine,4140300
condition_occurrence during day -365 through 0 days relative to index: Cardiac arrest with successful resuscitation,4120088
condition_era group during day -365 through 0 days relative to index: Cardiac arrest with successful resuscitation,4120088
measurement during day -365 through 0 days relative to index: Pain score,4022240
measurement during day -365 through 0 days relative to index: Rise time setting Ventilator,40760770
condition_occurrence during day -365 through 0 days relative to index: Evaluation procedure,4297090
drug_exposure during day -365 through 0 days relative to index: Diltiazem 50 MG Injection,42950300
"measurement during day -365 through 0 days relative to index: Current medication, Basal rate",3031982
drug_exposure during day -365 through 0 days relative to index: Ceftriaxone 2000 MG Injection,46287335
measurement during day -365 through 0 days relative to index: T wave axis,3027358
condition_era group during day -365 through 0 days relative to index: Inflammation of skin and/or subcutaneous tissue,4181062
drug_exposure during day -365 through 0 days relative to index: Esomeprazole 40 MG Injection,19112920
condition_era group during day -365 through 0 days relative to index: Inflammatory dermatosis,45766714
"drug_exposure during day -365 through 0 days relative to index: Insulin, Aspart Protamine, Human 70 UNT/ML / Insulin, Aspart, Human 30 UNT/ML Pen Injector",42902356
drug_exposure during day -365 through 0 days relative to index: Ketorolac Tromethamine 30 MG/ML Injection,46287423
measurement during day -365 through 0 days relative to index: Fluid intake urinary bladder irrigation Measured,3009994
measurement during day -365 through 0 days relative to index: Therapeutic drug monitoring studies (set),3015960
drug_exposure during day -365 through 0 days relative to index: ertapenem 1000 MG Injection,35606488
measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Cerebral spinal fluid,3019473
drug_exposure during day -365 through 0 days relative to index: Hydrochlorothiazide 12.5 MG / Losartan Potassium 50 MG Oral Tablet,40184187
drug_exposure during day -365 through 0 days relative to index: Nitroglycerin 0.6 MG Sublingual Tablet,19019337
drug_era group during day -365 through 0 days relative to index: OTHER ANTIANEMIC PREPARATIONS,21601131
drug_era group during day -365 through 0 days relative to index: Other antianemic preparations,21601132
condition_era group during day -365 through 0 days relative to index: Chronic disease of respiratory system,4063381
drug_exposure during day -365 through 0 days relative to index: Esomeprazole 40 MG Oral Tablet,19101745
drug_exposure during day -365 through 0 days relative to index: Metronidazole 250 MG,19081680
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of neck vessels,45765485
drug_era during day -365 through 0 days relative to index: Diltiazem,1328165
drug_era group during day -365 through 0 days relative to index: Diltiazem,1328165
drug_era group during day -365 through 0 days relative to index: Benzothiazepine derivatives,21601770
condition_era group during day -365 through 0 days relative to index: Delirium,373995
condition_era group during day -365 through 0 days relative to index: Confusional state,381273
condition_era group during day -365 through 0 days relative to index: Organic mental disorder of unknown etiology,4023986
drug_exposure during day -365 through 0 days relative to index: Pramipexole dihydrochloride 1 MG Oral Tablet,40165177
measurement during day -365 through 0 days relative to index: Microalbumin/Creatinine panel in random Urine,3044897
measurement during day -365 through 0 days relative to index: Tidal volume Ventilator --on ventilator,21490854
drug_exposure during day -365 through 0 days relative to index: darbepoetin alfa Injection,46234250
drug_exposure during day -365 through 0 days relative to index: Hydrochlorothiazide 25 MG Oral Tablet,19078106
drug_exposure during day -365 through 0 days relative to index: Triamcinolone 40 MG,41294127
drug_era group during day -365 through 0 days relative to index: DRUGS USED IN DIABETES,21600712
measurement during day -365 through 0 days relative to index: Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay,3040363
drug_exposure during day -365 through 0 days relative to index: 120 ML Desonide 0.5 MG/ML Topical Lotion,42919237
drug_exposure during day -365 through 0 days relative to index: 10 ML Megestrol 40 MG/ML Oral Suspension [MEGESTROL ACETATE DAEWON SUSPENSION],42920603
drug_exposure during day -365 through 0 days relative to index: Magnesium Oxide 250 MG,993740
drug_exposure during day -365 through 0 days relative to index: Ranitidine 150 MG,961169
condition_occurrence during day -365 through 0 days relative to index: Motor vehicle traffic accident,437165
condition_era group during day -365 through 0 days relative to index: Infectious disease of nervous system,4028069
condition_era group during day -365 through 0 days relative to index: Infectious disease of central nervous system,4028070
measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Body fluid,3010910
measurement during day -365 through 0 days relative to index: Leukocytes other [#/volume] in Body fluid,3033169
measurement during day -365 through 0 days relative to index: Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,3009306
drug_era during day -365 through 0 days relative to index: ertapenem,1717963
drug_era group during day -365 through 0 days relative to index: ertapenem,1717963
measurement during day -365 through 0 days relative to index: Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic method,3014914
measurement during day -365 through 0 days relative to index: Ketones [Presence] in Serum or Plasma,3035132
condition_occurrence during day -365 through 0 days relative to index: Dysphagia,31317
condition_era group during day -365 through 0 days relative to index: Dysphagia,31317
drug_exposure during day -365 through 0 days relative to index: candesartan cilexetil 8 MG Oral Tablet,1351559
measurement during day -365 through 0 days relative to index: Adenovirus DNA [Identifier] in Unspecified specimen by NAA with probe detection,3040853
condition_occurrence during day -365 through 0 days relative to index: Mild cognitive disorder,4297400
condition_era group during day -365 through 0 days relative to index: Mild cognitive disorder,4297400
condition_era group during day -365 through 0 days relative to index: Cognitive disorder,40480615
drug_exposure during day -365 through 0 days relative to index: Acetylcysteine 200 MG Oral Capsule,19103575
drug_exposure during day -365 through 0 days relative to index: Ceftriaxone 1000 MG Injection,46287328
measurement during day -365 through 0 days relative to index: Nitrogen dioxide [VFr/PPres] Airway adaptor,21490727
drug_era group during day -365 through 0 days relative to index: POSTERIOR PITUITARY LOBE HORMONES,21602697
drug_era group during day -365 through 0 days relative to index: Vasopressin and analogues,21602698
drug_era group during day -365 through 0 days relative to index: UROLOGICALS,21602627
drug_exposure during day -365 through 0 days relative to index: 50 ML Nimodipine 0.2 MG/ML Injection,21058968
drug_exposure during day -365 through 0 days relative to index: pamidronate 15 MG,21133960
measurement during day -365 through 0 days relative to index: Choriogonadotropin (pregnancy test) [Presence] in Urine,3018954
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of central nervous system,4155285
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of nervous system,4157331
index year: 2007,0
measurement during day -365 through 0 days relative to index: Amikacin [Mass/volume] in Serum or Plasma,3036152
drug_exposure during day -365 through 0 days relative to index: Ambroxol 3 MG/ML,19088507
condition_era group during day -365 through 0 days relative to index: Disease due to Gram-positive bacteria,4161193
drug_exposure during day -365 through 0 days relative to index: lansoprazole 30 MG,19095273
drug_era during day -365 through 0 days relative to index: Atenolol,1314002
drug_era group during day -365 through 0 days relative to index: Atenolol,1314002
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of genitourinary system,4159963
condition_era group during day -365 through 0 days relative to index: Gastrointestinal perforation,4202064
drug_era during day -365 through 0 days relative to index: capecitabine,1337620
drug_era group during day -365 through 0 days relative to index: capecitabine,1337620
drug_exposure during day -365 through 0 days relative to index: Lactulose,987245
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the cardiovascular system,4029816
index year: 2013,0
condition_era group during day -365 through 0 days relative to index: Seizure disorder,4029498
condition_occurrence during day -365 through 0 days relative to index: Eruption,140214
drug_exposure during day -365 through 0 days relative to index: Fesoterodine Fumarate 4 MG Extended Release Oral Tablet,19134957
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of mediastinum,4189294
condition_occurrence during day -365 through 0 days relative to index: Epilepsy,380378
drug_exposure during day -365 through 0 days relative to index: Hydrochlorothiazide 25 MG / Spironolactone 25 MG Oral Tablet,974226
measurement during day -365 through 0 days relative to index: Platelet aggregation ADP induced [Units/volume] in Platelet rich plasma,3048603
condition_era group during day -365 through 0 days relative to index: Malignant tumor of pelvis,4177236
measurement during day -365 through 0 days relative to index: Albumin/Protein.total in Serum or Plasma by Electrophoresis,3007424
drug_exposure during day -365 through 0 days relative to index: Mupirocin 20 MG/ML Topical Cream,951536
condition_occurrence during day -365 through 0 days relative to index: Pneumothorax,253796
drug_exposure during day -365 through 0 days relative to index: levocetirizine 2.5 MG / Pseudoephedrine 120 MG Oral Tablet,42956326
drug_era during day -365 through 0 days relative to index: Ramipril,1334456
drug_era group during day -365 through 0 days relative to index: Ramipril,1334456
drug_era during day -365 through 0 days relative to index: Midodrine,1308368
drug_era group during day -365 through 0 days relative to index: Midodrine,1308368
drug_exposure during day -365 through 0 days relative to index: midodrine hydrochloride 2.5 MG,40222923
measurement during day -365 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma --2 hours post XXX challenge,3012064
drug_exposure during day -365 through 0 days relative to index: etizolam 0.5 MG Oral Tablet,42959405
drug_exposure during day -365 through 0 days relative to index: 5 ML iron sucrose 20 MG/ML Injection,35605708
drug_exposure during day -365 through 0 days relative to index: Cefotaxime 2000 MG Injection,46275711
drug_exposure during day -365 through 0 days relative to index: tramadol hydrochloride 50 MG,19134046
drug_era during day -365 through 0 days relative to index: Vasopressin (USP),1507835
drug_era group during day -365 through 0 days relative to index: Vasopressin (USP),1507835
drug_exposure during day -365 through 0 days relative to index: Vasopressin (USP),1507835
measurement during day -365 through 0 days relative to index: Beta-2-Microglobulin [Mass/volume] in Urine,3018081
drug_exposure during day -365 through 0 days relative to index: Naloxone 2 MG,1114261
condition_era group during day -365 through 0 days relative to index: Lesion of esophagus,4113545
drug_exposure during day -365 through 0 days relative to index: capecitabine 500 MG Oral Tablet,19023530
condition_era group during day -365 through 0 days relative to index: Epilepsy,380378
measurement during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Body fluid by Manual count,3003540
drug_exposure during day -365 through 0 days relative to index: Thrombin,1300673
measurement during day -365 through 0 days relative to index: Prostate specific Ag [Mass/volume] in Serum or Plasma,3013603
condition_era group during day -365 through 0 days relative to index: Pain,4329041
condition_era group during day -365 through 0 days relative to index: Space-occupying lesion of nervous system,4094202
condition_era group during day -365 through 0 days relative to index: Arterial embolism,312339
condition_era group during day -365 through 0 days relative to index: Thrombosis of blood vessel,4208466
condition_occurrence during day -365 through 0 days relative to index: Metabolic acidosis,4245042
drug_era during day -365 through 0 days relative to index: Indocyanine Green,19078612
drug_era group during day -365 through 0 days relative to index: Indocyanine Green,19078612
measurement during day -365 through 0 days relative to index: Pain scale [Type],21494994
measurement during day -365 through 0 days relative to index: Microalbumin/Creatinine ratio in urine,2000000330
measurement during day -365 through 0 days relative to index: Aldosterone [Mass/volume] in Serum or Plasma,3011337
condition_era group during day -365 through 0 days relative to index: Inflammation of large intestine,4201402
drug_exposure during day -365 through 0 days relative to index: Lactobacillus helveticus R0052 / Lactobacillus rhamnosus R0011 Oral Capsule,42962852
drug_era during day -365 through 0 days relative to index: Simethicone,966991
drug_era group during day -365 through 0 days relative to index: Simethicone,966991
drug_exposure during day -365 through 0 days relative to index: Doxazosin 2 MG,1363083
drug_exposure during day -365 through 0 days relative to index: Ofloxacin 3 MG/ML Ophthalmic Ointment,43766809
drug_era during day -365 through 0 days relative to index: Lactobacillus helveticus R0052,43008986
drug_era group during day -365 through 0 days relative to index: Lactobacillus helveticus R0052,43008986
drug_era during day -365 through 0 days relative to index: Lactobacillus rhamnosus R0011,43008987
drug_era group during day -365 through 0 days relative to index: Lactobacillus rhamnosus R0011,43008987
drug_exposure during day -365 through 0 days relative to index: tamsulosin 0.200000000000000011 MG Disintegrating Oral Tablet,42931543
observation during day -365 through 0 days relative to index: Fall from bed,436882
measurement during day -365 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,3018677
observation during day -365 through 0 days relative to index: Personal history finding,4143884
drug_era group during day -365 through 0 days relative to index: ANTIDEPRESSANTS,21604686
condition_occurrence during day -365 through 0 days relative to index: Congestive heart failure,319835
condition_era group during day -365 through 0 days relative to index: Congestive heart failure,319835
drug_exposure during day -365 through 0 days relative to index: Bethanechol Chloride 25 MG Oral Tablet,40162835
condition_occurrence during day -365 through 0 days relative to index: Chronic obstructive lung disease,255573
measurement during day -365 through 0 days relative to index: Inhaled oxygen flow rate,3005629
drug_era group during day -365 through 0 days relative to index: Taxanes,21603722
condition_era group during day -365 through 0 days relative to index: Sepsis,132797
condition_era group during day -365 through 0 days relative to index: Organ dysfunction syndrome,4080011
condition_era group during day -365 through 0 days relative to index: Thoughts of self harm,4009713
condition_era group during day -365 through 0 days relative to index: Harmful thoughts,4037303
condition_era group during day -365 through 0 days relative to index: Dangerous and harmful thoughts,4111213
condition_era group during day -365 through 0 days relative to index: Disturbance in thinking,4131797
condition_era group during day -365 through 0 days relative to index: Disturbance in content of thought,4185673
condition_era group during day -365 through 0 days relative to index: Suicidal thoughts,4273391
drug_exposure during day -365 through 0 days relative to index: Amiodarone,1309944
condition_era group during day -365 through 0 days relative to index: Acute inflammatory disease,4134294
condition_era group during day -365 through 0 days relative to index: Motor neuron disease,374631
condition_era group during day -365 through 0 days relative to index: Renal mass,4204187
drug_exposure during day -365 through 0 days relative to index: Phenylephrine / Tropicamide Ophthalmic Solution,40073281
drug_era group during day -365 through 0 days relative to index: CALCIUM HOMEOSTASIS,21602779
drug_era during day -365 through 0 days relative to index: Paclitaxel,1378382
drug_era group during day -365 through 0 days relative to index: Paclitaxel,1378382
condition_era group during day -365 through 0 days relative to index: Upper abdominal pain,4306292
drug_era group during day -365 through 0 days relative to index: Selective serotonin reuptake inhibitors,21604709
condition_era group during day -365 through 0 days relative to index: Edema,433595
condition_occurrence during day -365 through 0 days relative to index: Insomnia,436962
condition_era group during day -365 through 0 days relative to index: Insomnia,436962
condition_era group during day -365 through 0 days relative to index: Disorders of initiating and maintaining sleep,439708
condition_era group during day -365 through 0 days relative to index: Sodium disorder,4048216
condition_occurrence during day -365 through 0 days relative to index: Hyponatremia,4232311
condition_era group during day -365 through 0 days relative to index: Hyponatremia,4232311
drug_exposure during day -365 through 0 days relative to index: Indocyanine Green 25 MG,21062407
condition_occurrence during day -365 through 0 days relative to index: Sepsis due to urinary tract infection,36715430
condition_era group during day -365 through 0 days relative to index: Sepsis due to urinary tract infection,36715430
drug_exposure during day -365 through 0 days relative to index: lafutidine 10 MG,42961124
condition_occurrence during day -365 through 0 days relative to index: Syncope,135360
condition_era group during day -365 through 0 days relative to index: Retinal disorder,378416
condition_era group during day -365 through 0 days relative to index: Choroidal and/or chorioretinal disorder,4116208
drug_era during day -365 through 0 days relative to index: doxofylline,43009019
drug_era group during day -365 through 0 days relative to index: doxofylline,43009019
condition_occurrence during day -365 through 0 days relative to index: Adult health examination,4145333
drug_era group during day -365 through 0 days relative to index: Selective immunosuppressants,21603892
drug_era during day -365 through 0 days relative to index: Bethanechol,937439
drug_era group during day -365 through 0 days relative to index: Bethanechol,937439
drug_era group during day -365 through 0 days relative to index: Choline esters,21604809
drug_exposure during day -365 through 0 days relative to index: Lorazepam 1 MG,792001
drug_era group during day -365 through 0 days relative to index: OTHER ANTIBACTERIALS,21603041
condition_era group during day -365 through 0 days relative to index: Pulmonary edema,4078925
drug_exposure during day -365 through 0 days relative to index: Benserazide 25 MG / Levodopa 100 MG Oral Tablet,789621
"drug_era group during day -365 through 0 days relative to index: Other antiinflammatory and antirheumatic agents, non-steroids",21603998
drug_era during day -365 through 0 days relative to index: Ibandronate,1512480
drug_era group during day -365 through 0 days relative to index: Ibandronate,1512480
drug_exposure during day -365 through 0 days relative to index: Cefuroxime 750 MG,46287418
drug_era during day -365 through 0 days relative to index: Theobromine,19137056
drug_era group during day -365 through 0 days relative to index: Theobromine,19137056
drug_era during day -365 through 0 days relative to index: Cefotaxime,1774470
drug_era group during day -365 through 0 days relative to index: Cefotaxime,1774470
drug_era during day -365 through 0 days relative to index: almagate,43008989
drug_era group during day -365 through 0 days relative to index: almagate,43008989
drug_exposure during day -365 through 0 days relative to index: Cefotaxime 1000 MG,46275704
drug_exposure during day -365 through 0 days relative to index: Fibrinogen 1000 MG,21129644
drug_exposure during day -365 through 0 days relative to index: Donepezil hydrochloride 5 MG Oral Tablet,40223778
condition_era group during day -365 through 0 days relative to index: Edema of trunk,4199409
measurement during day -365 through 0 days relative to index: Tube cuff pressure Intubation tube,3028878
drug_exposure during day -365 through 0 days relative to index: Ranitidine 50 MG/ML,961237
condition_era group during day -365 through 0 days relative to index: Esophageal mass,4103988
condition_era group during day -365 through 0 days relative to index: Neoplasm of esophagus,4130990
condition_era group during day -365 through 0 days relative to index: Malignant tumor of esophagus,4181343
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of stomach,196044
drug_era during day -365 through 0 days relative to index: cefepime,1748975
drug_era group during day -365 through 0 days relative to index: cefepime,1748975
drug_era during day -365 through 0 days relative to index: benproperine,19056541
drug_era group during day -365 through 0 days relative to index: benproperine,19056541
drug_era group during day -365 through 0 days relative to index: Fourth-generation cephalosporins,21602914
condition_era group during day -365 through 0 days relative to index: Lesion of brain,4200516
condition_occurrence during day -365 through 0 days relative to index: Bacterial pneumonia,257315
condition_era group during day -365 through 0 days relative to index: Bacterial pneumonia,257315
condition_occurrence during day -365 through 0 days relative to index: Tooth loss,433244
condition_era group during day -365 through 0 days relative to index: Tooth loss,433244
condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of endocrine gland,4156115
condition_era group during day -365 through 0 days relative to index: Neoplasm of bone marrow,4186405
measurement during day -365 through 0 days relative to index: Erythrocyte sedimentation rate,3015183
measurement during day -365 through 0 days relative to index: Platelet function (closure time) collagen+EPINEPHrine induced [Time] in Blood,3005807
drug_exposure during day -365 through 0 days relative to index: Acyclovir 250 MG,21169993
procedure_occurrence during day -365 through 0 days relative to index: Bone scan,2007462
condition_era group during day -365 through 0 days relative to index: Hematoma of subdural space of neuraxis,42709922
drug_exposure during day -365 through 0 days relative to index: Baclofen 10 MG Oral Tablet,715235
condition_occurrence during day -365 through 0 days relative to index: Diabetic neuropathy,4044391
condition_era group during day -365 through 0 days relative to index: Traumatic AND/OR non-traumatic brain injury,4133611
drug_era during day -365 through 0 days relative to index: pioglitazone,1525215
drug_era group during day -365 through 0 days relative to index: pioglitazone,1525215
drug_era during day -365 through 0 days relative to index: Fibrinogen,19054702
drug_era group during day -365 through 0 days relative to index: Fibrinogen,19054702
drug_era group during day -365 through 0 days relative to index: Thiazolidinediones,21600779
"drug_era group during day -365 through 0 days relative to index: ANTIARRHYTHMICS, CLASS I AND III",21600248
condition_occurrence during day -365 through 0 days relative to index: Cerebral hemorrhage,376713
drug_era during day -365 through 0 days relative to index: sodium sulfate,939976
drug_era group during day -365 through 0 days relative to index: sodium sulfate,939976
procedure_occurrence during day -365 through 0 days relative to index: MRI of cervical spine with contrast,4245419
drug_era during day -365 through 0 days relative to index: Amiodarone,1309944
drug_era group during day -365 through 0 days relative to index: Amiodarone,1309944
"drug_era group during day -365 through 0 days relative to index: Antiarrhythmics, class III",21600269
"drug_era group during day -365 through 0 days relative to index: ANGIOTENSIN II ANTAGONISTS, PLAIN",21601822
"drug_era group during day -365 through 0 days relative to index: Angiotensin II antagonists, plain",21601823
drug_era group during day -365 through 0 days relative to index: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,21601782
measurement during day -365 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma,3016244
drug_era group during day -365 through 0 days relative to index: ANTIBIOTICS FOR TOPICAL USE,21602055
drug_exposure during day -365 through 0 days relative to index: cefepime 1000 MG Injection,46287354
drug_era during day -365 through 0 days relative to index: Ibuprofen,1177480
drug_era group during day -365 through 0 days relative to index: Ibuprofen,1177480
drug_era group during day -365 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,21604034
drug_era group during day -365 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,21604035
"drug_era group during day -365 through 0 days relative to index: Antiinflammatory preparations, non-steroids for topical use",21604036
condition_era group during day -365 through 0 days relative to index: Hematoma,4299449
drug_exposure during day -365 through 0 days relative to index: pyridoxine 500 MG,40242337
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of head,36713289
measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose,3026300
condition_era group during day -365 through 0 days relative to index: Mycosis,433701
condition_occurrence during day -365 through 0 days relative to index: Epigastric pain,197381
drug_exposure during day -365 through 0 days relative to index: Sodium Chloride Nasal Spray,40080090
condition_occurrence during day -365 through 0 days relative to index: Alzheimer's disease,378419
condition_era group during day -365 through 0 days relative to index: Myelopathy due to another disorder,140708
condition_occurrence during day -365 through 0 days relative to index: Abdominal aortic aneurysm,198177
drug_exposure during day -365 through 0 days relative to index: Losartan Potassium 50 MG Oral Tablet,40185304
procedure_occurrence during day -365 through 0 days relative to index: Aneurysm clipping,4167069
condition_occurrence during day -365 through 0 days relative to index: Cardiorespiratory failure,4259490
condition_era group during day -365 through 0 days relative to index: Cardiorespiratory failure,4259490
drug_exposure during day -365 through 0 days relative to index: irbesartan 300 MG Oral Tablet,19022949
condition_era group during day -365 through 0 days relative to index: Acute leukemia,138708
condition_era group during day -365 through 0 days relative to index: Leukemia,317510
condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of bone marrow,4247726
condition_occurrence during day -365 through 0 days relative to index: Cardiac pacemaker in situ,40479553
measurement during day -365 through 0 days relative to index: Glasgow coma score motor,3008223
measurement during day -365 through 0 days relative to index: Glasgow coma score verbal,3009094
measurement during day -365 through 0 days relative to index: Glasgow coma score eye opening,3016335
measurement during day -365 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,3037556
condition_era group during day -365 through 0 days relative to index: Thrombosis,4231363
drug_era during day -365 through 0 days relative to index: Hydrochlorothiazide,974166
drug_era group during day -365 through 0 days relative to index: Hydrochlorothiazide,974166
"drug_era group during day -365 through 0 days relative to index: LOW-CEILING DIURETICS, THIAZIDES",21601462
"drug_era group during day -365 through 0 days relative to index: Thiazides, plain",21601463
measurement during day -365 through 0 days relative to index: Digoxin [Mass/volume] in Serum or Plasma,3011335
drug_exposure during day -365 through 0 days relative to index: sitagliptin 100 MG Oral Tablet,19125041
drug_era group during day -365 through 0 days relative to index: Other antibiotics for topical use,21602061
drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES,21605188
drug_era group during day -365 through 0 days relative to index: Antiinfectives,21605189
drug_era during day -365 through 0 days relative to index: Gentamicin,45892419
drug_era group during day -365 through 0 days relative to index: Gentamicin,45892419
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of head,4181187
drug_exposure during day -365 through 0 days relative to index: Magnesium Sulfate Injection,46275855
drug_era group during day -365 through 0 days relative to index: Carbapenems,21602920
drug_era during day -365 through 0 days relative to index: Dobutamine,1337720
drug_era group during day -365 through 0 days relative to index: Dobutamine,1337720
measurement during day -365 through 0 days relative to index: Left ventricular Cardiac index,21490712
drug_exposure during day -365 through 0 days relative to index: 500 ML Sodium Chloride 9 MG/ML Injection,40221387
drug_exposure during day -365 through 0 days relative to index: prednisolone 5 MG,1550777
drug_era group during day -365 through 0 days relative to index: DRUGS FOR CONSTIPATION,21600531
drug_era group during day -365 through 0 days relative to index: DRUGS FOR CONSTIPATION,21600532
measurement during day -365 through 0 days relative to index: HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,3035962
drug_era group during day -365 through 0 days relative to index: Other antiemetics,21600498
measurement during day -365 through 0 days relative to index: Blood bank,45875997
measurement during day -365 through 0 days relative to index: Inspiratory pause time setting Ventilator,36303489
drug_era during day -365 through 0 days relative to index: Cisplatin,1397599
drug_era group during day -365 through 0 days relative to index: Cisplatin,1397599
drug_era during day -365 through 0 days relative to index: Vancomycin,1707687
drug_era group during day -365 through 0 days relative to index: Vancomycin,1707687
drug_era during day -365 through 0 days relative to index: Dexamethasone,1518254
drug_era group during day -365 through 0 days relative to index: Dexamethasone,1518254
drug_exposure during day -365 through 0 days relative to index: Calcium Gluconate,19037038
measurement during day -365 through 0 days relative to index: Fluid intake oral Estimated,3006552
measurement during day -365 through 0 days relative to index: Pressure support setting Ventilator,3000461
drug_era during day -365 through 0 days relative to index: gabapentin,797399
drug_era group during day -365 through 0 days relative to index: gabapentin,797399
drug_exposure during day -365 through 0 days relative to index: Calcitriol 0.00025 MG,19035662
procedure_occurrence during day -365 through 0 days relative to index: Esophagogastroduodenoscopy,4294382
"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",21600728
drug_exposure during day -365 through 0 days relative to index: Lidocaine 40 MG/ML,19085781
drug_era group during day -365 through 0 days relative to index: INSULINS AND ANALOGUES,21600713
measurement during day -365 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,3007164
measurement during day -365 through 0 days relative to index: Complement C4 [Mass/volume] in Body fluid,3002695
condition_occurrence during day -365 through 0 days relative to index: Spinal stenosis,77079
drug_era during day -365 through 0 days relative to index: Clarithromycin,1750500
drug_era group during day -365 through 0 days relative to index: Clarithromycin,1750500
measurement during day -365 through 0 days relative to index: Complement C3 [Mass/volume] in Serum or Plasma,3000620
drug_era group during day -365 through 0 days relative to index: Other quaternary ammonium compounds,21604077
drug_exposure during day -365 through 0 days relative to index: 20 ML Lidocaine 20 MG/ML Injection,36895687
drug_exposure during day -365 through 0 days relative to index: Ceftazidime 2000 MG,46275519
drug_era during day -365 through 0 days relative to index: lansoprazole,929887
drug_era group during day -365 through 0 days relative to index: lansoprazole,929887
measurement during day -365 through 0 days relative to index: Urinary catheter in situ,4208026
drug_exposure during day -365 through 0 days relative to index: Haloperidol 5 MG/ML,19081398
condition_era group during day -365 through 0 days relative to index: Fracture of vertebral column,4174520
condition_era group during day -365 through 0 days relative to index: Abdominal pain,200219
drug_era during day -365 through 0 days relative to index: pitavastatin,40165636
drug_era group during day -365 through 0 days relative to index: pitavastatin,40165636
condition_occurrence during day -365 through 0 days relative to index: Abdominal pain,200219
drug_era group during day -365 through 0 days relative to index: Xanthines,21603328
measurement during day -365 through 0 days relative to index: Grip strength,4089159
measurement during day -365 through 0 days relative to index: Water intake,4027184
measurement during day -365 through 0 days relative to index: Influenza virus A+B Ag [Presence] in Nasopharynx,3029458
drug_era during day -365 through 0 days relative to index: ropivacaine,1136487
drug_era group during day -365 through 0 days relative to index: ropivacaine,1136487
drug_era during day -365 through 0 days relative to index: Haloperidol,766529
drug_era group during day -365 through 0 days relative to index: Haloperidol,766529
drug_era group during day -365 through 0 days relative to index: Butyrophenone derivatives,21604515
drug_era during day -365 through 0 days relative to index: Urokinase,1307515
drug_era group during day -365 through 0 days relative to index: Urokinase,1307515
condition_occurrence during day -365 through 0 days relative to index: Pre-surgery evaluation,4004516
drug_exposure during day -365 through 0 days relative to index: Cefazolin 2000 MG,46287344
drug_era during day -365 through 0 days relative to index: montelukast,1154161
drug_era group during day -365 through 0 days relative to index: montelukast,1154161
drug_era group during day -365 through 0 days relative to index: Leukotriene receptor antagonists,21603353
condition_occurrence during day -365 through 0 days relative to index: Aphasia,440424
measurement during day -365 through 0 days relative to index: Rewarming time,4090823
"drug_exposure during day -365 through 0 days relative to index: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection",46276277
drug_exposure during day -365 through 0 days relative to index: atorvastatin 10 MG,19122208
measurement during day -365 through 0 days relative to index: DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA),3032250
drug_exposure during day -365 through 0 days relative to index: azelastine 1 MG,42963918
drug_era during day -365 through 0 days relative to index: Risperidone,735979
drug_era group during day -365 through 0 days relative to index: Risperidone,735979
drug_exposure during day -365 through 0 days relative to index: calcium polycarbophil 625 MG,940514
drug_exposure during day -365 through 0 days relative to index: doxofylline 400 MG,42959926
drug_era during day -365 through 0 days relative to index: Insulin Lispro,1550023
drug_era group during day -365 through 0 days relative to index: Insulin Lispro,1550023
drug_era during day -365 through 0 days relative to index: ebastine,19092433
drug_era group during day -365 through 0 days relative to index: ebastine,19092433
procedure_occurrence during day -365 through 0 days relative to index: CT of facial bones without contrast,36713189
drug_exposure during day -365 through 0 days relative to index: 20 ML Ropivacaine hydrochloride 7.5 MG/ML Injection,40173915
condition_era group during day -365 through 0 days relative to index: Pain finding at anatomical site,4132926
drug_exposure during day -365 through 0 days relative to index: 5 ML Levofloxacin 5 MG/ML Ophthalmic Solution,21126995
measurement during day -365 through 0 days relative to index: Erythrocytes.dysmorphic/100 erythrocytes in Urine sediment by Light microscopy,3038315
"drug_exposure during day -365 through 0 days relative to index: Tetanus immune globulin, human 250 UNT/ML",561425
condition_era group during day -365 through 0 days relative to index: Open wound,444187
drug_exposure during day -365 through 0 days relative to index: 1 ML Sodium Chloride 9 MG/ML Irrigation Solution,40717789
drug_exposure during day -365 through 0 days relative to index: almagate 1000 MG,42960902
drug_exposure during day -365 through 0 days relative to index: Gliclazide 30 MG,19102035
condition_occurrence during day -365 through 0 days relative to index: Subarachnoid hemorrhage,432923
drug_era group during day -365 through 0 days relative to index: RESPIRATORY SYSTEM,21605007
drug_era during day -365 through 0 days relative to index: Gliclazide,19059796
drug_era group during day -365 through 0 days relative to index: Gliclazide,19059796
condition_occurrence during day -365 through 0 days relative to index: Hypertensive disorder,316866
condition_era group during day -365 through 0 days relative to index: Intracranial hemorrhage,439847
"drug_era during day -365 through 0 days relative to index: diphtheria toxoid vaccine, inactivated",529303
"drug_era group during day -365 through 0 days relative to index: diphtheria toxoid vaccine, inactivated",529303
"drug_era during day -365 through 0 days relative to index: tetanus toxoid vaccine, inactivated",529411
"drug_era group during day -365 through 0 days relative to index: tetanus toxoid vaccine, inactivated",529411
drug_era group during day -365 through 0 days relative to index: BACTERIAL VACCINES,21601279
drug_era group during day -365 through 0 days relative to index: Diphtheria vaccines,21601288
drug_era group during day -365 through 0 days relative to index: Tetanus vaccines,21601315
drug_era group during day -365 through 0 days relative to index: Other antipsychotics,21604557
drug_era during day -365 through 0 days relative to index: Clindamycin,997881
drug_era group during day -365 through 0 days relative to index: Clindamycin,997881
drug_era group during day -365 through 0 days relative to index: Antiinfectives for treatment of acne,21602304
drug_era group during day -365 through 0 days relative to index: Lincosamides,21602984
"drug_era group during day -365 through 0 days relative to index: ANESTHETICS, GENERAL",21604182
drug_era during day -365 through 0 days relative to index: Tetanus immune globulin,35604680
drug_era group during day -365 through 0 days relative to index: Tetanus immune globulin,35604680
condition_era group during day -365 through 0 days relative to index: Hemorrhage of intracranial meningeal space,42873123
drug_era group during day -365 through 0 days relative to index: VACCINES,21601278
condition_era group during day -365 through 0 days relative to index: Hemorrhage into subdural space of neuraxis,42709921
drug_era group during day -365 through 0 days relative to index: Specific immunoglobulins,21601258
condition_era group during day -365 through 0 days relative to index: Hemorrhage into meningeal space of neuraxis,42873124
drug_exposure during day -365 through 0 days relative to index: pitavastatin Oral Tablet,40165649
condition_occurrence during day -365 through 0 days relative to index: Blood in urine,437038
drug_era group during day -365 through 0 days relative to index: ANESTHETICS,21604181
condition_era group during day -365 through 0 days relative to index: Respiratory arrest,317109
"procedure_occurrence during day -365 through 0 days relative to index: MRI of cervical, thoracic, and lumbar spine with contrast",36713268
measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,3022250
drug_era during day -365 through 0 days relative to index: Rifampin,1763204
drug_era group during day -365 through 0 days relative to index: Rifampin,1763204
drug_era group during day -365 through 0 days relative to index: Antibiotics,21603095
drug_era group during day -365 through 0 days relative to index: Preparations inhibiting uric acid production,21604130
drug_era during day -365 through 0 days relative to index: levosulpiride,43009023
drug_era group during day -365 through 0 days relative to index: levosulpiride,43009023
drug_era during day -365 through 0 days relative to index: Clavulanate,1759842
drug_era group during day -365 through 0 days relative to index: Clavulanate,1759842
drug_exposure during day -365 through 0 days relative to index: Aspirin,1112807
procedure_occurrence during day -365 through 0 days relative to index: External drainage procedure from ventricle of brain,4045461
drug_era during day -365 through 0 days relative to index: Streptodornase,19136184
drug_era group during day -365 through 0 days relative to index: Streptodornase,19136184
drug_era during day -365 through 0 days relative to index: Streptokinase,19136187
drug_era group during day -365 through 0 days relative to index: Streptokinase,19136187
condition_era group during day -365 through 0 days relative to index: Chronic disease of musculoskeletal system,4134133
drug_exposure during day -365 through 0 days relative to index: Carboxymethylcellulose Sodium 5 MG/ML Ophthalmic Solution,40243494
drug_exposure during day -365 through 0 days relative to index: gabapentin 100 MG Oral Capsule,19077547
condition_era group during day -365 through 0 days relative to index: Cholangitis,195856
drug_exposure during day -365 through 0 days relative to index: 20 ML Ammonium Chloride 10 MG/ML / Chlorpheniramine 0.149999999999999994 MG/ML / dihydrocodeine 0.5 MG/ML / methylephedrine 1.31000000000000005 MG/ML Oral Suspension,42920399
drug_era group during day -365 through 0 days relative to index: Other psychostimulants and nootropics,21604768
measurement during day -365 through 0 days relative to index: Infusion pump Communication status,21490898
measurement during day -365 through 0 days relative to index: Infusion dose.programmed [Mass] Infusion pump,21490922
drug_exposure during day -365 through 0 days relative to index: Fluconazole 50 MG,1755077
condition_era group during day -365 through 0 days relative to index: Mood disorder,444100
drug_era during day -365 through 0 days relative to index: Ammonium Chloride,912362
drug_era group during day -365 through 0 days relative to index: Ammonium Chloride,912362
drug_era during day -365 through 0 days relative to index: dihydrocodeine,1189596
drug_era group during day -365 through 0 days relative to index: dihydrocodeine,1189596
drug_era group during day -365 through 0 days relative to index: Acidifiers,21602629
drug_era during day -365 through 0 days relative to index: methylephedrine,35604767
drug_era group during day -365 through 0 days relative to index: methylephedrine,35604767
drug_exposure during day -365 through 0 days relative to index: Paclitaxel 30 MG Injection,42937770
measurement during day -365 through 0 days relative to index: Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence,3032077
drug_era group during day -365 through 0 days relative to index: ANTI-PARATHYROID AGENTS,21602785
drug_era during day -365 through 0 days relative to index: pneumococcal capsular polysaccharide type 23F vaccine,40163692
drug_era group during day -365 through 0 days relative to index: pneumococcal capsular polysaccharide type 23F vaccine,40163692
drug_exposure during day -365 through 0 days relative to index: Ethambutol Hydrochloride 400 MG Oral Tablet,40222616
drug_exposure during day -365 through 0 days relative to index: Naloxone 5 MG / Oxycodone 10 MG Oral Tablet,41240924
measurement during day -365 through 0 days relative to index: Helminth identified in Unspecified specimen,3007286
drug_exposure during day -365 through 0 days relative to index: Pyrazinamide 500 MG,19100017
drug_exposure during day -365 through 0 days relative to index: Paclitaxel 6 MG/ML,1378386
condition_era group during day -365 through 0 days relative to index: Cyst of abdomen,40486024
drug_exposure during day -365 through 0 days relative to index: Naloxone 10 MG / Oxycodone 20 MG Oral Tablet,41021908
drug_exposure during day -365 through 0 days relative to index: Doxycycline Monohydrate 100 MG Oral Tablet,46233710
drug_era during day -365 through 0 days relative to index: Ethambutol,1749301
drug_era group during day -365 through 0 days relative to index: Ethambutol,1749301
drug_era group during day -365 through 0 days relative to index: Other drugs for treatment of tuberculosis,21603109
condition_occurrence during day -365 through 0 days relative to index: Primary malignant neoplasm of stomach,196044
drug_exposure during day -365 through 0 days relative to index: Rifampin 150 MG,1763295
measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection,3002482
drug_era during day -365 through 0 days relative to index: xanthine,42900552
drug_era group during day -365 through 0 days relative to index: xanthine,42900552
"drug_era during day -365 through 0 days relative to index: Insulin, Protamine Lispro, Human",1513876
"drug_era group during day -365 through 0 days relative to index: Insulin, Protamine Lispro, Human",1513876
drug_era during day -365 through 0 days relative to index: Pyrazinamide,1759455
drug_era group during day -365 through 0 days relative to index: Pyrazinamide,1759455
drug_era during day -365 through 0 days relative to index: Isosorbide Dinitrate,1383925
drug_era group during day -365 through 0 days relative to index: Isosorbide Dinitrate,1383925
condition_era group during day -365 through 0 days relative to index: Heart valve regurgitation,4230774
procedure_occurrence during day -365 through 0 days relative to index: CT angiography of neck and chest and abdomen,36713032
condition_era group during day -365 through 0 days relative to index: Mitral valve disorder,319843
drug_era group during day -365 through 0 days relative to index: Other general anesthetics,21604208
drug_exposure during day -365 through 0 days relative to index: meropenem 1000 MG Injection,35606006
"drug_era group during day -365 through 0 days relative to index: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",21602681
measurement during day -365 through 0 days relative to index: Train of four count,4353950
drug_exposure during day -365 through 0 days relative to index: Hydroxyzine 10 MG,777330
drug_era during day -365 through 0 days relative to index: fexofenadine,1153428
drug_era group during day -365 through 0 days relative to index: fexofenadine,1153428
drug_exposure during day -365 through 0 days relative to index: Magnesium Oxide 500 MG,993741
drug_era during day -365 through 0 days relative to index: Ambroxol,19088167
drug_era group during day -365 through 0 days relative to index: Ambroxol,19088167
condition_era group during day -365 through 0 days relative to index: Lymphoproliferative disorder,4079147
condition_era group during day -365 through 0 days relative to index: Lymphoreticular tumor,4173971
drug_era group during day -365 through 0 days relative to index: ANTI-PARKINSON DRUGS,21604443
drug_exposure during day -365 through 0 days relative to index: Lamivudine 100 MG,1704216
drug_era group during day -365 through 0 days relative to index: DOPAMINERGIC AGENTS,21604462
measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis stimulated gamma interferon and spot count panel - Blood,44786924
condition_occurrence during day -365 through 0 days relative to index: Early gastric cancer,4174763
condition_era group during day -365 through 0 days relative to index: Early gastric cancer,4174763
condition_era group during day -365 through 0 days relative to index: Seizure,377091
drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE,21602722
"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",21602723
drug_era group during day -365 through 0 days relative to index: Glucocorticoids,21602728
drug_era group during day -365 through 0 days relative to index: OTHER BETA-LACTAM ANTIBACTERIALS,21602868
drug_exposure during day -365 through 0 days relative to index: Ramipril 2.5 MG Oral Tablet,1334461
condition_era group during day -365 through 0 days relative to index: Bacterial gastroenteritis,4167082
condition_era group during day -365 through 0 days relative to index: Bacterial gastrointestinal infectious disease,4193166
drug_era group during day -365 through 0 days relative to index: Folic acid analogues,21601422
condition_era group during day -365 through 0 days relative to index: Bronchitis,256451
condition_occurrence during day -365 through 0 days relative to index: Vascular insufficiency of intestine,192673
condition_era group during day -365 through 0 days relative to index: Disease due to Gram-negative bacteria,435742
condition_occurrence during day -365 through 0 days relative to index: Sputum,4164116
condition_era group during day -365 through 0 days relative to index: Mass of soft tissue,40481517
drug_exposure during day -365 through 0 days relative to index: tiotropium 0.018 MG Inhalation Powder,19112761
condition_occurrence during day -365 through 0 days relative to index: Intestinal obstruction,193518
condition_era group during day -365 through 0 days relative to index: Anxiety,441542
drug_exposure during day -365 through 0 days relative to index: Propranolol Hydrochloride 10 MG,40163311
drug_era during day -365 through 0 days relative to index: Riluzole,735951
drug_era group during day -365 through 0 days relative to index: Riluzole,735951
drug_exposure during day -365 through 0 days relative to index: Riluzole 50 MG,735974
drug_era group during day -365 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,21604838
drug_era group during day -365 through 0 days relative to index: Other nervous system drugs,21604840
condition_occurrence during day -365 through 0 days relative to index: Late gastric cancer,4174764
condition_era group during day -365 through 0 days relative to index: Late gastric cancer,4174764
condition_era group during day -365 through 0 days relative to index: Tomography abnormal,4058326
condition_occurrence during day -365 through 0 days relative to index: Tomography - chest abnormal,4060492
condition_era group during day -365 through 0 days relative to index: Tomography - chest abnormal,4060492
drug_era group during day -365 through 0 days relative to index: AMINOGLYCOSIDE ANTIBACTERIALS,21602990
condition_era group during day -365 through 0 days relative to index: Hypopituitarism,4254542
drug_era during day -365 through 0 days relative to index: entacapone,782211
drug_era group during day -365 through 0 days relative to index: entacapone,782211
drug_era group during day -365 through 0 days relative to index: Other dopaminergic agents,21604485
drug_exposure during day -365 through 0 days relative to index: Mirtazapine 15 MG Oral Tablet,725178
drug_exposure during day -365 through 0 days relative to index: Proparacaine hydrochloride 5 MG/ML Ophthalmic Solution,40243589
condition_era group during day -365 through 0 days relative to index: Spasm,140821
drug_exposure during day -365 through 0 days relative to index: Amoxicillin 500 MG / Clavulanate 125 MG Oral Tablet,1713694
drug_exposure during day -365 through 0 days relative to index: xanthine,42900552
condition_era group during day -365 through 0 days relative to index: Senile dementia,4048875
"condition_era group during day -365 through 0 days relative to index: Primary degenerative dementia of the Alzheimer type, senile onset",4220313
condition_occurrence during day -365 through 0 days relative to index: Muscle pain,442752
condition_era group during day -365 through 0 days relative to index: Helicobacter-associated disease,440321
condition_era group during day -365 through 0 days relative to index: Alzheimer's disease,378419
condition_occurrence during day -365 through 0 days relative to index: Parkinson's disease,381270
condition_era group during day -365 through 0 days relative to index: Parkinson's disease,381270
condition_era group during day -365 through 0 days relative to index: Proliferative retinopathy with diabetes mellitus,380096
condition_era group during day -365 through 0 days relative to index: Proliferative retinopathy,45757798
measurement during day -365 through 0 days relative to index: Vital signs,3028553
measurement during day -365 through 0 days relative to index: Pain assessment panel,3035819
condition_era group during day -365 through 0 days relative to index: Bile duct proliferation,4068261
condition_era group during day -365 through 0 days relative to index: Abdominal discomfort,4183041
drug_era during day -365 through 0 days relative to index: alverine,19030751
drug_era group during day -365 through 0 days relative to index: alverine,19030751
measurement during day -365 through 0 days relative to index: Post Anesthetic Recovery score,37204082
measurement during day -365 through 0 days relative to index: Ambulation,42529380
drug_era during day -365 through 0 days relative to index: pemetrexed,1304919
drug_era group during day -365 through 0 days relative to index: pemetrexed,1304919
condition_era group during day -365 through 0 days relative to index: Chronic gastritis,4225273
drug_exposure during day -365 through 0 days relative to index: 3 ML ibandronic acid 1 MG/ML Injection,40174360
condition_era group during day -365 through 0 days relative to index: Muscle pain,442752
drug_exposure during day -365 through 0 days relative to index: Alprostadil 0.01 MG,35603369
drug_era during day -365 through 0 days relative to index: Enalapril,1341927
drug_era group during day -365 through 0 days relative to index: Enalapril,1341927
condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the eye,444207
drug_era during day -365 through 0 days relative to index: leflunomide,1101898
drug_era group during day -365 through 0 days relative to index: leflunomide,1101898
condition_era group during day -365 through 0 days relative to index: Open wound of face,4049957
condition_era group during day -365 through 0 days relative to index: Facial laceration,4156265
condition_era group during day -365 through 0 days relative to index: Comfort alteration,4036154
condition_era group during day -365 through 0 days relative to index: Discomfort,4090431
drug_era group during day -365 through 0 days relative to index: Amino acids,21601215
drug_exposure during day -365 through 0 days relative to index: alanylglutamine,42904285
drug_era during day -365 through 0 days relative to index: alanylglutamine,42904285
drug_era group during day -365 through 0 days relative to index: alanylglutamine,42904285
condition_occurrence during day -365 through 0 days relative to index: Facial laceration,4156265
drug_era during day -365 through 0 days relative to index: Finasteride,996416
drug_era group during day -365 through 0 days relative to index: Finasteride,996416
condition_occurrence during day -365 through 0 days relative to index: Perforation of colon,4177183
condition_era group during day -365 through 0 days relative to index: Perforation of colon,4177183
condition_occurrence during day -365 through 0 days relative to index: Multiple system atrophy,4044053
condition_era group during day -365 through 0 days relative to index: Multiple system atrophy,4044053
measurement during day -365 through 0 days relative to index: 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma,40765040
condition_era group during day -365 through 0 days relative to index: Mycobacteriosis,440631
drug_era during day -365 through 0 days relative to index: myrtol,19018433
drug_era group during day -365 through 0 days relative to index: myrtol,19018433
condition_era group during day -365 through 0 days relative to index: Retroperitoneal cyst,4342885
condition_era group during day -365 through 0 days relative to index: Infection caused by Actinomycetales,36715956
measurement during day -365 through 0 days relative to index: Free Hemoglobin [Mass/volume] in Plasma,3022493
"drug_era group during day -365 through 0 days relative to index: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",21600810
drug_era group during day -365 through 0 days relative to index: Vitamin D and analogues,21600815
drug_era during day -365 through 0 days relative to index: Chlorpheniramine,1192710
drug_era group during day -365 through 0 days relative to index: Chlorpheniramine,1192710
drug_era group during day -365 through 0 days relative to index: Substituted alkylamines,21603458
drug_era during day -365 through 0 days relative to index: Etomidate,19050488
drug_era group during day -365 through 0 days relative to index: Etomidate,19050488
drug_exposure during day -365 through 0 days relative to index: Zolpidem tartrate 10 MG,744795
drug_exposure during day -365 through 0 days relative to index: Levetiracetam 500 MG Oral Tablet,711589
drug_era group during day -365 through 0 days relative to index: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,21603327
drug_era during day -365 through 0 days relative to index: Cephradine,1786842
drug_era group during day -365 through 0 days relative to index: Cephradine,1786842
condition_era group during day -365 through 0 days relative to index: System disorder of the nervous system,4041681
index year: 2003,0
condition_era group during day -365 through 0 days relative to index: Movement disorder,372604
condition_era group during day -365 through 0 days relative to index: Central nervous system complication,373087
drug_era during day -365 through 0 days relative to index: Pancuronium,19026674
drug_era group during day -365 through 0 days relative to index: Pancuronium,19026674
drug_exposure during day -365 through 0 days relative to index: Pancuronium Injection,1718612
drug_era during day -365 through 0 days relative to index: Ketorolac,1136980
drug_era group during day -365 through 0 days relative to index: Ketorolac,1136980
"drug_era group during day -365 through 0 days relative to index: Antiinflammatory agents, non-steroids",21603638
drug_exposure during day -365 through 0 days relative to index: alginic acid,19030059
drug_era during day -365 through 0 days relative to index: ibudilast,43009091
drug_era group during day -365 through 0 days relative to index: ibudilast,43009091
condition_era group during day -365 through 0 days relative to index: Pelvic mass,201131
"drug_exposure during day -365 through 0 days relative to index: 50 ML Immunoglobulin G, Human 50 MG/ML Injection",40220546
condition_era group during day -365 through 0 days relative to index: Fracture of bones of trunk,4279139
drug_era during day -365 through 0 days relative to index: Amikacin,1790868
drug_era group during day -365 through 0 days relative to index: Amikacin,1790868
drug_era group during day -365 through 0 days relative to index: Other aminoglycosides,21602994
condition_occurrence during day -365 through 0 days relative to index: Cerebral infarction,443454
condition_era group during day -365 through 0 days relative to index: Hyperlipidemia,432867
condition_era group during day -365 through 0 days relative to index: Lipids abnormal,4042056
condition_era group during day -365 through 0 days relative to index: Increased lipid,4051221
drug_exposure during day -365 through 0 days relative to index: 20 ML Sodium Chloride 9 MG/ML Injection,40221390
condition_era group during day -365 through 0 days relative to index: Chest injury,4094683
drug_era group during day -365 through 0 days relative to index: ANTACIDS,21600047
drug_era during day -365 through 0 days relative to index: Magnesium Oxide,993631
drug_era group during day -365 through 0 days relative to index: Magnesium Oxide,993631
drug_era group during day -365 through 0 days relative to index: Magnesium compounds,21600048
drug_era during day -365 through 0 days relative to index: erdosteine,19058933
drug_era group during day -365 through 0 days relative to index: erdosteine,19058933
drug_era during day -365 through 0 days relative to index: sevelamer,952004
drug_era group during day -365 through 0 days relative to index: sevelamer,952004
measurement during day -365 through 0 days relative to index: Pain frequency [Minimum Data Set],3045901
measurement during day -365 through 0 days relative to index: IgM [Mass/volume] in Serum or Plasma,3028026
drug_era during day -365 through 0 days relative to index: Amoxicillin,1713332
drug_era group during day -365 through 0 days relative to index: Amoxicillin,1713332
measurement during day -365 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,3005719
"measurement during day -365 through 0 days relative to index: Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)",3049187
drug_era during day -365 through 0 days relative to index: calcium acetate,951469
drug_era group during day -365 through 0 days relative to index: calcium acetate,951469
condition_era group during day -365 through 0 days relative to index: Acute respiratory disease,4006969
drug_era group during day -365 through 0 days relative to index: Other immunosuppressants,21603926
drug_exposure during day -365 through 0 days relative to index: sevelamer hydrochloride 800 MG Oral Tablet,40163383
drug_exposure during day -365 through 0 days relative to index: Sucralfate 250 MG,42955238
drug_exposure during day -365 through 0 days relative to index: Acetylcarnitine 500 MG Oral Tablet,19107043
drug_era during day -365 through 0 days relative to index: Methotrexate,1305058
drug_era group during day -365 through 0 days relative to index: Methotrexate,1305058
condition_occurrence during day -365 through 0 days relative to index: Sepsis,132797
condition_era group during day -365 through 0 days relative to index: Disease due to Alphaherpesvirinae,4249437
drug_exposure during day -365 through 0 days relative to index: isoconazole 10 MG/ML Topical Cream,19003498
condition_era group during day -365 through 0 days relative to index: Parasomnia,440087
drug_exposure during day -365 through 0 days relative to index: Flumazenil 0.1 MG/ML Injection,36892710
condition_occurrence during day -365 through 0 days relative to index: Chill,434490
condition_era group during day -365 through 0 days relative to index: Chill,434490
condition_era group during day -365 through 0 days relative to index: Shivering or rigors,4087630
condition_era group during day -365 through 0 days relative to index: Post-viral disorder,444205
condition_occurrence during day -365 through 0 days relative to index: Proliferative retinopathy with diabetes mellitus,380096
measurement during day -365 through 0 days relative to index: Legionella sp DNA [Identifier] in Unspecified specimen by NAA with probe detection,3033068
condition_occurrence during day -365 through 0 days relative to index: Herpes zoster,443943
condition_era group during day -365 through 0 days relative to index: Herpes zoster,443943
condition_era group during day -365 through 0 days relative to index: Varicella-zoster virus infection,4206579
drug_era group during day -365 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,21603311
drug_exposure during day -365 through 0 days relative to index: Succinylcholine 200 MG,42970663
drug_era during day -365 through 0 days relative to index: modafinil,710650
drug_era group during day -365 through 0 days relative to index: modafinil,710650
drug_exposure during day -365 through 0 days relative to index: olanzapine 5 MG Oral Tablet,19079154
